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UNDERSTANDING THE MECHANISM OF GENOMIC INSTABILITY  
DURING REPLICATIVE AGING IN BUDDING YEAST  
 
Sangita Pal, M.S. 
 
Advisory Professor: Jessica K. Tyler, Ph.D. 
 
Aging brings a gradual decline in molecular fidelity and biological 
functionality, resulting in age related phenotypes and diseases. Despite 
continued efforts to uncover the conserved aging pathways among eukaryotes, 
exact molecular causes of aging are still poorly understood. One of the most 
important hallmarks of aging is increased genomic instability. However, there 
remains much ambiguity as to the cause. I am studying the replicative life span 
(RLS) of the genetically tractable model organism Saccharomyces cerevisiae, or 
budding yeast using the innovative “mother enrichment program” as the method 
to isolate unparalleled numbers of aged yeast cells to investigate the molecular 
changes associated with aging. My goal is to determine the possible causes of 
loss of genomic integrity during replicative aging in budding yeast to gain 
potential insight into this vastly complex process. 
In my work presented here, I uncovered a global loss of cohesion in 
mitotically aged yeast cells and this most likely serves as the cause of increased 
rDNA instability and/or ERC accumulation as observed during aging. These 
events, in turn, influence the global genomic integrity in replicatively aged cells. 
	   ix 
Furthermore, I discovered a profound defect in double strand break (DSB) repair 
with aging due to limiting levels of key components of the homologous 
recombination machinery. This DSB repair defect in old cells limited the 
replicative lifespan, because restoration of DSB repair by overexpressing key HR 
proteins ameliorated age-associated changes, to extend lifespan. We propose 
that the limiting levels of repair factors and cohesin proteins impair the ability of 
the aged cells to counteract the increased burden of genomic damage 
accumulation coupled with chromosomal rearrangements and potentially 
chromosome loss, eventually to cross a threshold of genomic damage that is 
sensed by the cell to cause cessation of cell division marking the end of the 
replicative lifespan.  
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CHAPTER 1: INTRODUCTION 
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Some parts of this chapter are based upon our published review: Pal, S., and 
Tyler, J.K. (2016). “Epigenetics and aging”. Science Advances 2, e1600584. 
Copyright permission is not required as the copyright policy for this article 
published in the journal of Science Advances states that “This is an open-access 
article distributed under the terms of the Creative Commons Attribution-
NonCommercial license, which permits use, distribution, and reproduction in any 
medium, so long as the resultant use is not for commercial advantage and 
provided the original work is properly cited.” 
 
1.1. General overview of the aging process  
In general, propagation of any given organism primarily depends on either 
forever maintaining its cellular homeostasis or effectively renewing the population 
with healthy young individuals. Nature primarily selected for the latter option 
throughout evolution and potentially selected against any organism living forever. 
Aging is a complex multi-factorial biological process that is an inevitable outcome 
of life and is universally shared by all organisms. Generally, organismal health is 
directly proportional to the overall fitness of its organs, tissues, cells and finally 
biological macromolecules. It is characterized by a progressive decline of 
molecular, cellular, physiological and organismal function in a time-dependent 
manner. As an organism ages, its ability to retain normal cellular functions starts 
to decline, and susceptibility to diseases and other environmental stresses rises 
strikingly. How this functional decline initiates during organismal aging remains 
elusive till now. Understanding the molecular details of organismal aging thus  
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Figure 1. Decline of cellular functions and accumulation of cellular damage 
with aging. A simplified model illustrates that maintenance of proper cellular 
homeostasis in young cells is imperative to maintain proper health. However, 
with aging functional deteriorations of different cellular functions together with 
increased accumulation of cellular damage leads to altered cellular homeostasis 
resulting in increased susceptibility to different age-associated conditions, 
including cancer, metabolic disorders, cardiovascular diseases and 
neurodegenerative disorders. 
 
 
 
 
 
Figure 1 
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holds significant importance for human health because aging serves as the 
greatest risk factor for development of many diseases including cancer, 
metabolic disorders such as diabetes, cardiovascular disorders, 
neurodegenerative diseases and many others (Fig. 1) (1-8). Although the causes 
of aging are poorly understood, there are continued efforts to delineate longevity 
pathways conserved among all eukaryotes effectively linking physiology with 
signal transduction and genetic regulations to mediate extension of health and 
lifespan. 
 
1.2. Hallmarks of aging 
Over the past years, great strides have been made by numerous groups in 
the aging research field that efficiently categorized the cellular and molecular 
hallmarks of aging (9). These nine hallmarks are generally considered to be the 
pillars greatly contributing to and determining the aging process (Fig. 2). In order 
to be considered as a hallmark of aging, these candidates needed to be fulfilling 
the following criteria: that this event happens during normal aging, experimentally 
worsening this event would accelerate the natural aging process and 
experimental improvement of this event delays onset of aging to extend natural 
lifespan (9). Although some of these hallmarks are specific for metazoans, the 
majority of them are conserved in all eukaryotic organisms from yeast to humans, 
including epigenetic alterations and genomic instability (Fig. 3), which will be 
further elaborated here.  
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Figure 2. Hallmarks of aging. Schematic representation of nine known 
hallmarks of aging in multicellular eukaryotes, while some of them are conserved 
across species to unicellular eukaryotes also. The nine hallmarks are further 
grouped into three categories of primary, antagonistic and integrative hallmarks 
of aging. Epigenetic alterations and genomic instability are conserved aging 
hallmarks in multiple organisms and here are categorized as primary hallmarks of 
aging, i.e. those that serve as the drivers of aging. (Adapted from: Lopez-Otin, 
C., M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer. 2013. The hallmarks 
of aging. Cell 153: 1194-1217. The figure is used with permission from Elsevier 
under the license number 4091620498639) 
Figure 2_v4 
Primary 
hallmarks 
Antagonistic 
hallmarks 
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Figure 3. Epigenetic alterations and genomic instability during aging. While 
in young individuals cells maintain uniformity in their epigenetic information and 
also a stable genome, during aging exposures to different exogenous and 
endogenous factors result in abnormal chromatin states coupled with increased 
genomic instability. (Adapted from: Pal, S., and J. K. Tyler. 2016. Epigenetics 
and aging. Science advances 2: e1600584) 
 
 
 
 
 
 
 
Figure 3 
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1.2.1. Epigenetic changes during aging 
Among these hallmarks, epigenetic alterations represent one crucial 
mechanism behind the deteriorated cellular functions observed during aging and 
in age-related disorders. By definition, epigenetics represents the reversible 
heritable mechanisms that occur without any alteration of the underlying DNA 
sequence. Although the chromosomes in our genome carry the genetic 
information, the epigenome is responsible for the functional use and stability of 
that valuable information. In other words, it connects the genotype with the 
phenotype (10-13). These epigenetic changes can either be spontaneous or 
driven by external or internal influences. Epigenetics potentially serves as the 
missing link to explain why the pattern of aging is different between two 
genetically identical individuals, such as identical twins or in the animal kingdom 
between animals with identical genetic make-up, such as queen bees and worker 
bees (2, 14, 15). Though longevity studies in the human population have shown 
that genetic factors could explain a fraction (20-30%) of the differences observed 
in the lifespans of monozygotic twins, the majority of the remainder of variation is 
thought to have arisen through epigenetic drift during their lifetime (11, 12, 14, 
16, 17). Similarly, different environmental stimuli including diet cause differential 
alterations of stored epigenetic information to create a striking contrast in 
physical appearance, reproductive behavior, and lifespan in queen and worker 
honeybees, despite their identical DNA content (18). The resulting variability in 
the pattern of epigenetic information within individual cells in the population 
during aging, in turn, leads to transcriptional drift and genomic instability. Being 
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established by enzymes, epigenetic information is reversible. As such, 
epigenetics holds great prospects for targeting by therapeutic interventions, 
which may potentially lead the way to the development of novel therapeutic 
approaches to delay aging and age-related diseases.  
There are different types of epigenetic information encoded within our 
epigenome, including but not limited to the presence or absence of histones on 
any particular DNA sequence, DNA methylation, chromatin remodeling, post-
translational modifications of the histone proteins, structural and functional 
variants of histones, and transcription of non-coding RNAs (ncRNAs) (2, 4, 12). 
These different types of epigenetic information together comprise our epigenome 
and are important determining factors behind the function and fate of all cells and 
tissues, in uni- and multi-cellular organisms. Invariably, each of these different 
types of epigenetic information is functionally significant for the process of aging. 
Growing evidence in recent years also clearly implicates chromatin structure, 
which carries much of the epigenetic information, as a major player during the 
aging process. The basic unit of chromatin structure is the nucleosome, which 
consists of 147 bp of DNA wrapped around a histone octamer that comprises two 
copies of each core histone protein, H2A, H2B, H3 and H4 (19, 20). The addition 
of linker histones, such as histone H1, and other non-histone proteins, such as 
heterochromatin protein 1 (HP1), facilitate the formation of higher-order 
repressive chromatin structures, such as heterochromatin (21). The packaging of 
the genomic DNA into the highly organized chromatin structure regulates all 
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genomic processes in the nucleus including DNA replication, transcription, 
recombination and DNA repair, by controlling access to the DNA (4).  
Studies in humans and the powerful models of aging are revealing that, 
similar to all other biological structures inside the cells, the epigenome suffers 
from a progressive loss in its configuration during aging. This results in a 
profound change in the chromosomal architecture, genomic integrity and gene 
expression patterns (2, 12). Where examined, these effects are mostly 
conserved all the way from single-celled organisms such as budding yeast to 
complex multicellular eukaryotes. These conserved mechanisms help us gain a 
clearer picture of the aging process. 
 
The heterochromatin loss model of aging 
One of the earlier proposed models of aging was “the heterochromatin 
loss model of aging” (22, 23). This model suggests that the loss of 
heterochromatin that accompanies aging leads to changes in global nuclear 
architecture and expression of genes residing in those regions, directly or 
indirectly causing aging and cellular senescence. As with any other model of 
aging, the heterochromatin loss model is supported by experimental data, but 
there are also confounding observations. Loss of transcriptional silencing, due to 
decay of the heterochromatin, occurs during aging in all eukaryotes examined 
from yeast to humans (22-26), and there is evidence that accelerating or 
reversing this process can either shorten or lengthen lifespan, respectively (Fig. 
2). Gene silencing requires the absence of histone acetylation within 
 10 
heterochromatin regions. Accordingly, treatment with histone deacetylase 
(HDAC) inhibitors or deletion of genes encoding HDACs, such as yeast SIR2 or 
its sirtuin counterparts in metazoan species, shortens lifespan while chemical 
activation or overexpression of SIR2 / sirtuins extends lifespan (27, 28). Yeast 
Sir2 was first recognized as an H4 K16Ac deacetylase, while mammalian SIRT1 
is an H3 K9Ac / H4 K16Ac deacetylase (27). However, it is now appreciated that 
sirtuins do not just deacetylate histones, but also many other transcriptional 
regulators and indeed their roles in aging extend far beyond heterochromatin, 
including genome maintenance (29). It has been observed previously in budding 
yeast that redistribution of Sir proteins from the silent mating type loci to sites of 
increased genomic instability during aging causes loss of silencing from 
heterochromatic mating type loci to cause sterility and to promote aging (30). 
Similarly, the mammalian homolog of Sir2, SIRT1, has been shown to repress 
repetitive elements and other regions across the mouse genome. However, in 
response to DNA damage, SIRT1 is redistributed from these loci to DNA breaks, 
resulting in alterations in gene expression that is comparable to those in the 
aging mice brain (29). Therefore, repression of heterochromatic repeat elements 
seems to be evolutionarily conserved and extremely critical in lifespan 
maintenance (29, 31). Another example where it is clear that loss of 
heterochromatin promotes aging is at the rDNA locus, where loss of silencing of 
the rDNA promotes genomic instability and aging in budding yeast (32, 33). 
Further evidence supporting the heterochromatin loss theory comes from the 
analysis of chromatin structures from Hutchinson-Gilford Progeria Syndrome 
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(HGPS) patients and most recently from a Werner syndrome stem cell model of 
premature aging (12, 34-37). These disorders exemplify how the deregulation of 
heterochromatin, illustrated by global loss of heterochromatin marks (discussed 
more below) and altered heterochromatin structure, accelerates aging. Although 
some of the defects observed in premature aging patients have also been 
observed in aged individuals (35), it is still debatable whether the findings are 
equally applicable to physiological aging.  
 
Global histone protein reduction during aging 
Recently, the aging research field has experienced a leap from the earlier 
paradigm of the heterochromatin loss model. Not only is the heterochromatin 
reorganized during aging, but in addition, a global loss of core histone proteins 
from the genome during aging has been observed in multiple scenarios, and this 
has been shown to be a cause of aging in yeast. In budding yeast, replicative 
aging is accompanied by loss of approximately half of the core histone proteins 
(38, 39). The extensive nucleosome loss from the entire yeast genome during 
replicative aging results in globally increased transcription in aged cells (40). 
These global changes in transcription and chromatin structure were only 
detectable due to the development of novel normalization approaches for 
genomic datasets (41). Notably, during yeast replicative aging, not only 
transcriptionally silent regions showed dramatic de-repression, but all genomic 
regions showed transcriptional up-regulation, presumably due to increased 
access of the transcription machinery to the DNA sequences (40). The drastic 
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decline of the core histone proteins in S. cerevisiae is due to reduced protein 
synthesis of the histones (38). Clearly, the fact that the levels of histone 
transcripts, like all other transcripts, actually increase during replicative aging in 
yeast (38, 39, 42) has no functional consequence because of the reduced 
histone protein synthesis in old yeast. Other cells may indeed use transcriptional 
regulation to reduce histone levels during aging because quiescent muscle stem 
cell aging is accompanied by reduced histone transcript levels (43). Supply of 
extra histone H3 and H4 proteins, either from an inducible promoter, by deleting 
the genes encoding the Hir repressor of histone gene transcription, or deleting 
the gene encoding the protein Tom1 that is involved in degradation of excess 
histone proteins, results in lifespan extension of yeast, identifying loss of histone 
proteins as a cause of aging (38, 44). The pathway of lifespan extension utilized 
by supplying extra histones appears to be independent from the pathway of 
calorie restriction (CR) in budding yeast (38), which is a widely-accepted way to 
extend lifespan in seemingly all species (45). Interestingly, the lifespan extension 
that results from lithium exposure in worms is accompanied by increased histone 
gene expression (46), although it is not known if increased histone gene 
expression plays a causative role in lifespan extension. The reduction of bulk 
core histone protein levels observed during replicative aging is not restricted to 
budding yeast, but has also been observed during aging in worms (47), during 
replicative aging of human diploid primary fibroblasts (48) and in senescent 
human cells (49). It is noteworthy that global histone loss has not yet been 
reported in mitotically dividing mammalian tissues in vivo. In human primary 
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fibroblasts, the reduced synthesis of new histones during replicative senescence 
was a consequence of the shortened telomeres activating the DNA damage 
response (48), potentially explaining the mechanism by which telomere 
shortening limits the number of cell divisions. As such, loss of core histones may 
be a more generalized phenomenon observed with aging in many organisms.  
Decreased levels of core histone proteins in aged cells would likely cause 
a dramatic effect on the chromatin landscape by providing inappropriate access 
to the genetic material. The consequences of having limiting amounts of histone 
proteins on DNA during age progression has been elaborately examined in a 
recent global analysis of chromatin from aged cells in budding yeast in 
comparison to the young rejuvenated population (40). Most of the nucleosomal 
positions are maintained in aged cells, while nucleosome occupancy is reduced 
to half the normal proportion, and nucleosome locations on particular DNA 
sequences become less stringent, or fuzzier. Additionally, moderate over-
expression of histone proteins H3/H4 partially reversed the transcriptional defects 
observed during aging. It will be intriguing to investigate in the future whether the 
longevity effect conferred by supplying extra histones is equally pertinent in 
multicellular organisms.   
 
1.2.2. Genomic instability during aging  
Genomic instability represents another major hallmark that has long been 
implicated as a major causal factor for aging (9, 50). It refers to alterations in the 
genome under physiological conditions in response to endogenous or exogenous 
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stresses. The stability and integrity of the genome are under continuous 
challenge from these endogenous or exogenous threats. Lesions in the genome 
can arise either as chemical damage to the DNA, mutations of actual base pairs 
or epimutations of DNA that refers to heritable changes in DNA modifications 
affecting gene expression without changing the actual sequence of DNA (9, 50). 
The resulting effects of these genomic lesions accumulated in DNA are in 
general highly diverse and include point mutations, deletions/insertions, 
inversions, transpositions, translocations, chromosomal gains/losses, telomere 
shortening etc. While the ability to endure a certain level of changes in the 
genomic content of any species is important for its evolvability, too much change 
also drives a species towards its extinction. Therefore, very complex yet refined 
systems of genome maintenance exist to guard the genome, which is the primary 
template for structural and functional information in any organism (50, 51). 
Although distinct from the nuclear DNA, changes in mitochondrial DNA and 
nuclear architecture can give rise to genomic instability (9). The focus of this 
study will be geared towards the genetic instability of nuclear DNA during aging. 
As mentioned earlier, the eukaryotic genome is packaged into chromatin 
structures. Therefore, a more relaxed chromatin structure observed during aging, 
due to heterochromatin loss or histone loss, is predictive of not only 
transcriptional deregulation but also genome instability. Indeed, the reduced 
nucleosome occupancy in old yeast led to increased genomic perturbations, 
including higher levels of DNA breaks, damage foci formation, inter- and intra-
chromosomal translocations, insertion of mitochondrial DNA into the nuclear 
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genome and high levels of retrotransposition (40). Noteworthy, partial over-
expression of histone proteins H3 and H4 partially reversed the transcriptional 
defects observed during aging and reduced retrotransposition, indicating that the 
increased retrotransposition in old yeast was a consequence of histone loss 
during aging (40). Increased levels of DNA breaks or unrepaired DNA damage, 
as illustrated by formation of γ-H2AX foci (a hallmark of DNA damage) have been 
observed in cells from multiple species including aged mice, senescent human 
cells and cells derived from patients with premature aging disorders (52-55). In 
addition, other forms of DNA damage including copy number variations and 
chromosomal aneuploidy have also been shown to be associated with increased 
age (56, 57). This evidence suggest that DNA damage may be a driving force 
behind organismal aging, although the full extent of the role of DNA damage 
during age progression still needs to be explored.  
One form of genomic instability observed during aging that results from 
heterochromatin decay is increased mobility of endogenous genetic elements, 
called retrotransposable elements. Retrotransposable elements have been 
implicated in the aging process by several lines of evidence across organisms 
including budding yeast, flies, worms, mice and even during cellular senescence 
in adult human stem cells (40, 58-63). Retrotransposable elements are tightly 
silenced by heterochromatin in young cells/organisms. However, the loss of 
heterochromatin with aging leads to increased expression of otherwise silent 
retrotransposons, essentially causing transposition of these elements, because 
the transcripts are reverse transcribed to make a genomic cDNA copy that gets 
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integrated elsewhere into the genome. The end result is increased mobility of 
retrotransposable elements within genomes, resulting in disruption of cellular 
homeostasis during aging (64). Proof that the loss of chromatin-mediated 
silencing of retrotransposable elements during the course of aging directly leads 
to their increased transposition during aging came from the ability to repress Ty 
transcription and retrotransposition in old yeast by overexpressing histones (40). 
Lifespan-extending interventions, such as calorie restriction, have also been 
shown to counteract the increased expression of retrotransposons in aged mice 
(63).  
As mentioned previously, sirtuins play important roles not only in 
deacetylating histones but also in their roles in genome maintenance (29). In 
addition to redistribution of Sir proteins from the silent mating type loci to sites of 
increased genomic instability during aging to cause loss of silencing from mating 
type loci and to promote aging in budding yeast (30), in mice SIRT1 has also 
been shown to repress repetitive elements and other regions across the genome. 
In response to DNA damage, SIRT1 is redistributed from these loci to DNA 
breaks, resulting in alterations in gene expression comparable to those in the 
aging mice brain (29). Another example where it is clear that loss of 
heterochromatin promotes aging is at the rDNA locus, where loss of silencing of 
the rDNA promotes genomic instability and aging in budding yeast (32, 33). The 
most recent evidence for sirtuin proteins acting in genome maintenance come 
from studies focusing on SIRT6. While the lifespan of transgenic male mice over-
expressing Sirt6 is significantly longer than WT mice (65), SIRT6 deficient mice 
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are smaller in size, have acute early-aging degenerative phenotypes and early 
death (66). In the absence of SIRT6, increased genomic abnormalities and 
increased sensitivity to DNA damaging agents were observed, implying roles of 
SIRT6 in genome maintenance (66). Another study of SIRT6 in mouse cells 
showed that it has ADP-ribosylase activity and SIRT6-mediated mono ADP-
ribosylation of KAP1 promotes its interaction with HP1 and the packaging of L1 
LINE elements into repressive heterochromatin (67). During aging, SIRT6 is 
sequestered away from the L1 elements, presumably to DNA breaks elsewhere 
in the genome, resulting in activation of the retrotransposons (67). Recently, it 
has also been shown that SIRT6 is responsible for rescuing the declining 
efficiency of homologous recombination in vitro during senescence of human 
fibroblasts (68). All these evidence further emphasize the critical roles of sirtuin 
proteins in genome maintenance, and lifespan extension (29, 31). 
It is a long-standing belief that accumulation of DNA mutations over a 
period of time impacts organismal aging, as mutation accumulation happens as a 
function of age in different organisms such as flies or mice, and in some cases 
also correlates with lifespan (69, 70). However, a recent study indicated that 
accumulation of somatic DNA mutations at least in budding yeast does not have 
a causal role in aging (71). Therefore, it is yet to be conclusively determined if the 
persistent DNA damage observed in aging cells is the result of increased 
susceptibility of the accessible genome to accumulate DNA damage with time or 
the inability of aged cells to efficiently repair the damage or a combination of 
both. It has been hypothesized for a long time that a declining DNA repair 
 18 
response is a possible contributing factor for the increased DNA damage 
observed during aging, thus contributing to the aging process itself (51, 72). 
Notably, another recent analysis of the DNA repair transcriptome of liver in 
species with significant lifespan differences revealed that the longer-lived species 
express certain DNA repair genes at higher levels compared to species with 
shorter lifespan, suggesting a superior genome maintenance mechanism in the 
longer-lived species, which could potentially be responsible for their longer 
lifespan (73).  
Importantly, cancer is considered a disease of aging as cancer 
development exponentially increases in the aging human population, but the 
mechanism by which aging predisposes cells to cancer initiation still remains 
elusive (74, 75). Aging and cancer, in the majority of instances, share common 
etiologies (76). The increased genomic instability that is a prominent hallmark for 
aging also serves as one of the primary hallmarks of cancer (9, 77). Thus, 
understanding the events associated with an increase in genomic instability 
during aging will also enhance our knowledge about carcinogenesis, and 
therefore help in the accurate prediction, effective treatment, and prevention of 
cancer.  
Noteworthy, the processes described in this section are unlikely to 
function independently from each other, and one event may lead to another 
during the aging process. For example, heterochromatin decay and histone loss 
may lead to increased genomic instability and changes in gene expression. In 
consideration of the increase in genome instability during aging, strong lines of 
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evidence are there to demonstrate genomic alterations in aging cells but how it is 
causally related to aging needs further exploration. We are currently limited in our 
knowledge of the sequence of the causal events during aging in healthy 
individuals. Given the complexity of the genome maintenance mechanisms in 
eukaryotic cells and the redundant roles played by different factors, it is difficult to 
model physiological aging in any given model organisms. Attempts should be 
made in the near future to define the cascade of events during age progression 
to attain a comprehensive view of the aging process. 
 
1.3. Human aging disorders and genomic instability 
The importance of genome maintenance mechanisms on the aging 
process is further exemplified by different premature aging disorders, the majority 
of which result from defects in genes important for DNA repair pathways (78, 79). 
Hutchinson-Gilford Progeria Syndrome (HGPS), Werner syndrome (WS), 
Cockayne syndrome (CS) and trichothiodystrophy (TTD) are rare human genetic 
disorders characterized by premature aging phenotypes with a shortened 
lifespan (79). This group of diseases resembles physiological aging to a certain 
extent, serving as excellent models to gain insight into the biology of aging in 
humans (80, 81). These diseases are either due to mutations in genes involved 
in the DNA repair pathways or the A-type lamin, leading to defective DNA 
damage response and/or disorganized chromatin structures (78, 79, 82). The 
causative mutations behind these progeria syndromes indicate that genomic 
instability and chromatin deterioration are causes of human aging. Furthermore, 
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the knowledge we gain from understanding the molecular pathology of these 
human premature aging diseases provides us with useful information to 
understand the complex aging process. Individuals with progeric syndromes do 
not always recapitulate all aging phenotypes, as they usually show segmental 
progeria affecting multiple tissues (79). Furthermore, the accelerated aging 
phenotypes observed in these disorders may not be solely due to the 
chromatin/repair defects, but a considerable contribution of ineffective genome 
maintenance to these disease etiologies has to be acknowledged. By 
recapitulating some molecular and cellular changes characteristic of the natural 
aging process, these models provide us with a unique opportunity to understand 
the aging process in a human model (80, 81). 
 
1.4. Use of model organisms for aging studies  
Use of model organisms in studying aging is invaluable for laying the 
groundwork in this field of study. Much of our knowledge of aging today comes 
from the studies in different model organisms (83, 84). Studies on the aging of 
mammals are rather limited by the long lifespan of the commonly used model 
organisms. Both non-vertebrate and invertebrate organisms, with their shorter 
lifespan and ease of genetic and environmental manipulations, are popular 
among researchers in the aging field as experimental models for aging studies. 
Among them, budding yeast or Saccharomyces cerevisiae is a highly informative 
organismal model for aging studies with its genetic tools, short lifespan and fully 
sequenced genome (85, 86). It is also possible to investigate mitotic and post-
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mitotic aging in this model organism. Though unicellular, budding yeast has been 
an excellent model to identify and characterize conserved basic biological 
processes, including aging (5, 6). It has been extensively used for identifying 
genes and interventions responsible for lifespan extension, to gain insights 
relevant to the aging processes of all eukaryotic organisms. In parallel, over the 
years studies in invertebrate organisms such as Drosophila melanogaster (flies) 
and Caenorhabditis elegans (worms) and in certain vertebrate models such as 
mice, zebrafish, naked mole rats and most recently African turquoise killifish 
have also provided invaluable information to help us understand the complexity 
of the process of aging and the effect of overlapping pathways influencing 
longevity (5, 8, 84). Both flies and worms have a relatively short lifespan and are 
extensively used to characterize the involvement of different genetic pathways in 
longevity, but both of these model organisms primarily focus on post-mitotic 
aging (5). African killifish rather recently provided the aging field with a short-lived 
vertebrate model that recapitulates age-associated human pathologies, but this 
model system is the newest in the field and yet to be developed fully (84). On the 
other hand, mice and zebrafish represent well-established vertebrate models of 
aging those are evolutionarily closer to humans. In particular, the available 
resources and different models of aging including premature aging and long-lived 
aging mice were instrumental in our current understanding of this complex 
process (5). However, the relatively longer lifespans of mice and zebrafish 
models (3-4 years and 5 years, respectively) make the experimental aging 
studies in these models more complicated (5, 84). In addition to these model 
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organisms, accelerated aging disorders in humans or progeria syndromes also 
provide some insightful details of the aging process (5, 6). Having taken all these 
variable factors into consideration, we utilized Saccharomyces cerevisiae or the 
budding yeast as our experimental model in our study. In this unicellular model 
organism, we can distinguish and characterize mitotic aging (Replicative aging) 
from post-mitotic aging (Chronological aging) very easily. In this study, our entire 
focus will be on the replicative aging or mitotic aging in budding yeast. Since the 
replicative age curve of budding yeast follows the same shape as the lifespan 
distribution in multicellular eukaryotes and the majority of the cellular processes 
are conserved among all eukaryotes, the knowledge I gain from my studies in 
budding yeast has the potential to be directly relevant to understanding the aging 
of multicellular eukaryotes, including humans.  
 
1.4.1. Chronological aging in budding yeast  
Chronological lifespan (CLS) is the aspect of longevity in budding yeast 
that measures the amount of time a cell is viable in a quiescent or non-dividing 
state (87, 88). It is a model of aging for non-dividing cells in multicellular 
eukaryotes. During CLS, following the initial growth phase, the cells are normally 
maintained in a postdiauxic phase that is a high metabolism phase, followed by a 
low metabolism stationary phase until death (88). Experimentally, CLS is 
commonly achieved by initially growing the yeast cell population in rich medium 
until it reaches a saturation level and then maintaining the cells in the same 
media without further replenishing any components. In the rich medium, yeast 
cells grow very rapidly, but then they go through first the diauxic shift and stop 
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growing. Then there is another switch from the fermentative stage to respiratory 
metabolism, following which the cells resume growth at a very slow rate, followed 
by cell cycle arrest and entry into the low metabolism stationary phase (88). 
While many different pathways have been implicated so far in regulation of 
chronological lifespan in yeast, a consensus mechanism for its regulation is yet 
to be developed, but nutrient sensing pathways, mitochondrial respiratory 
capacity and oxidative stress responses seem to play vital roles in regulating 
CLS (87). 
1.4.2. Replicative aging in budding yeast  
The second aspect of longevity that is extensively studied in budding 
yeast is Replicative lifespan (RLS), which is the measurement of the reproductive 
potential of a yeast mother cell achieved by measuring the number of times a 
mother cell produces a daughter cell before entering senescence. This is a 
model of aging for mitotically dividing cells in multicellular eukaryotes (Fig. 4) (87, 
89-91). Budding yeast divides a finite number of times, and in general, the 
median lifespan for a yeast mother cell is around 25 generations (89). RLS 
assays utilize the asymmetric division of budding yeast and the size difference 
between the mother and daughter cells to its advantage. This means after each 
cell division the daughter cell produced is rejuvenated, i.e. its age clock is set 
back to zero, and the aging factors are asymmetrically segregated to the mother 
cell. Conceptually the assay is simple and relies on the fact that when a mother 
cell produces a daughter cell by budding, the size of the daughter cell is smaller 
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Figure 4. Replicative aging model in budding yeast. Replicative aging of 
budding yeast as the model of mitotic aging of dividing cells in multicellular 
eukaryotes. It represents the reproductive potential of an individual yeast mother 
cell, measuring the number of times a mother cell divides before entering 
senescence. M indicates mother cell, while D indicates daughters. 
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and distinguishable from the mother cell. Towards the end of its life cycle, the 
mother cell increases in its size (89, 92-94) and develop a loose and wrinkled 
appearance (89, 95, 96), and starts to produce daughter cells that are larger in 
size, with apparent breakdown in the asymmetric division (94). With age, old 
mother cells also start to produce daughters with heterogenous morphologies 
that include both spherical and ellipsoidal shapes (92).  
Budding of the daughter cell from the mother cell leaves behind a new bud 
scar, which is mainly composed of chitin, on the surface of the mother cell (97). 
Replicative age of a mother cell can be determined via staining of the yeast cell 
wall by calcofluor and counting the number of bud scars on the mother cell 
surface that represents how many daughter cells the mother cell has produced. 
However, the more precise method of measuring replicative lifespan, namely 
micromanipulation, involves manual separation of daughter cells from a mother 
cell using a standard tetrad dissection microscope (87). Although enabling 
accurate determination of the RLS, the process is labor-intensive as well as low 
throughput. More recently, high-throughput methods have been developed to 
study budding yeast during the RLS using microfluidic systems coupled with 
high-resolution microscopy at the single cell level (92, 98), that can efficiently 
measure cell morphology and other aging-associated characteristics. Attempts to 
isolate old mother cells for molecular analyses previously have used either the 
elutriation method (42) or affinity purification of mother cells following cell wall 
labeling with biotin (24, 99). However, isolation of a large amount of old mother 
cells is difficult because the daughter cells quickly outpopulate the old cells. The 
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end result is that these methods are only able to isolate aged cells that have 
undergone less than 15 divisions. Recently, the development of another powerful 
genetic system called “mother enrichment program (MEP)” improved the ability to 
obtain a larger amount of older aged mother cells (100). 
 
The “Mother Enrichment Program (MEP)” 
The more recently developed genetic method of isolating old mother cells, 
called mother enrichment program (MEP), utilizes an inducible selection against 
daughter yeast cells coupled with a biotin purification system of the mothers 
(100). Selection against daughter cells is achieved by disruption of two essential 
genes, CDC20 and UBC9, only in daughter cells using Cre-lox recombination. 
The expression of Cre is regulated by the transcription factor Ace2, which is 
specifically expressed in daughter cells owing to the asymmetric division of 
budding yeast. Cre activity is also inducible in nature as it is a fusion protein 
between Cre and estradiol-binding domain of the estrogen receptor (Cre-
EBD78). Induction of Cre activity is achieved by the addition of estradiol which 
mediates translocation of the fusion protein Cre-EBD78 to the nucleus, where 
Cre functions to disrupt the two essential genes (CDC20, UBC9) via its 
recombinase activity, resulting in permanent mitotic arrest of daughter cells 
selectively (Fig. 5) (100). For the purification step, a biotin pulse is used to label 
the initial mother cell population so that the mother cell wall is coated with biotin. 
This biotin labeling is only restricted to the cell surface of mothers as the cell wall 
synthesis in budding yeast is generated de novo (24), meaning that the biotin is  
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Figure 5. Model of the “mother enrichment program (MEP)”. Illustration of 
the genetic system called the MEP, to selectively induce mitotic arrest of 
daughter cells via estradiol induced Cre-loxP mediated deletion of two essential 
genes, and to allow yeast mother cells to continue replicating and age. This 
genetic method coupled with a biochemical purification approach provides a 
powerful system to isolate replicatively aged mother cells. (Adapted from: 
Lindstrom, D. L., and D. E. Gottschling. 2009. The mother enrichment program: a 
genetic system for facile replicative life span analysis in Saccharomyces 
cerevisiae. Genetics 183: 413-422, 411SI-413SI) 
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non-transferrable to newborn daughter cells. After aging the cells in liquid culture 
in the presence of estradiol to ensure the mitotic arrest of daughter cells, it is 
possible to magnetically sort the starting population of biotin-labeled old mother 
cells utilizing the high-affinity interaction of biotin and streptavidin (100). 
Throughout my studies presented here, I extensively utilized this highly efficient 
genetic system to isolate sufficient numbers of aged mother cells at a much older 
age than previously possible to analyze the events determining yeast replicative 
lifespan as a model for aging of mitotically dividing cells of multicellular 
eukaryotes. These analyses enabled me to gain potential insight into the natural 
aging processes and to broaden our overall knowledge in the aging research.  
 
1.5. Structure of the yeast rDNA locus and connection with aging 
1.5.1. Structure of yeast rDNA  
The ribosomal RNA gene cluster, also known as the rDNA locus is a 
unique locus in the eukaryotic genome. It has a large number of tandemly 
repeated sequences, comprising both genes and intergenic regions with non-
coding elements (Fig. 6). In budding yeast, the rDNA locus resides within the 
nucleolus in a single cluster on chromosome XII and contains approximately 150 
tandemly repeated copies in the haploid genome. The rDNA locus occupies 
approximately 60% of the chromosome and almost 10% of the budding yeast 
genome. The rDNA cluster is critical as it produces the structural RNA 
components of ribosomes, serving a crucial housekeeping function in the cell 
(33, 101, 102). The rRNA genes are the most abundant genes and are highly  
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Figure 6. Structure of the yeast rDNA locus. The budding yeast rDNA locus is 
a part of chromosome XII right arm, comprising of ~150 tandem repeating arrays. 
Each repeat (~9.2 Kb) contains 35S rDNA and 5S rDNA genes, and intergenic 
spacer regions NTS1 and NTS2. The NTS1 region contains a bidirectional 
promoter E-pro, which is normally silenced via recruitment of Sir2, and contains a 
replication fork barrier (RFB) site, which is bound by Fob1. The NTS2 region 
contains a replication origin (ARS) and a cohesin associating region (CAR). 
(Adapted from: Ganley, A. R., and T. Kobayashi. 2014. Ribosomal DNA and 
cellular senescence: new evidence supporting the connection between rDNA and 
aging. FEMS yeast research 14: 49-59.) 
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conserved across species (33). In budding yeast, rRNAs (26S, 18S, and 5.8S) 
are transcribed from 35S rDNA repeats by RNA polymerase I and then mature 
into three individual rRNAs via splicing. 5S rRNAs are independently transcribed 
from 5S rDNA repeats located in between two 35S repeats (Fig. 6). All these 
rRNAs together form the ribosome structure along with ribosomal proteins (102). 
Repetitive in nature and actively transcribing, the rDNA is one of the most fragile 
sites in the genome and highly recombinogenic resulting in frequent fluctuations 
in rDNA copy numbers (103). Though earlier studies primarily emphasized its 
roles in ribosome biogenesis, later evidence underscores its extra-coding 
functions including crucial roles in determining lifespan (33, 102). 
An individual rDNA repeat is approximately 9.2 Kb in size, consisting of 
two rRNA genes (35S rRNA and 5S rRNA) and two non-transcribing spacer 
regions (NTS1 and NTS2). The NTS2 region contains a replication origin (ARS) 
and cohesin associating region (CAR). The NTS1 region contains a replication 
fork barrier (RFB) site, which is responsible for inhibiting rightward movement of 
the replication fork, through the action of a specific protein, Fob1. The RFB 
prevents the replication fork from colliding with RNA polymerase I, and results in 
a DNA double-strand break during replication that can be used to maintain the 
proper number of rDNA repeats via sister chromatid recombination. The NTS1 
region further contains a bidirectional promoter, E-pro, which is normally silenced 
via recruitment of a silencing complex that includes Sir2 (Fig. 6). The rDNA 
cluster is unique in this way that it contains all these diverse genomic elements 
(33, 101-103). 
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1.5.2. The ERC (extrachromosomal rDNA circle) theory of aging  
The rDNA locus has long been implicated in genome maintenance, having 
critical effects on lifespan in yeast and Drosophila (25, 33, 102, 104). The rDNA 
is located within the nucleolus of the cell and aging yeast cells typically display 
the phenotype of nucleolar enlargement and fragmentation, which serves as an 
indicator of rDNA changes with aging (105, 106). An initial aging theory was 
proposed that emphasized the roles of extrachromosomal rDNA circles (ERCs) 
as causative agents for yeast aging (32). According to this theory, ERCs are 
excised from the rDNA locus mostly due to unequal sister chromatid 
recombination between the rDNA repeats. When excised, they form circular 
loops with the ability to replicate because of the presence of autonomous 
replicating sequence (ARS) elements in them. These ERCs are asymmetrically 
segregated to yeast mother cells, causing aging mother cells to accumulate 
ERCs exponentially (32, 107). This inherent instability of the rDNA locus because 
of its RFB and its tandem repeats, together with the asymmetric segregation of 
ERCs serving as aging factors in the yeast mother cells may provide an 
explanation for why there is an enlarged and fragmented nucleolus during aging. 
Although it is unknown exactly how ERCs form during aging or how ERCs cause 
aging, it has been proposed that exponential accumulation of ERCs in aged 
yeast mother cells may possibly titrate away factors important to maintain diverse 
nuclear functions including replication, transcription or genome maintenance 
(32). Validation of this model of aging comes from lifespan analysis of certain 
mutants, such as sir2 and fob1 mutants, where increased accumulation of ERCs 
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lead to shortening of lifespan (in the sir2 mutant) and decreased accumulation of 
ERCs lead to lifespan extension (in the fob1 mutant) (108-110). 
 
1.5.3. rDNA theory of aging 
While ERC accumulation had been proposed earlier as a cause of aging 
in yeast (32), in several other instances it has been observed that there is an 
inverse correlation between accumulation of ERC levels with lifespan and 
lifespan cannot always be explained by the ERC theory of aging (104, 111, 112). 
Thus, later studies suggested ERCs were merely a byproduct of rDNA instability 
and that the rDNA instability itself was the regulator of aging (102, 104, 109, 
112). Notably, the rDNA locus is one of the most unstable regions in the budding 
yeast genome (112). In the rDNA theory of aging, instead of the accumulation of 
ERCs, rDNA instability itself has been proposed to be the major driving force 
behind yeast aging (112). At the molecular level, transcription from the intergenic 
regions of the rDNA locus that occurs in sir2 mutants has been proposed to 
specifically displace cohesin from the rDNA leading to unequal sister chromatid 
recombination, rDNA instability and aging (112, 113). The rDNA theory of aging 
proposes that being already unstable, the rDNA locus shows more sensitivity to 
the age-associated accumulation of DNA damage compared to other parts of the 
genome, and that the unstable rDNA locus serves as a DNA damage sensor that 
eventually induces senescence in aging cells (112). Evidence supporting this 
theory comes from a study partially decoupling ERC levels with rDNA instability 
by using strains with different strengths of rDNA replication origins (rARS) (104). 
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Here two strains with differing rARS activities, one with increased and the other 
with decreased ERC levels, lived shorter than a wild-type (WT) strain, but both 
displayed increased rDNA instability in terms of marker loss assays and a less 
intact chromosome XII (104). Although several other studies suggested the rDNA 
theory of aging would better explain the connection of rDNA to aging than the 
ERC theory of aging (112), the causal relationship of this theory has not yet been 
tested in the context of physiological aging in budding yeast. 
 
1.6. DNA double-strand break (DSB) repair in yeast and connections with 
aging  
1.6.1. DNA double-strand break (DSB) repair in yeast  
The integrity of the genome is under constant threat due to exposure to 
different exogenous and endogenous damaging agents. Exposure to damage 
generates a variety of DNA lesions including, but not limited to, DNA single-
strand break (SSB) and DNA double-strand break (DSB) formation. Among all 
different DNA lesions, the most deleterious kinds are DSBs because they can 
lead to loss of chromosome arms. In order to faithfully maintain chromosomal 
integrity, the DSB need to be accurately repaired. Thus, cells possess several 
complex and intricate but related signal transduction and repair pathways that 
efficiently repair the DNA (114-116). The elaborate system of repairing the DSBs 
within the cells is called the DNA damage response that includes sensing the 
damage, transducing the signals and efficiently repairing the DNA (115). Along 
with the numerous proteins involved in these signal transduction pathways, there 
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is involvement of different post-translational modifications as well. The major 
pathways to repair DSBs are homologous recombination (HR) and non-
homologous end joining (NHEJ). HR is considered as an error-free repair 
pathway while NHEJ is widely regarded as a more error-prone repair pathway 
(117-119).  
HR is the primary DNA repair pathway utilized by budding yeast in 
response to DSBs (117). The crucial step for HR is the invasion of single-
stranded DNA (ssDNA) generated following resection into a homologous DNA 
duplex (119). In budding yeast, following DSB formation, repair by the HR 
pathway involves DNA end processing/resection by Mre11-Rad50-Xrs2, known 
as MRX (MRN in mammals) and the Sae2 protein, followed by Replication 
Protein A/RPA loading onto ssDNA. The RPA is removed and replaced by the 
ssDNA providing a substrate for Rad51 nucleoprotein filament assembly. There 
are a few critical mediators, such as Rad52, in budding yeast that promote 
Rad51 binding. Rad51 assembly onto the ssDNA, assisted by Rad52 and other 
proteins, is needed for strand invasion into the duplex DNA of the sister 
chromatid. The 3’ end of the invading strand provides a primer for repair 
synthesis while the intact sister chromatid serves as the template. The strand 
invasion intermediate (D-loop) can then be resolved in a number of ways, leading 
to either crossover (CO) or non-crossover (NCO). But in either scenario, precise 
information is copied from the sister chromatid template to drive error-free repair 
and to restore the genomic information (Fig. 7) (116, 117, 119, 120).  
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Figure 7. Key steps of homologous recombination (HR) in budding yeast. 
Upon induction of a DSB, the Mre11-Rad50-Xrs2 (MRX) complex is recruited to 
DSB sites to drive end resection of DSB ends generating single-stranded DNA 
(ssDNA). RPA hetero-trimers then bind to the ssDNA ends and is subsequently 
Figure 7 
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replaced with RAD51 nucleoprotein filament formation. The RAD51/ssDNA 
complex invades the complementary sister chromatid strand in search of 
homology, and then, DNA synthesis occurs. HR repair is completed following the 
resolution of resulting Holliday junction. (Adapted from: Jasin, M., and R. 
Rothstein. 2013. Repair of strand breaks by homologous recombination. Cold 
Spring Harbor perspectives in biology 5: a012740., and Mehta, A., and J. E. 
Haber. 2014. Sources of DNA double-strand breaks and models of 
recombinational DNA repair. Cold Spring Harbor perspectives in biology 6: 
a016428.) 
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1.6.2. Connection of impairment of DNA repair with aging 
As mentioned earlier, one important hallmark of aging is increased 
genomic instability due to constant insults from numerous DNA damaging 
agents, and it has long been implicated as a causal factor behind aging (9, 50). 
Of note, premature aging syndromes in humans are often characterized by 
defects in genes involved in DSB repair, such as WRN, which is involved in both 
HR and NHEJ repair pathways, is mutated in Werner syndrome (121-123). 
Maintenance of genomic integrity thus remains a major mechanism to retain 
viability and promote longevity (79). Our earlier studies showed that replicative 
aging in budding yeast is associated with significant increases in DNA breaks, 
DNA amplifications and chromosomal translocations (40). As HR is the major 
pathway of DNA repair in budding yeast, defects in the HR pathway could 
potentially account for the defective DNA repair that occurs in old yeast cells 
leading to these chromosomal rearrangements and more DNA damage. It is 
intriguing to observe that DNA lesions accumulate to such a great extent during 
aging, given that the DNA repair system is highly proficient in nature and 
abundant in cells (50). This observation leads to the prediction that the DNA 
repair activity would decline with aging (123, 124). Declining DNA repair 
efficiency during aging has so far been reported only in C. elegans at the 
organismal level, although the exact mechanism is yet to be characterized (125). 
There are additional instances of reduced DSB repair activity in aging rat 
neurons and cultured primary human cells (68, 126-128), as well as in peripheral 
lymphocytes from aged humans (129-131), indicating the generalized nature of 
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an impaired DNA repair system during aging among all eukaryotes. Using the 
replicatively aged yeast cells, it is possible to determine whether this decline in 
repair efficiency occurs during aging and whether this contributes to genomic 
instability and aging.  	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2.1. Yeast strains  
All the yeast strains used in this study are haploid strains and are listed in Table 
1. Yeast deletion mutants were made by homologous recombination-mediated 
gene replacement, that is the replacement of the open reading frame of a specific 
gene with a selection marker gene. Tagging yeast strains with an HA epitope tag 
at the C-terminus of a specific gene was achieved by PCR-mediated DNA 
fragment integration followed by selection for the appropriate marker. The 
pFA6a-3XHA-KANMX6 Longtine vector was used as the PCR template to 
generate the DNA fragment for making C-terminal 3XHA tagged strains (132). 
Over-expression of a single copy gene was achieved by integrating yeast 
integrative vectors with a HIS3 marker containing the specific genes with the 
flanking sequence. Standard YEP media and SC media were used to grow yeast 
cells. YSI129 and YSI130 strains were kindly gifted to us by T. Kobayashi (133). 
 
Strain  Genotype Source 
ZHY2 MATalpha ade2::hisG his3 leu2 met15Δ::ADE2 
trp1Δ63 ura3Δ0:: URA3 hoΔ::SCW11pr-Cre-EBD78-
NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX 
Hu et al, 
Genes & Dev, 
2014 
rad52Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
rad52∆::KANMX 
Giaever et al, 
Nature, 2002 
SPY006 MATalpha ade2::hisG his3 leu2 met15D::ADE2 
trp1D63 ura3D0:: URA3 hoD::SCW11pr-Cre-
EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX 
MCD1-6HA:his5+ 
This study 
SPY021 MATalpha ade2::hisG his3 leu2 met15D::ADE2 
trp1D63 ura3D0:: URA3 hoD::SCW11pr-Cre-
EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX 
fob1∆::KANMX4 
This study 
YSI129 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 
can1-100 fob1∆::LEU2 his3-11::GFP-LacI-HIS3 
RDN1::LacO(50)-ADE2 (110 rDNA copies) 
Ide et al, 
Science, 
2010 
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YSI130 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 
can1-100 fob1∆::LEU2 his3-11::GFP-LacI-HIS3 
LacO(50)-ADE2:445kb ChXII (110 rDNA copies) 
Ide et al, 
Science, 
2010 
SPY056 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 
can1-100 MCD1-6HA:his5+ 
This study 
SPY065 MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 E-
pro∆::GAL1/10-URA3 MCD1-6HA:his5+ 
This study 
SPY048 MATalpha ade2::hisG his3 leu2 met15D::ADE2 
trp1D63 ura3D0:: URA3 hoD::SCW11pr-Cre-
EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX 
RAD54-3HA::KANMX6 
This study 
SPY054 MATalpha ade2::hisG his3 leu2 met15D::ADE2 
trp1D63 ura3D0:: URA3 hoD::SCW11pr-Cre-
EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX 
SAE2-3HA::KANMX6 
This study 
SPY031 MATalpha ade2::hisG his3 leu2 met15D::ADE2 
trp1D63 ura3D0:: URA3 hoD::SCW11pr-Cre-
EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX 
RAD51-HIS3 
This study 
SPY074 MATalpha ade2::hisG his3 leu2 met15D::ADE2 
trp1D63 ura3D0:: URA3 hoD::SCW11pr-Cre-
EBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX 
MRE11-HIS3 
This study 
SPY025 MATalpha ade2::HisG his3 leu2 met15∆::ADE2 
trp1∆63 ho∆::SCW11pr-CRE-EBD78-NatMX loxP-
UBC9-loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX 
ade3::GAL HO 
This study 
 
Table 1: A list of yeast strains used in this study 
 
2.2. Yeast media and plates 
YEP (yeast extract peptone) media: To make 1L YEP, 10 g of yeast extract and 
20 g of peptone were dissolved in 900 ml distilled water. The yeast media was 
sterilized by autoclaving at 120°C for 20-30 min. For YEP, either glucose (20% 
w/v stock, sterilized by autoclaving), galactose (20% w/v stock, sterilized by 
filtration) or raffinose (20% w/v stock, sterilized by filtration) was added to make 
YEPD or YEPR respectively to make a final concentration of 2% of the 
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appropriate sugar. To make solid media plates, 1.5% agar A was added to the 
liquid media prior to autoclaving.  
 
2.3. Yeast genomic DNA isolation 
Yeast genomic DNA was isolated as previously described (134). Cell pellets from 
overnight cultures were resuspended in 200 µl genome preparation buffer (2% 
Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0), 250 µl glass 
beads, and 250 µl phenol:chloroform:isoamyl alcohol (25:24:1) and then vortexed 
in the cold room for 5 minutes. The sample was centrifuged for 5 minutes at 
maximum speed at room temperature and the top aqueous layer was transferred 
to a fresh microfuge tube. 1 mL 100% ethanol was added to the sample and 
mixed well before centrifugation for several minutes until a small pellet of DNA 
was obtained on the side of the tube. Finally, the pellet was washed twice with 
70% ethanol, the excess ethanol was removed, and the pelleted DNA was 
resuspended in 200 µl millipore water for further application. 
 
2.4. Yeast transformation 
Yeast transformation was performed using the lithium acetate method and single-
stranded salmon sperm DNA as the carrier DNA (135). In brief, cultures were 
inoculated into 5 ml of YEPD for growing overnight at 300C. The following 
morning, overnight cultures were diluted to an optical density (OD600) of 0.3-0.4 in 
5 ml fresh YEPD media and allowed to double in density at 300C to reach OD600 
of 0.8. Cells were then spun to get a pellet and the pellet was washed in 1X TE / 
 43 
1X LiAc (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 100 mM LiAc) and vortexed 
vigorously for 30 seconds before finally resuspending in 50 µl of 1X TE / 1X LiAc 
solution. In a separat tube, 10 µl of denatured salmon sperm DNA and 3-5 µl of 
transforming DNA (either a plasmid or PCR amplified product) were mixed and 
then added to the resuspended cell pellet. 300 µl of polyethylene glycol (PEG) 
solution (40% PEG, 100 mM LiAc, 10 mM Tris-HCl pH 8.0, 1 mM EDTA) was 
then added to the cell suspension followed by addition of 50 µl DMSO. The 
resuspension was mixed thoroughly by vortexing followed by incubation at 300C 
for 10 min and heat shock at 420C for 20 min. Following the incubations, cells 
were spun and washed in YEPD media before resuspending in 100 µl distilled 
water and plating in appropriate selection agar media plates to grow yeast 
colonies.  
 
2.5. Purification of old cells by the mother enrichment program method 
Isolation of aged cells was performed using the “mother enrichment program” 
(MEP), as described previously (40, 100). Briefly, 2x107 cells from YEPD (1% 
yeast extract, 2% peptone, 2% dextrose) mid-log phase culture were collected 
and washed twice in 1X PBS, followed by resuspension in PBS containing 3 
mg/ml Ez-link Sulfo-NHS–LC-LC biotin (Thermo-scientific, P121338). Cells were 
incubated at room temperature for 30 min and washed twice using YEPD. These 
cells were used to seed a culture at a density of 2x 104 biotinylated cells per ml in 
YEPD. 17β-Estradiol (Sigma, E8875) was added to a final concentration of 1 µM 
to initiate the MEP and cells were cultured at 30°C for 30 hours to obtain cells of 
 44 
desired age (confirmed by calcofluor staining). Typically, cultures were 2L in 
volume. At the collection time, cells were collected via centrifugation and washed 
twice in PBS, resuspended at a density of 5x108 cells/ml in 1 ml of PBS, and 
incubated for 30 min at room temperature with 50 µl streptavidin-coated magnetic 
beads (Miltenyi Biotec, NC9821945). After streptavidin incubation, cells were 
washed in PBS, resuspended in 8 ml of PBS, and loaded onto an LS MACS 
column (Miltenyi Biotec, NC9777034) equilibrated with 5 ml of PBS. After gravity 
flow-through of unlabeled cells and debris, columns were washed thrice with 8 ml 
of PBS. The columns were then removed from the magnetic field and aged cells 
were eluted by gravity flow with 8 ml of PBS, and processed accordingly for the 
subsequent experimental purpose. 
 
2.6. Purification of old cells by serial biotin purification 
Yeast old mother cells were isolated using 2–3 rounds of purification; the initial 
population of cells was labeled with 3 mg/ml biotin (Thermo-scientific, P121338) 
in 10 ml cultures for 30 minutes, then the cells were washed with 1X PBS, 3 
times to remove the biotin, cultured overnight, followed by affinity purification 
using 50 µl streptavidin-coated magnetic beads (Miltenyi Biotec, NC9821945) in 
LS MACS column (Miltenyi Biotec, NC9777034) in the cold room following 
published method (136). Mean ages of isolated cells were estimated by counting 
Calcofluor-stained bud scars. Briefly, cells were grown in YEPD media to 
OD600 of 0.7. Then the cells were spun, washed twice with in 1X PBS, and 
resuspended in cold 1X PBS. 3 mg/ml Ez-link Sulfo-NHS–LC-LC biotin was 
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added to the cells following resuspension in PBS. The mixture was incubated for 
30 min at room temperature followed by spinning and washing three times in 1X 
PBS. Cells were then diluted and grown in YEPD for 6-8 generations and spun 
down, washed with 1X PBS, and resuspended in 10 ml of cold 1X PBS. 50 µl 
Streptavidin coated magnetic beads were added to the resuspension and 
incubated for 45 min at room temperature. The suspension was washed three 
times using 1X cold PBS and purified using LS MACS columns. Isolated cells 
were used again for another 1-2 rounds of growth and purification using similar 
procedure maintaining cell density within logarithmic growth phase (OD600 < 1.0). 
 
2.7. RNA isolation, cDNA synthesis and quantitative PCR (qPCR) 
Total RNA isolation was performed using the Master Pure Yeast RNA Isolation 
Kit (Epicentre Biotechnologies, MPY03100) following the manufacturer’s 
protocols using the same number of cells for each sample. The DNase I 
digestion steps were included in our RNA isolation to obtain a purer sample for 
subsequent analyses. The quality of the RNA was confirmed by running RNA 
samples on formaldehyde gels . cDNA synthesis was performed using 
Transcriptor first strand cDNA synthesis kit (Roche, 04379012001) using strand 
specific primers, to be analyzed by subsequent qPCR analyses using LightCycler 
480 SYBR green I master mix (Roche, 04887352001) using manufacturer’s 
instructions in a LightCycler 480 II PCR machine (Roche). Plotted are the 
average and standard error of the mean of three independent experiments. 
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P values were determined using Student t-test using Prism 6 software 
(GraphPad Software, Inc.). The primers used are listed in Table 2.  
 
Primers Purpose Sequence 
NTS2-1_A cDNA synthesis of 
NTS2 (+) strand 
5’- GGT AGG TCG AAA CAG AAC 
ATG AAA GTT GG -3’ 
NTS2-1_B cDNA synthesis of 
NTS2 (-) strand 
5’- GCT ACT CTC ATG GTC TCA 
ATA CTG CC -3’ 
NTS1-2_A cDNA synthesis of 
NTS1 (+) strand 
5’- CAG AGC GGC AAA CAT GAG 
TGC TTG TAT AAG -3’ 
NTS1-2_B cDNA synthesis of 
NTS1 (-) strand 
5’- CGT AGT ACA TCT TAC AAC 
TCC GCA TAC C -3’ 
ACT1_RV cDNA synthesis of 
ACT1 (Crick strand) 
5’- CGG ACA ATT TCT CTT TCA 
GCA GTG GTG G -3’ 
qNTS2_1_FW qPCR analysis of 
NTS2 region 
5'- GAG GTA GTT TCA AGG TGA 
CAG G -3' 
qNTS2_1_RV 5'- CTC TCA TGG TCT CAA TAC 
TGC C -3' 
qNTS1_2_FW qPCR analysis of 
NTS1 region 
5'- GAG GCT ACT GGG AAG AAG 
AAA GAG -3' 
qNTS1_2_RV 5'- CAT CTT ACA ACT CCG CAT 
ACC G -3' 
qACT1_1_FW qPCR analysis of 
ACT1 control 
5'- GTG ATG GTG TTA CTC ACG 
TC -3' 
qACT1_1_RV 5'- GTA GTC AGT CAA ATC TCT 
ACC GGC -3' 
rDNA_probe2_FW Primers to design 
probe for Southern 
blot against rDNA 
(Chr XII) 
5'- CAG GTT ATG AAG ATA TGG 
TGC AA -3' 
rDNA_probe2_RV 5'- AAA ATG GCC TAT CGG AAT 
ACA -3' 
Chr2_1.FW Primers to design 
probe for Southern 
blot against Chr II 
5’- GTC TAT ATC GAC GGT AGC 
CCA CAC TTG C -3’ 
Chr2_1.RV 5’- CTT GTC GCC CTG TTT CAC 
CAC ATC G -3’ 
qCARL2_.FW  ChIP primers to check 
Mcd1 occupancy at 
different regions of 
Chr XII 
5'- CCT GCA TTG TCC TCA TTT 
AGT GCT CAG G -3' 
qCARL2_.RV 5'- TTT GGC AAC GAG ATA GTT 
GTG CCC -3' 
qCARL3_.FW  5'- ATG CCA CCT ACC GAC CAA 
CTT TCA -3' 
qCARL3_.RV 5'- AGA GGT GTT ATG GGT GGA 
GGA CAA -3' 
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qCARL3-N_.FW 5'- TCC ACT TTC AAC CGT CCC 
TCC AAA -3' 
qCARL3-N_.RV 5'- AGA ATG TCG GCG GCA GTA 
TTG AGA -3' 
qCARC1_positive.
FW 
ChIP primers to check 
Mcd1 occupancy at 
centromeric regions of 
Chr III (+ve control) 
5'- CAG ACG ATA AGT TGA GTA 
GCG G -3' 
qCARC1_positive.
RV 
5'- GTC CAC TAG GAG ACT CTT 
GAA C -3' 
qCARC_negative.
FW 
ChIP primers to check 
Mcd1 occupancy at 
genomic regions of 
Chr III lacking Mcd1 
binding (-ve control) 
5'-CAG TGC TAT CGG ATC TAG 
GAA G -3' 
qCARC_negative.
RV 
5'- GTA TTT GAC GTC TCC GCT 
TTC C -3' 
DSB probe.FW Primers to design 
probe for Southern 
blot against DSB 
probe 
5'- GCC ATT TAC AAA AAC ATA 
ACG -3' 
DSB probe.RV 5'- GGG CCT AGT TTA GAG AGA 
AGT-3' 
Probe C.FW Primers to design 
probe for Southern 
blot against Control 
probe 
5'- ACA GAT GTG CCG CCC CAG 
CCA AAC TCC -3' 
Probe C.RV 5'- CCT GGA TAT GGA TTC TTC 
ACG GTA ACG -3' 
Chr1_left.FW Primers to design 
probe for Southern 
blot against Chr I 
5'- GAT TGC CTC TTT TGG GAG 
GTC TGG -3' 
Chr1_left.RV 5'- CCA TCA GGC TCA GAT GAA 
TCA TGG GCC -3' 
ChrX_right.FW Primers to design 
probe for Southern 
blot against Chr X 
5'- CAC CAC ACC CTG CTT ATT 
AAA GC -3' 
ChrX_right.RV 5'- GAC AGA GGA CTT GTG TGA 
CG -3' 
ChrIV_left.FW Primers to design 
probe for Southern 
blot against Chr IV 
5'- CAT TGG GAC AGG TAC TAG 
ATG G -3' 
ChrIV_left.RV 5'- CTA TCT GTC TCT GCT CAG 
TGT GG -3' 
HOMAT.FW Primers used for 
multiplex PCR to 
analyze HO cutting 
and repair efficiency 
5'- AGG TAA ATT ACA GCA AAT 
AG -3' 
HOMAT.RV 5'- AAC AAC AAC CTA GAG TAA 
TG -3' 
RAD27.FW 5'- ACA TCG CGC AAA TGA AGG 
TT -3' 
RAD27.RV 5'- TCA AGT TCC CAG AAA AAC 
TG -3' 
 
Table 2: A list of primers used in this study 
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2.8. Pulse field gel electrophoresis (PFGE) 
Analyses of intact yeast chromosomes were performed using a CHEF DR II 
system (Bio-Rad), which is followed by Southern hybridization using probes 
against different chromosomes. Yeast cells grown in YEPD or YEPR were 
isolated at different time points using the MEP as indicated in the figure or figure 
legends. In general, 2X107 cells were used in each well to prepare agarose gel 
molds following the manufacturer's instructions (Bio-Rad, Cat#1703593). In brief, 
the cell pellet was resuspended in cell suspension buffer and equilibrated at 
500C. Plug mold was created using 2% CleanCut agarose in cell suspension 
buffer (10 mM Tris, pH 7.2, 20 mM NaCl, 50 mM EDTA), to make a final 
concentration of 1% agarose in agarose plug molds. Just before mixing the cells 
with agarose, 10 mg/mL Zymolyase (100T) was added, followed by solidification 
of the agarose plugs. The agarose plugs were further enzymatically treated with 
10 mg/ml Zymolyase in buffer A (10 mM Tris, pH 7.2, 50 mM EDTA) and 
incubated at 350C for 2 hours followed by Proteinase K digestion with 1mg/ml 
Proteinase K in Proteinase K reaction buffer (100 mM EDTA, pH 8.0, 0.2% 
sodium deoxycholate, 1% sodium lauryl sarcosine) at 500C overnight. After 
enzymatic digestions, the plugs were washed in wash buffer(20 mM Tris, pH 8.0, 
50 mM EDTA) at room temperature and stored at 40C for future use. The 
electrophoretic conditions used for my analysis: 3V/cm for 72 h at 14°C with a 
300 to 900 sec pulse time and a 1% agarose gel with 0.5X Tris-borate-EDTA 
(TBE). The gel was stained with SYBR safe dye (Invitrogen, Cat#S33102) and 
visualized using a ProteinSimple Imager (FluorChem E system). 
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2.9. Southern blot analysis 
Intact chromosomes were resolved in by PFGE on a CHEF agarose gel using 
0.5% TBE or digested DNA was resolved in 1% TBE agarose gels. In both 
cases, the gels were partially depurinated using 0.25N HCl for 20 minutes at 
room temperature and were denatured using denaturing solution (0.5M 
NaOH/0.6M NaCl) for 20 minutes at room temperature. The DNA was then 
transferred to a nitrocellulose membrane via the capillary method using 2X 
SSCPE buffer (to make 1L of 20X concentrate of SSCPE buffer, we combined 
140g NaCl, 88g Na-citrate, 35g KH2PO4, 7.4g EDTA, and pH adjusted to 7.2 
using NaOH) and UV crosslinked to the membrane. The membrane was then 
pre-hybridized using Ultra-hyb buffer (Applied Biosystems, Cat# AM8669) at 
420C for 1 hour, followed by hybridization using specific probes against particular 
chromosomes or specific DNA sequences at 420C overnight. The probes were 
labeled by random prime labeling with 32P (Rediprime II Random Prime Labelling 
system, GE, RPN1633) following manufacturer’s protocol. The primer sequences 
used for amplifying the probes are listed in the tables for Primers (Table 2). 
Specific signal was detected after washing off unbound probe, using 10-15 ml 
wash buffer (2X SSPCE, 0.2% SDS), 2 times for 30 minutes each at 65-700C, 
using autoradiography. 
 
2.10. Analysis of branched recombination intermediates (stuck DNA 
analysis) 
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Branched recombination intermediates do not enter the gels during PFGE and 
remain in the plug well (stuck DNA). The analysis of branched recombination 
intermediate formation has been done for two chromosomes, chr II and chr XII 
(rDNA), in both young and old samples. Relative proportions of stuck DNA in the 
well during aging was measured by quantifying the signal from Southern blot 
using probes against the respective chromosomes. Plotted are the average and 
standard error of the mean of three independent experiments. P values were 
determined using Student t-test using Prism 6 software (GraphPad Software, 
Inc.). 
 
2.11. DSB analysis 
Measurement of DSB formation at the rDNA (using restriction digestion by BglII) 
was performed according to the following procedure with certain modifications 
(137). The procedure of embedding the cells in agarose plugs followed by all 
different enzymatic digestions was followed as described and the gel plugs were 
loaded into 1% agarose gels, ran in 1XTBE at 30V for 14 hours. The gel was 
stained with SYBR safe dye to visualize DNA and used for subsequent Southern 
blot using specific probes as mentioned in the figure.  
 
2.12. Chromatin immunoprecipitation (ChIP) and qPCR 
Samples for ChIP were collected at different time points of the MEP as indicated 
in the figure legends. In brief, cells were cross-linked with 1% formaldehyde for 
20 minutes and quenched by addition of 1M glycine to the final concentration of 
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125 mM. Cells were lysed using lysis buffer (140 mM NaCl, 50 HEPES pH 7.5, 1 
mM EDTA, 0.1% deoxycholic acid, 1% Triton X-100) in the presence of a 
protease inhibitor cocktail (protease inhibitor cocktail set IV, Calbiochem, cat# 
539136) using glass beads at 40C for 10 minutes in a bead beater and then kept 
on ice for 15 minutes. The extract was removed, transferred to a fresh tube, 
followed by shearing of the chromatin by sonication using a Branson 350 Sonifier 
(Output: 2, Timer: Hold, Duty cycle: Constant, 100% power). The samples were 
centrifuged at maximum speed at 40C and for 5 minutes, 2 times to separate 
supernatant from the cell pellet. A small portion of supernatant (50 µl) was mixed 
with 30 µl ChIP elution buffer (50 mM Tris-HCl pH 7.5, 10 mM EDTA, 1% SDS) to 
be used as input controls and immunoprecipitation was performed with the rest of 
the supernatants using specific antibody. For immunoprecipitation for each 
sample, 10 µl Dynabeads Protein A (Invitrogen, 100-02D) pre-mixed with 2 µl 
antibody was added to the cell lysate to incubate at 40C overnight. The following 
day beads were washed using magnetic stand in the following buffers: two times 
washing in cold Lysis buffer (0.1% deoxycholic acid, 1mM EDTA, 50mM HEPES 
pH 7.5, 140mM NaCl, 1% Triton X-100), two times washing in cold Lysis buffer-
500 (0.1% deoxycholic acid, 1mM EDTA, 50mM HEPES pH 7.5, 500mM NaCl, 
1% Triton X-100), two times washing in cold LiCl detergent (0.5% deoxycholic 
acid, 1mM EDTA, 250mM LiCl, 0.5% NP-40, 10mM Tris pH 7.9) and once with 
cold 1X TE buffer. Following the washes, for each IP sample 80 µl of ChIP 
elution buffer was added to the beads. After elution step, 20 µl 20 mg/ml Pronase 
was added to both 80 µl of Input and IP samples to incubate in a PCR cycler for 
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the following program (420C for 2 hours; 650C for 8 hours; 40C, hold) to reverse 
crosslink and to digest proteins. The DNA was then purified using MinElute DNA 
purification kit (Qiagen, 28004). Quantitation of the DNA sequences in the input 
samples and immune-precipitates was performed via real-time qPCR analyses 
using LightCycler 480 SYBR green I master mix (Roche, 04887352001) using 
manufacturer’s instructions in a LightCycler 480 II PCR machine (Roche). A 
polyclonal antibody against rabbit hemagglutinin (HA) (Abcam, ab9110) was 
used to measure the occupancy of Mcd1, a cohesion subunit, at different regions 
around the rDNA locus and control regions. Plotted are the average and standard 
error of the mean of three independent cultures for each experiment. P values 
were determined using Student t-test using Prism 6 software (GraphPad 
Software, Inc.). The primers used are listed in Table 2.  
 
2.13. Western blot analysis 
Total protein extracts were isolated by boiling samples (same cell number for 
each sample) in 2X sample buffer (0.06M Tris-HCl, pH 6.8, 10% glycerol, 2% 
SDS, 5% 2-mercaptoethanol, 0.0025% bromophenol blue) prior to loading gels. 
Samples were resolved using 4-20% Criterion TGX precast gels (Biorad, 567-
8095) using 80 volt for 2 hours, and then transferred to nitrocellulose membrane 
using 450 mAmps for 45 minutes at cold room. The membrane was blocked 
using 5% non-fat milk diluted in 1X TBS with Tween 20 (TBST) for 30 minutes, 
followed by incubation in presence of primary antibody in TBST for 1 hour at 
room temperature, and washing the membrane with 1X TBST three times, 10 
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minutes each. After the washes incubation with secondary antibody in TBST was 
done, 1 hour at room temperature, followed by three washes with 1X TBST, 10 
minutes each. Membranes were then developed using either Amersham ECL 
western blotting detection reagent (GE) or Immobilon Western HRP substrate 
(Millipore). Dilutions for primary and secondary antibodies used are listed in 
Table 3. 
 
2.14. Cohesion assay (GFP two spot analysis) 
To investigate sister-chromatid cohesion, strains where the LacO array is 
inserted into rDNA (RDN) or telomere (TEL) expressing LacI-GFP fusion protein 
were used (133). Aged cells were collected following two rounds of biotin affinity 
sorting. The exponential growth of the culture was maintained by limiting the cells 
to going through ~6 doublings before each round of sorting. Cell surface was 
labeled with Ez-link Sulfo-NHS–LC-LC biotin (Thermo-scientific) with a 30 minute 
long pulse of 3 mg/ml concentration biotin in YPD, were washed 3 times in 1X 
PBS, followed by 10-12 hrs of exponential growth in YPD media and affinity 
purified following incubation with streptavidin-coated magnetic beads (Miltenyi 
Biotec, NC9821945) using LS MACS column (Miltenyi Biotec) using the 
procedure as previously described (138). Cells at G2/M phase (large budded 
cells) were scored for a single fluorescent GFP dot (maintenance of cohesion) 
versus two separated fluorescent GFP dots (loss of cohesion) as visualized by 
fluorescence microscopy. More than 100 cells were counted for each sample. 
Plotted are the average and standard error of the mean of three independent 
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experiments. P values were determined using Student t-test using Prism 6 
software (GraphPad Software, Inc.). 
 
2.15. Repair assay using MMS 
For the repair assay, biotinylated cells were grown in YEPD media according to 
the MEP method and samples were collected before inducing any damage. For 
damage induction, 0.07% Methyl Methanesulfonate (MMS) (Sigma-Aldrich, 
129925-5G) was used for 30 minutes followed by washing the cells in fresh YPD 
media thrice. For analyzing post-damage repair kinetics samples were collected 
3 and 6 hours after washing out the MMS. All the samples collected at different 
time points were subject to magnetic biotin-streptavidin purification as described 
previously in the cold room. For old samples, damage induction with MMS was 
started at 22 hours into growing the cells following MEP procedure so that the 6 
hours repair time course was finished within 30 hours of the start of the MEP. For 
each time point, 2x107 cells were collected and processed for making DNA plugs 
in agarose for subsequent PFGE analysis. 
 
2.16. Immunofluorescence (IF) analysis 
Samples for IF analysis were collected following the MEP procedure in 2L 
cultures. Cells were fixed with 4% formaldehyde followed by spheroplasting using 
10 mg/mL Zymolyase (100T) (USBiological, Z1004) for 40 to 60 minutes. 
Spheroplasting was confirmed visually under the microscope. Spheroplasts were 
harvested and applied to a poly-lysine coated microscope slide. The cells were 
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permeabilized using methanol and acetone followed by blocking with 3% PBS-
BSA and incubation with primary and appropriate fluorescent secondary 
antibodies. The antibodies used are listed in Table 3.  
 
Antibody (animal source) Source (Catalog #) Dilution 
HA (Rabbit) Abcam (ab9110) 1:4000 (WB);  
2 µl (per ChIP) 
H3-C (Rabbit) Abcam (ab1791) 1:5,000 (WB) 
Rfa1 (Rabbit) Brush et al., NAR, 2000 1:2,500 (WB) 
Rfa2 (Rabbit) Brush et al., NAR, 2000 1:2,500 (WB) 
Rad51 (Rabbit) Abcam (ab63798) 1:5,000 (WB) 
Rad52 (Rabbit)  Santa Cruz (sc-50445) 1:500 (WB) 
Rad53 (Mouse) Fiorani et al., Cell cycle, 
2008 
1:100 (WB) 
Mre11 (Rabbit)  LSBio (LS-C155765) 1:1,000 (WB) 
α-Tubulin (Rat) AbD Serotec (MCA78G) 1:1,000 (WB) 
phospho-H2A S129  (Rabbit) Abcam (ab15083) 1:10,000 (IF) 
Anti-mouse, HRP  Promega (W4021) 1:10,000 (WB)  
Anti-rabbit, HRP  Promega (W4011) 1:10,000 (WB)  
Anti-rat, HRP  Sigma (A5795) 1:4,000 (WB)  
Anti-rabbit IgG (H+L) Alexa 
flour 594  
Invitrogen (A-11037) 1:1,000 (IF) 
 
Table 3: A list of antibodies used in this study 
 
2.17. PCR analysis of HO cutting and repair efficiency 
Following collection of samples at each time point of the repair time-course 
experiment, yeast cells were collected by centrifugation and genomic DNA was 
isolated as described earlier. A multiplex PCR assay was done following 
published protocol (139) using HOMAT and RAD27 (as a control) primers (140). 
PCR products were resolved by 1.5% agarose gel electrophoresis. The gel was 
stained with SYBR safe dye and visualized using a ProteinSimple Imager 
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(FluorChem E system). While the PCR product generated by RAD27 primers is 
expected to be ~1.4 Kb, HOMAT primer pairs generated a MATa product with the 
size of ~1.1 Kb, and a MATα product with the size of ~1.2 Kb. Quantification of 
the relative amount of MATa or MATα products (normalized to control) during HO 
cutting and repair assay was performed using AlphaView software available with 
the ProteinSimple Imager. 
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CHAPTER 3: ROLE OF RIBOSOMAL DNA (rDNA) 
INSTABILITY IN REGULATION OF LIFESPAN IN 
BUDDING YEAST 
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3.1. Introduction and Rationale 
As described in Chapter 1, the ribosomal DNA (rDNA) locus is a unique 
locus in the eukaryotic genome. It is located within the nucleolus and is crucial to 
maintain critical housekeeping functions for the cells, as well as other extra-
coding functions that have been emphasized more recently (33, 102). It is also 
one of the highly unstable regions of the genome (141). rDNA instability has long 
been implicated in lifespan determination in yeast and Drosophila (25, 104), but 
most of the evidence was circumstantial. For example, characteristic aging 
phenotypes in budding yeast are nucleolar enlargement and fragmentation that 
implicated that there are changes to the rDNA locus during aging (105, 112). At 
the same time, even after it was unclear whether ERCs are the cause of aging or 
simply the by-products of rDNA instability (112), increased accumulation of ERCs 
during aging only underscores the inherent instability of this locus that worsens 
with age. Furthermore, increased LOH at the rDNA locus of the daughters of 
aged yeast cells also serve as an indirect indicator of increased rDNA instability 
with aging (105, 142). Interestingly, the age-induced hyper-recombinational state 
of the rDNA is not solely restricted to budding yeast but has also been found in 
adult solid tumors (143). Of note, aging is the highest risk factor for cancer. All 
these evidence correlate and potentially implicate changes in rDNA instability to 
aging. However, it is yet to be addressed directly if there is indeed increased 
rDNA instability in aged cells and whether rDNA instability affects lifespan as 
predicted by the “rDNA theory of aging”. As the use of the MEP now enables us 
to uncover specific events in a truly aged population of yeast cells, which are at 
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or beyond their median lifespan, it is possible to address what happens at the 
rDNA locus during the aging process.  
Previously our lab revealed chromatin structure as a major modulator of 
aging in yeast and provided evidence of drastic histone protein loss from different 
regions of the genome including the rDNA locus during aging (38). A more open 
chromatin structure with aging is likely to provide inappropriate access to the 
genome, leading to loss of genomic integrity affecting all the genomic regions, 
but may be affecting the fragile genomic regions like the rDNA even more. Our 
earlier study, which showed massive nucleosome loss during replicative aging 
coupled with drastic transcriptional upregulation and increase in genomic 
instability, also provided evidence of the involvement of the rDNA in increased –
intra and –interchromosomal translocation and amplifications of the chromosome 
segment distal to the rDNA during aging (40). Thus, the objective of the first part 
of my project is to test the ‘rDNA theory of aging’ to determine whether there is 
increased rDNA instability during yeast replicative aging and if so, to characterize 
the mechanism behind it. As rDNA is universally present in all eukaryotes and 
most of the fundamental biological pathways are well conserved among 
eukaryotes, it has the potential to serve as a more common lifespan determinant 
(102). Altogether, this study has the potential to be applicable to the replicative 
aging of stem cells, which are mitotically dividing cells, unlike most of the adult 
tissues in multicellular eukaryotes where cells are maintained in a non-dividing 
state. 
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3.2. Results 
 
3.2.1. Non-coding RNA transcription is highly induced from NTS1 and NTS2 
in the intergenic spacer region of the rDNA locus in old cells 
The rDNA locus in budding yeast is located in a single cluster at the right 
arm of chromosome (chr) XII, consisting of approximately 150 tandem repeats of 
rDNA units, as described earlier (Fig. 6). Within each individual rDNA repeat 
there are non-transcribed spacer regions 1 and 2 (NTS1 and NTS2). These 
regions are silenced via the recruitment of the Sir2 containing complex known as 
RENT (regulator of nucleolar silencing and telophase exit) (144). During the 
course of our previous RNA-seq analyses during yeast replicative aging (40), we 
noted that transcription from the NTS1 and NTS2 regions was the most induced 
out of all the yeast genes during aging. Given that transcription of the NTS1 and 
NTS2 non-coding RNAs has never been observed in wild type yeast previously, I 
validated the RNA-seq results using strand specific reverse transcription PCR. 
Using aged cells isolated using the MEP that are 25 or more generations old on 
average, I found 21-87 fold transcriptional induction from NTS1 when normalized 
to ACT1 transcription and 18-34 fold induction from NTS2 depending on which 
strand was being examined in old cells in comparison to their young counterparts 
(Fig. 8A, B). Strand-specific transcript analysis revealed induction of non-coding 
RNA from both Watson (+) and Crick (-) strands at NTS1 and NTS2 consistent 
with their having bidirectional promoters (113, 145). Transcriptional upregulation 
has been observed from all genes in the yeast genome during replicative aging  
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Figure 8: Transcriptional up-regulation from non-transcribed regions of 
rDNA during aging. (A, B) Strand-specific qRT-PCR analysis to examine the 
fold increase in non-coding RNA levels in old cells from both Watson (+) and 
Crick (-) strands of (A) NTS1 and (B) NTS2 regions of rDNA in comparison to 
young cells. RNA levels were normalized to ACT1 transcript levels in both young 
and old cells before normalizing to 1 for young cells in each case. Average and 
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standard error of the mean of three replicates are plotted. Asterisk (*) indicates 
significant changes in old from young (p<0.05), as determined by the Student’s t-
test. (C) Levels of ACT1 strand-specific transcription from same number of young 
and old cells. Average of two independent replicates are plotted here.  
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(40). Therefore, before using the ACT1 transcript as our normalization control, I 
determined the level of ACT1 transcription from same number of cells in both 
young and old cells, and found that the ACT1 transcript levels were slightly 
higher in aged cells (Fig. 8C). These results validate that transcriptional silencing 
is lost from both NTS1 and NTS2 during aging. As mentioned before, the rDNA 
locus contains diverse genomic elements and activities of all three RNA 
polymerases (RNA Pol I, II, and III) are observed at this locus (146). An earlier 
study found RNA polymerase I transcription is inversely proportional to ncRNA 
production at the rDNA locus, suggesting that RNA polymerase I activity may act 
to silence ncRNA production at this locus (146). However, when I compared the 
levels of 25S and 18S rRNA level as an indication of RNA polymerase I activity in 
young and old cells, I did not find any significant difference between them (Fig. 
9A, B), indicating that the increased NTS1 and NTS2 transcription observed 
during aging is not a reflection of loss of RNA polymerase I-mediated regulation. 	  
 
3.2.2. Cohesin occupancy is reduced from the rDNA region during aging 
Transcription from the bidirectional E-pro promoter of NTS1 in yeast 
deleted for SIR2 has been reported to promote dissociation of cohesin from the 
rDNA locus to regulate recombination (113). Since I observed increased non-
coding RNA produced from the rDNA region during aging as a consequence of 
histone loss during aging (40), I asked whether this transcription displaces 
cohesin from the rDNA during aging. I epitope tagged Mcd1, the limiting subunit 
of the cohesin complex (147) with HA and measured cohesin occupancy by  
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Figure 9. No significant difference in RNA Polymerase I (Pol I) 
transcriptional activity is observed during aging. (A, B). Pol I transcriptional 
activity as observed from the levels of 25S and 18S rRNA levels. (A) Results 
from three independent replicates are shown. (B) Ten fold serial dilutions of each 
samples to illustrate the differences between young and old samples from three 
independent replicates. The same number of cells are analyzed for young and 
old cells. 
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Figure 10. Mcd1 occupancy at different genomic regions is reduced during 
aging. (A) Location of the ChIP primers around rDNA locus in chromosome XII to 
check Mcd1 occupancy. (B) Young and old cells isolated via the MEP were 
subjected to chromatin immuno-precipitation (ChIP) Young cells from untagged 
strain were used as a negative control. Data shown here are the average of four 
independent replicates. Error bars represent standard error of the mean. Asterisk 
(*) indicates significant changes in old from young (p<0.05 as determined by the 
Student’s t-test.  
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chromatin immunoprecipitation (ChIP) during aging. I examined two known 
cohesion associated regions (CAR) within different rDNA repeats during aging 
(CARL3, CARL3-N) and one region outside rDNA locus but still located at the 
right arm of chromosome XII (CARL2) (Fig. 10A). As a positive control, I used 
the centromeric region of chromosome III and a cohesin-depleted region of 
chromosome III (Chr III: 309955 to 310355) as a negative control (148). Mcd1 
occupancy was significantly lower in aged cells within the rDNA in comparison to 
young cells (Fig. 10B). However, there was also a similar degree of cohesin 
occupancy reduction at a different cohesin binding site of chromosome XII 
outside of rDNA locus and also at the centromeric region of chromosome III in 
old cells (Fig. 10B), indicating that reduced cohesin occupancy during aging 
extends beyond the rDNA locus.  
 
3.2.3. Cohesion is lost not only from the rDNA locus, but also globally 
during aging 
In order to determine whether the reduction of cohesin occupancy from 
different genomic locations that I observed during aging (Fig. 10) is functionally 
relevant, I measured cohesion during aging using a functional assay. I visualized 
cohesion at the rDNA and telomere by observing Lac repressor-GFP localization 
in G2/M phase cells in strains where the lacO array was inserted into either the 
rDNA or telomere (33). When the sister chromatids are cohesed, there is a single 
GFP signal per cell, while cohesion loss gives rise to two GFP spots in each cell 
(33) (Fig. 11A). I found that the percentage of separated sister chromatids was  
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Figure 11. Loss of cohesion is observed during aging. (A) Representative 
images of the cohesion assay are shown on the left and quantitation is shown on 
the right. (B) Quantification of loss of cohesion at rDNA and telomeric regions 
with aging as indicated by separated sister-chromatid percentage, from 
visualizing GFP lac repressor in G2/M cells. Average and standard error of mean 
of three replicates are plotted. Arrows indicate one spot (young cell) or two spots 
(old cell) of GFP lac repressor. Asterisk (*) indicates significant changes in old 
from young (p<0.05), as determined by the Student’s t-test. 
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significantly higher at both the rDNA and telomere in older cells (Fig. 11B). As 
such, there is a significant loss of cohesion with aging at the rDNA and other 
regions of the genome. 
 
3.2.4. Cohesin displacement from the rDNA does not correlate with non-
coding RNA transcription  
I further examined the relationship between non-coding RNA expression 
from the rDNA and cohesion, as it relates to longevity in the rDNA theory of aging 
(112). Previously, when transcription was induced from the galactose-inducible 
bidirectional Gal1/10 promoter (Gal-pro) that was inserted in place of the native 
E-pro promoter in the NTS1 locus (Fig. 12A), it increased rDNA instability and 
reduced lifespan (149). On the contrary, transcription inhibition from Gal-pro by 
addition of glucose reduced rDNA instability and increased lifespan (149). Using 
the same strains but with HA-tagged Mcd1, I asked whether induction of non-
coding transcription from NTS1 is sufficient to displace cohesin. I found that 
neither repression nor induction of NTS1 transcription by Gal-pro had a 
significant effect on cohesin occupancy at CARL2 (Fig. 12). Meanwhile, both 
repression and induction of NTS1 transcription by Gal-pro caused a significant 
reduction of cohesin occupancy at CARL3 and CARL3-N, two intergenic non-
coding regions of the rDNA within other copies of the rDNA repeat (Fig. 12). 
Noteworthy, repression of NTS1 transcription led to the greatest loss of cohesin 
occupancy at these sites (Fig. 12). As such, while NTS1 transcription may limit 
replicative lifespan (149), this is independent of its effect on cohesin occupancy  
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Figure 12: NTS1 or NTS2 transcription does not directly correlate with 
cohesin association. (A) Schematic representation of the experimental system, 
where native E-pro promoter at NTS1 locus of all the rDNA repeat units has been 
replaced with galactose-inducible and glucose-repressible Gal-pro promoter. (B) 
ChIP analysis to measure Mcd1 occupancy at the indicated regions of rDNA from 
strains with E-pro or Gal-pro driving expression at NTS1 following transcriptional 
induction of Gal-pro by galactose or repression by glucose. Data shown here was 
Figure'12'
Galactose Glucose 
NTS1 
Cohesin 
CAR 
5S 
rDNA 
NTS2 
Gal-pro 
35S 
rDNA 
R
el
at
iv
e 
M
cd
1-
H
A 
le
ve
l 
(r
el
at
iv
e 
to
 E
-p
ro
) 
Galactose Glucose 
CARL2 CARL3 CARL3-N  
0.0
0.2
0.4
0.6
0.8
1.0
1.2
A 
B 
 70 
normalized to a positive control region and then to E-pro. Average of two 
independent experiments are plotted here. Error bars indicate experimental 
variations.  
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at the rDNA. Our findings disagree with the previously made conclusion that 
NTS1 transcription leads to displacement of cohesin while NTS1 repression 
leads to maintenance of cohesion (113). 
 
3.2.5. The majority of the non-coding RNA in old cells arises from ERCs 
Since I found no correlation between NTS1 transcription and cohesin 
occupancy (Fig. 12), I asked whether the non-coding RNAs produced during 
aging come from the rDNA on chromosome XII or whether they are expressed 
from the ERCs. I measured the non-coding rDNA transcript levels in wild type 
yeast and a fob1∆ mutant, where ERCs accumulate to a much lower degree 
during aging (110). Because the fob1∆ mutant cells live longer, we isolated cells 
with a mean age of ~30 replicative divisions and found that deletion of FOB1 
caused an 8-fold reduction in NTS1 transcription, and a 30 fold reduction in 
NTS2 transcription, in old cells (Fig. 13A, B). As such, I conclude that the 
majority of NTS1/2 transcription in old cells comes from the ERCs and not from 
chromosome XII. 
 
3.2.6. Expression of Mcd1, the limiting sub-unit of cohesin complex, is 
reduced during aging 
All of our evidence so far suggested that the loss of cohesin and cohesion 
during aging was not related to non-coding transcription from the rDNA. Rather I 
found the cohesion loss during aging extends in other genomic regions as well, 
indicating a more global change. Therefore, I asked whether the protein level of  
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Figure 13. NTS1 and NTS2 intergenic transcripts in old cells are largely 
contributed by extra-chromosomal rDNA circles (ERCs). Strand-specific 
qRT-PCR analysis to examine the fold increase in non-coding RNA levels in old 
cells from both strands of (A) NTS1 and (B) NTS2 in comparison to young cells in 
both WT and fob1∆ strains. RNA levels were normalized to ACT1 transcript 
levels before normalizing to 1 for young cells in each case. Average and 
standard error of mean of two replicates are plotted. Asterisk (*) indicates 
significant changes in between groups as indicated (p<0.05), as determined by 
the Student’s t-test.  
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cohesin components is reduced during aging. Loading total protein samples from 
equal numbers of cells, I found that the level of the rate limiting Mcd1 subunit of 
cohesin was drastically reduced during aging (Fig. 14A). I also observed a very 
similar decrease when I analyzed Mcd1 levels during aging when I normalized 
sample loading to equal DNA content (Fig. 14B). Therefore, I conclude that a 
lower protein level of Mcd1 is the likely explanation for the global cohesion defect 
in old cells. 
 
3.2.7. The rDNA locus undergoes unequal recombination and repeat 
number variation during aging  
Increased NTS1 and NTS2 transcription (Fig. 8) together with loss of 
cohesin occupancy (Fig. 10) at the rDNA region during aging, and the already 
existing correlation of rDNA with aging prompted us to ask if there is unequal 
recombination at rDNA in old cells resulting in rDNA repeat 
expansion/contraction. I compared the length of chromosome XII in young and 
old cells via pulse-field gel electrophoresis (PFGE) followed by Southern blot with 
an rDNA specific probe (Fig. 15A). Chromosome XII in aged cells showed 
variability in its size with two main populations, one having gained rDNA repeats 
and one having lost rDNA repeats. Meanwhile young cells showed only one band 
that corresponds to chromosome XII, indicating uniform rDNA locus length in the 
majority of young cells. I asked at what age the rDNA locus started showing 
variability, and found that the rDNA repeat number variability starts arising from 
middle age (~14-15 divisions) and progressed with the age (Fig. 15B). Of note,  
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Figure 14. Cohesin sub-unit, Mcd1, level is lower in old cells. (A) Western 
blot analysis to measure protein levels of HA-tagged Mcd1 in young and old 
cells, with untagged strain as a control. Samples are loaded according to equal 
cell numbers. Histone H3 protein level is used as a control, which is known to be 
decreased in old cells (Feser et al., 2010). (B) Western blot analysis similar to A, 
but samples are loaded here according to same DNA equivalent.  
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Figure 15. The rDNA locus undergoes unequal recombination with age. (A) 
Analysis of intact yeast chromosomes by PFGE from young and old yeast cells. 
Left panel shows staining pattern of chromosomes by SYBR safe. Right panel 
shows Southern hybridization using a Chr XII (rDNA) specific probe. The rad52∆ 
mutant is used as a control that shows a different rDNA copy number. (B) Similar 
analysis as Figure 15A, but in this case analysis was done from intact yeast 
chromosomes collected at indicated time points during aging. Left panel indicates 
SYBR safe staining, while right panel indicates Southern hybridization using a 
Chr XII (rDNA) specific probe. Fragmentation of DNA apparently increases with 
age progression, which may also be indicative of rDNA integration at other 
genomic sites.  
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while the rDNA probe displayed chromosome XII specificity in young cells, it 
hybridized to seemingly all other chromosomes in old cells, in addition to 
chromosome XII (Fig. 15A, B). Taken together with our previous observation of 
rDNA sequences fused to other chromosomal sequences apparent from deep 
sequencing of the old genome (40), these southern blots suggest that small 
rDNA repeat fragments insert into other yeast chromosomes during aging. 
 
3.2.8. Formation of branched recombination intermediates increases from 
rDNA during aging 
While insertions of rDNA repeats into other chromosomes, chromosomal 
amplifications having break points at the rDNA (40) and altered chromosome XII 
sizes (Fig. 15A) in old cells are likely to be the product of inaccurate repair of 
DSBs within the rDNA, I asked whether I could find direct evidence of rDNA 
recombination actively occurring in old cells. Recombination intermediates are 
unable to enter the PFGE gel, leading to their being stuck in the wells. An 
analysis of ‘stuck DNA’ in the wells has been used to show that there are more 
rDNA recombination intermediates in mother cells (~3-4 generations) compared 
to daughter cells (~0-1 generations) (104). By comparing daughters to much 
older mothers (25 or more generations), I found that chromosome XII from old 
mothers was 4 times more likely to be stuck in the well compared to chromosome 
II from old mothers (Fig. 16A, B), indicating that old cells have more rDNA 
recombination intermediates.   
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Figure 16. Increased rDNA recombination products is observed in old cells. 
(A) Stuck DNA analysis in the gel wells for Chr XII (rDNA) and Chr II. Intact yeast 
chromosomes were analyzed by PFGE. For each chromosome (XII and II), the 
left panel indicates the staining pattern of chromosomes by SYBR safe, the right 
panel shows Southern hybridization using the indicated probe. Closed triangles 
indicates stuck DNA in the well. The same number of cells were analyzed in each 
lane of the gel. (B) Quantification of A is shown. The signal of the chromosomes 
stuck in the well for respective chromosomes was quantified and plotted as the 
relative intensity of stuck DNA in old cells compared to young cells. Three 
independent replicates are plotted here and error bars represent standard error 
of the mean. Asterisk (*) indicates significant changes in band intensity from chr 
II to chr XII (p<0.05), as determined by the Student’s t-test.  
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3.2.9. DNA double-strand break formation at the rDNA locus does not 
increase during aging per se  
Next, I asked directly whether old yeast cells have more DSBs within the 
rDNA locus. To do this, I performed southern analysis with the BglII restriction 
enzyme that cuts proximal to the rDNA and used southern blotting to detect the 
intact DNA fragment and smaller chromosomal fragments due to DSBs at the 
replication fork block (RFB) site (137) (Fig. 17A). While I could detect DNA 
fragments that are due to DSBs around the RFB in young cells, their abundance 
was not significantly increased in aged cells (Fig. 17B). The evidence taken 
together suggests that DSBs at the RFB within the rDNA accumulate with the 
same frequency in old and young cells, but that old cells are more likely to repair 
these DSBs using unequal sister recombination or inaccurate fusion to other 
chromosomes.  
 
3.3. Conclusions 
According to the ‘rDNA theory of aging’, the rDNA locus plays a central 
role in regulating lifespan, where this already fragile region becomes even more 
unstable with the progression of age and acts as an internal sensor to gradually 
lengthen the cell cycle and finally induce senescence (112). This theory further 
emphasizes that ERCs are the by-products of rDNA instability (112), as opposed 
to the idea of ERCs being the cause of aging in budding yeast, as proposed 
earlier (32). Increased transcription from the intergenic regions of the rDNA locus 
due to loss of Sir2-mediated silencing has been proposed to specifically displace  
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Figure 17. rDNA locus does not accumulate more DSBs per se during 
aging. (A) Schematic representation of the location of the probes for Southern 
blot used in this assay within a single rDNA repeat unit. (B) Agarose gel 
electrophoresis measuring DSBs. Genomic DNAs from equal numbers of young 
and old cells are extracted in an agarose plug by restriction digestion by BglII and 
resolved in 1% agarose gel followed by Southern hybridization using DSB probe 
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or control probe, as indicated. Asterisks (*) indicate DNA fragments generated 
potentially from DSBs near the RFB, while arrows indicates control fragments 
resulting from restriction digestion by BglII and no DSB at RFB.  
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cohesin from the rDNA (113) leading to loss or gain of rDNA repeats, rDNA 
instability and aging. In my findings described in this chapter by analyzing the 
events in the true population of aged cells, I have uncovered that rDNA indeed 
becomes more unstable with age but is acting through a different mechanism 
than previously assumed. I observed massive increases in non-coding RNA 
(ncRNA) transcription from the intergenic spacer regions of the rDNA locus of 
aged cells (Fig. 8). However, I found the majority of this ncRNA transcription 
actually was contributed by ERCs by comparing WT cells with a mutant (fob1∆) 
that is known to accumulate fewer ERCs during aging (110) and has a longer 
lifespan (Fig. 13). As such, the idea that enhanced transcription from the non-
coding regions of the rDNA in old cells is what displaces cohesion to lead to 
rDNA instability and aging is likely to be inaccurate.  
Furthermore, I did not find any correlation between induction of non-
coding RNA transcription from the rDNA locus and cohesin occupancy, as even 
forced transcriptional induction of non-coding RNAs from the rDNA locus in 
young cells did not displace cohesin from the rDNA (Fig. 12). This further 
indicates that Sir2-mediated silencing of the non-coding spacer regions of the 
chromosomal rDNA locus is irrelevant to influencing replicative aging. However, 
my results indicate that the rDNA locus undergoes unequal sister-chromatid 
recombination, which starts around middle age and progresses with age (Fig. 
15). I also find that more rDNA recombination intermediates accumulate with 
aging (Fig. 16), which undeniably confirms the proposed increase in rDNA 
instability during aging. While trying to find the reason behind this repeat number 
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change of rDNA copies in old cells, I did not observe any increase in DSB 
accumulation at the rDNA locus in replicatively old cells per se compared to 
young cells (Fig. 17), which probably implies that old cells still repair these DSBs 
at the rDNA but in an inaccurate manner.  
Noteworthy, I observed a significant reduction in cohesin occupancy at the 
rDNA locus during aging (Fig. 10). However, I also found this loss of cohesin 
occupancy and loss of cohesion extended beyond the rDNA locus to other 
genomic sites such as, telomeres and centromeres during aging (Fig. 10, 11). 
This defect is most likely attributed to the reduced levels of the limiting cohesin 
protein Mcd1, which is due in turn to reduced protein synthesis of Mcd1 during 
aging (Tyler lab, unpublished observation) (Fig. 14). Taken together, I conclude 
from this part of my study that the rDNA locus becomes unstable with age, 
potentially contributing to limiting the replicative lifespan. However, this study 
does not rule out the contribution of the increased accumulation of ERCs to 
aging, which may be responsible for possible titration and sequestration of 
different repair factors away from the genome (see next chapter). The loss of 
cohesion observed with aging would explain finally the reason behind the 
accumulation of ERCs during aging, as cohesion is essential for equal sister 
chromatid recombination between the rDNA repeats. However, the effect 
cohesion loss supposedly should have larger implications during aging than only 
affecting the rDNA locus. Given the role of cohesin in promoting DSB repair, loss 
of cohesion may affect global genomic instability to limit replicative lifespan in 
yeast. Furthermore, loss of cohesion during aging is also likely to lead to 
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chromosomal loss and aneuploidy, which would also have a negative 
contribution to replicative lifespan. 
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CHAPTER 4: MECHANISTIC INSIGHTS INTO 
UNDERSTANDING INCREASED DNA LESION 
FORMATION DURING REPLICATIVE AGING 
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4.1. Introduction and Rationale 
As discussed in chapter 1, genomic instability serves as a primary 
hallmark of aging (9). It is a well-conserved aging factor across many different 
organisms (150, 151). As mentioned earlier, the implication of genomic instability 
during aging is further strengthened by the evidence that certain human 
premature aging diseases are characterized by a defect in DNA repair genes 
(121-123, 152). Also, mutations of several repair proteins in yeast result in 
shortening of replicative lifespan (153). However, it is yet to be demonstrated 
whether enhanced DNA repair causes extension of lifespan. Of note, a very 
interesting correlation analysis comparing species with extreme differences in 
lifespan suggested that the longer-living species have higher expression of DNA 
repair genes and superior genome maintenance versus the short-lived species 
(73).  
Our group previously demonstrated drastic loss of histone proteins during 
replicative aging in yeast, which also serves as a cause of aging in yeast (38). 
This loss of histones is a more generalized phenomenon and conserved also in 
multicellular eukaryotes as this has been observed during in vitro replicative 
aging of human fibroblasts (48). As mentioned previously, loss of histones during 
aging implies a more open chromatin conformation with less tight regulation for 
all the biological processes that require access to DNA. Given that chromatin 
structure is extremely critical to maintain genomic integrity, it is possible that an 
open chromatin structure observed during aging would give rise to increased 
genomic instability. We found that this is indeed the case during aging. We 
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showed significant increases in DNA breaks and associated changes resulting in 
increased genomic instability during yeast replicative aging (40). Building on 
these observations, an interesting and challenging goal is to determine the 
molecular mechanism behind the increase in DNA lesions observed during yeast 
replicative aging. Utilizing the budding yeast RLS model system, I sought to 
analyze the possible causes of loss of genomic integrity with aging. Using the 
replicatively aged yeast cells, it is possible to determine whether there is a defect 
in DNA repair per se during yeast replicative aging and whether a decline in DNA 
repair efficiency contributes to the high level of genomic instability and DNA 
lesions observed during aging.  
 
4.2. Results 
 
4.2.1. Increased chromosomal instability proportional to chromosome 
lengths is observed during aging  
My results showed clear evidence of chromosomal fragmentation in old 
cells, apparent from the smearing of the chromosomal signals for all 
chromosomes from old cells upon total DNA staining in all our PFGE analyses. If 
the aging genome experiences random DNA breakage, I predict that the loss of 
intactness of the chromosomes would be inversely proportional to chromosome 
length, with the longest chromosomes becoming least intact with age. From 
quantitation of total DNA staining, I did indeed observe that the intactness of 
chromosomes in old cells was inversely proportional to their length (because we  
 87 
 
Figure 18. The aging genome accumulates random damage. (A) Analysis of 
intact yeast chromosomes by PFGE from young and old yeast cells. Left panel 
shows staining pattern of chromosomes by SYBR safe. (B) Right panel indicates 
the quantification of the chromosomal band intensities as measured from the 
SYBR safe stained gel, following normalization of signal intensity of young cells 
to 100% for each chromosome or group of chromosomes (both for single 
chromosomal band or band corresponding to multiple chromosomes as 
indicated). Average and standard error of mean of three replicates are plotted. 
Asterisk (*) indicates significant changes in old from young (p<0.05), as 
determined by the Student’s t-test. 
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see multiple bands of chromosome XII indicating increased rDNA instability, we 
excluded chromosome XII from this analysis) (Fig. 18A, B). To more accurately 
examine this relationship, I performed PFGE followed by southern blot analysis 
of a long chromosome (chromosome 4, 2nd longest in the yeast genome), a 
middle sized chromosome (chromosome 10) and the smallest chromosome 
(chromosome 1). While the loss of intactness of chromosomes was least for the 
smallest chromosome in old cells, the longer the chromosome was, the greater 
was the loss of intactness observed during aging (Fig. 19A, B). These data 
indicate that there is DNA double-strand break accumulation along the length of 
all chromosomes in old cells.  
 
4.2.2. Global chromosomal instability in old cells is proportional to rDNA 
instability  
To determine whether the global chromosomal instability was somehow 
related to the rDNA instability, we compared the intactness of chromosomes 
during aging between wild type yeast and a fob1∆ mutant which has much less 
DSBs at the RFB within the rDNA (110). With the fob1∆ mutant, we observed a 
similar trend of chromosomal intactness inversely proportional to chromosome 
length in old cells by SYBR safe staining, but the general chromosomal 
intactness was greater in similarly aged fob1∆ mutants in comparison to wild type 
cells (Fig. 20). In order to confirm this finding, we performed southern analysis 
for three chromosomes of different lengths in wild type and fob1∆ mutant yeast, 
comparing the same number of same age cells. In agreement with our previous  
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Figure 19: Increased chromosomal instability proportional to chromosome 
length is observed during aging in WT cells. (A) Analysis of intact yeast 
chromosomes by PFGE from same numbers of young and old WT yeast cells 
followed by Southern hybridization using specific probes against three 
chromosomes of different sizes: long (Chr IV), middle-sized (Chr X) and short 
(Chr I). In each case, left panel shows staining pattern of chromosomes by SYBR 
Figure'19'
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safe and right panel shows Southern hybridization using the indicated probe. (B) 
Quantification of A is shown. The graph shows percent loss of band intensity in 
aged cells measured from Southern blots of respective chromosomes, following 
normalization signal intensity of young cells to 100% for each chromosome. 
Average and standard error of mean of three replicates are plotted. Asterisk (*) 
indicates significant changes in old from young (p<0.05), and also significant 
changes in chromosomal band intensities between chromosomes of different 
lengths in old cells as determined by the Student’s t-test.  
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Figure 20. rDNA instability appears to promote global genomic instability. 
(A) Analysis of intact yeast chromosomes by PFGE from same numbers of young 
and old yeast cells from both WT and fob1∆ strains. The panel shows staining 
pattern of chromosomes by SYBR safe. (B) Quantification of A is shown. The net 
percent loss of chromosomal band intensities during aging measured from 
quantifying band intensities of all chromosomes from SYBR safe stained agarose 
gels using AlphaView software following background correction. Average of two 
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replicates are plotted here. (C) Analysis of intact yeast chromosomes by PFGE 
from same numbers of young and old yeast cells from both WT and fob1∆ strains 
followed by Southern hybridization using specific probes against three 
chromosomes, Chr IV, Chr X and Chr I. In each case, left panel shows staining 
pattern of chromosomes by SYBR gold and right panel shows Southern 
hybridization using the indicated probe.  
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finding, we found the chromosomal intactness was better maintained in the fob1∆ 
mutant when compared to wild type for every chromosome, and that the loss of 
chromosome intactness in old cells was again more pronounced in longer 
chromosomes than smaller ones (Fig. 20). These data indicate that rDNA 
instability is proportional to, and at least in part likely responsible for, loss of 
global chromosomal stability in old cells. 
 
4.2.3. DSB repair is significantly impaired in old cells 
We observed previously that replicatively aged cells accumulate DNA 
breaks (40) and above we found that during the course of aging, DNA damage 
randomly accumulated across the genome (Fig. 18, 19). This raises the question 
of whether there are more DSBs in old cells because there is less repair and / or 
more DNA damage. In order to determine directly if there is a defect in DSB 
repair efficiency in aged cells, I attempted to take advantage of an inducible 
system of DSB induction at a specific site, that is HO endonuclease-inducible 
DSB formation at the MAT locus of budding yeast (139). The expression of HO 
endonuclease is under the control of galactose-inducible and glucose-repressible 
promoter. Therefore, it is possible to specifically induce a DSB at the MAT locus 
at any given time by the addition of galactose and follow the repair kinetics after 
the addition of glucose to repress endonuclease expression. Using semi-
quantitative multiplex PCR analysis, it is possible to measure the degree of HO 
cutting and repair efficiency over the time course, which measures DSB repair 
kinetics. Utilizing the MEP strain carrying inducible HO endonuclease, I  
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Figure 21. The HO endonuclease is ineffective in inducing DSBs in old 
cells. (A) Schematic diagram of the experiment using HO endonuclease for 
damage induction to follow repair dynamics in young and old cells. (B) PCR 
analyses of HO cutting and repair dynamics in young and old cells. While young 
cells show HO sensitivity and efficient cutting and repair dynamics, HO 
endonuclease activity is undetectable in old cells. 
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measured the HO cutting and repair dynamics in young and old cells following a 
repair time-course (Fig. 21A). While the young cells showed efficient cutting and 
repair dynamics as seen by loss of the MAT alpha PCR product and appearance 
of the MATa PCR product which is a consequence of DSB induction and DSB 
repair at the MAT locus, respectively. However, I could not achieve detectable 
DSB induction at the MAT locus in aged cells, reflected in the constant levels of 
the MAT alpha PCR product (Fig. 21). The most likely reason for this is that there 
is a defect in HO endonuclease protein synthesis, as we have recently observed 
a global defect in protein synthesis during aging (Tyler lab, unpublished 
observation). 
Therefore, in order to examine if DSB repair is defective in old yeast cells, 
I utilized a different approach and induced global DSBs in young and old yeast 
cells using the alkylating agent methyl methane sulfonate (MMS), and compared 
their ability to repair the DSBs by resolving intact yeast chromosomes using 
PFGE. In young cells, MMS treatment induced smearing of the otherwise intact 
chromosome bands that is indicative of DSBs (Fig. 22). However, following 
removal of MMS from the media, within 6 hours young cells repaired most of the 
DNA breaks and the intactness of the chromosomes was restored to the level 
observed before damage induction (Fig. 22). In contrast, there was a clear defect 
in old cells in the ability to re-establish intact chromosomes following MMS 
removal (Fig. 22). The presence of DNA breaks causes cells to accumulate in 
G2/M phase (154, 155). By examining the cell cycle stage of the cell populations 
during induction of MMS and washing out the DNA damaging agent, it was clear  
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Figure 22: Old cells have impaired DSB repair. Analysis of intact yeast 
chromosomes by PFGE from same numbers of young and old WT yeast cells for 
each time point during repair a time-course as indicated in the figure. Samples 
were collected before damage induction (Unt), addition of MMS to a final 
concentration of 0.07% for 30 mins (MMS), and post-MMS removal and recovery 
up to 6 hours (3 and 6, respectively). Samples in the first two lanes (Unt, MMS in 
Young) are not purified through columns as required for collection of samples 
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using MEP, as controls for the method. The panel shows staining pattern of 
chromosomes by SYBR safe.  
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Figure 23. Old cells are predominantly at the G2/M phase of the cell cycle. 
Budding index of young and old samples collected during DNA repair time-
course. Result from two independent replicates are shown here. Over a 100 cells 
were examined before (pre) or at various hours after washing out MMS, as 
indicated by the numbers.  
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that the young cells accumulate in G2/M phase consistent with activation of the 
DNA damage checkpoint, following DNA damage and subsequently reenter the 
cell cycle following DNA repair (Fig. 23). By contrast, the old cells were already 
predominantly in G2/M phase even prior to inducing damage, indicating that they 
may already be experiencing an activated cell cycle checkpoint due to DNA 
damage (Fig. 23). This is consistent with old cells having more DNA damage 
perhaps due to the inability of old cells to repair DSBs. Taken together, these 
data clearly show that DSB repair is defective in old yeast cells. 
 
4.2.4. Levels of several DNA repair proteins are reduced in old cells 
Most DSB repair in yeast is performed by the homologous recombination 
(HR) pathway (118). Therefore, I asked whether there are reduced levels of key 
HR proteins in old cells. Indeed, the levels of several key proteins involved in 
different stages of HR were severely reduced during aging when I compared the 
protein levels in young and old cells (Fig. 24), including the resection proteins 
Mre11 and Sae2, single strand DNA binding proteins RPA (Rfa1 and Rfa2), the 
stand exchange protein Rad51, the DNA damage response kinase Rad53 and 
Rad54, the protein involved in a late postsynaptic step of HR to complete the 
repair process (117, 119, 156). The only HR protein that did not appear to have 
significantly reduced levels during yeast aging was Rad52, Because the protein  
levels of most key HR proteins were significantly reduced in old cells, it is likely 
that this is the reason why DSB repair efficiency is compromised in aged yeast 
cells. 
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Figure 24. Reduced expression level is observed for key DNA repair 
proteins in old cells. Western blot analysis to measure levels of key DNA repair 
proteins in young and old cells. Samples are loaded according to equal cell 
numbers. Left panel indicates proteins tested using available antibodies, while 
panel in right shows HA-tagged proteins with untagged strain as additional 
control. Histone H3 protein level has been shown in each case as a control, 
which is decreased in old cells. Below is shown the Ponceau stained membrane 
to show equal protein loading. 
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4.2.5. Over-expression of key DNA repair proteins (Rad51 and Mre11) 
partially reverses the accumulation of DNA damage with age  
To investigate whether the reduced levels of HR proteins in old cells is 
responsible for the profound defect in DSB repair in old cells (Fig. 24), I 
overexpressed an extra copy of several of the key HR proteins and asked if it 
could restore DSB repair. We have shown previously that aged cells show 
increased accumulation of γH2A foci, which is indicative of increased break 
accumulation during aging (40). When I overexpressed Rad51, I found a 
significant reduction of γH2A foci formation in old cells (Fig. 25A). Similarly, 
overexpression of Mre11 also led to a significant reduction of γH2A foci formation 
in old cells (Fig. 25B). It has been shown previously that an extra copy of the 
RAD51 gene extends replicative lifespan in yeast (136). Taken together these 
data indicate that the reduced DSB repair that occurs in old cells is possibly a 
cause of aging, because partially fixing the DSB repair defect in old cells extends 
replicative lifespan. 
 
4.3. Conclusions 
There are several lines of evidence that illustrates the necessity for proper 
genome maintenance to rightfully execute different cellular functions (115, 116). 
Given the gradual decline in all molecular and cellular functions during aging, 
loss of genomic integrity has long been implicated as a causative factor for aging 
(9). Significant increase in the accumulation of DNA breaks has already been 
observed in replicatively aged yeast cells by our laboratory (40). In this chapter, I  
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Figure 25: Over-expression of key repair proteins reduces genomic 
instability. (A) Quantification of percentage of young and old cells with 
detectable γH2A foci as measured by immunofluorescence, in both WT and 
single copy Rad51-overexpression (OE) strains. Three independent replicates 
are analyzed here. Error bars represent standard error of mean. Asterisk (*) 
indicates significant changes in between groups as indicated (p<0.05), as 
determined by the Student’s t-test. (B) As in A, but for Mre11-overexpression.  
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sought to characterize the potential mechanism behind the reason for this 
increased genomic instability observed during aging.  
My findings suggest that an aging genome accumulates random damage 
as a function of time (Fig. 18, 19). I also found a direct correlation between rDNA 
instability / ERC levels and accumulation of global chromosomal damage during 
aging (Fig. 20). Specifically, global DSB damage accumulation was less in a 
mutant (fob1∆) where the rDNA is less recombinogenic and has less ERCs 
(110). It is believed for a long time that accumulation of DNA mutations over a 
period of time impacts organismal aging (69, 70). However, a recent study 
indicated that mere accumulation of somatic DNA mutations, at least in budding 
yeast, does not have a causal role in aging by measuring de novo mutations in 
daughters from mothers of different ages (71). Therefore, it needed to be 
conclusively determined whether a declining DNA repair response was 
responsible for the increased accumulation of damage as a function of age. 
Here, using the replicatively aged yeast cells, I found an impaired DNA repair 
response in aging cells that cannot resolve increasing accumulation of DNA 
lesions efficiently (Fig. 22). Although I could not rule out the possibility that this 
decline in DNA repair response is due to failure of specific DNA repair proteins to 
be recruited at the DSB sites during aging, I uncovered that the levels of most of 
the DNA repair proteins are lower in aged cells (Fig. 24). This indicates that while 
the demand for the repair proteins is higher in aged cells due to an increased 
burden of damage accumulation, the supply of repair proteins is lower, limiting 
the ability of the aging cell to maintain its genomic integrity. I confirmed this by 
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over-expressing specific proteins involved in the DNA repair response. Following 
over-expression of specific repair proteins, I found that similar age-matched cells 
to WT cells show lower abundance of DNA damage as indicated by decrease in 
γH2A foci formation (Fig. 25), indicating an improved DNA repair response 
following over-expression of these proteins. Over-expression of one of these 
proteins, Rad51, has already been shown to extend budding yeast replicative 
lifespan (136). Although the reason for this was unknown, this result together 
with ours indicates that enhancement of the DSB repair response leads to 
lifespan extension. Furthermore, I found evidence that maintaining rDNA stability 
protects global genomic integrity during aging, as a strain with higher rDNA 
stability and longer lifespan showed better chromosomal integrity in comparison 
to WT age-matched yeast cells. Taken together, I conclude from this part of my 
study that the combination of rDNA instability and lower levels of DNA repair 
proteins possibly due to translation defects are accountable for the functional 
decline of DNA repair in aged cells contributing to the loss of genomic integrity. 
Maintaining or enhancing the repair response may possibly serve as a potential 
way for the extension of replicative lifespan in budding yeast.  
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DISCUSSION 
The inherent complexity of aging biology is an ongoing area of interest, as 
there are continued efforts to find out therapeutic ways to delay the onset of 
aging or age-associated diseases. Understanding the molecular details during 
the aging process is thus imperative to achieve that goal. During an organisms’ 
lifetime, aging cells experience diverse changes and the aging phenotypes are 
the manifestation of the cumulative effect of all these alterations. Even after all 
these efforts by multiple groups to understand aging biology, there are still large 
gaps in our knowledge of what changes happen during aging. In this thesis work, 
I have presented an unparalleled analysis of the changes an aging cell 
experiences from a genomic integrity point of view. The goal of this work was to 
attain a comprehensive understanding of the loss of function experienced by an 
aging genome. To my advantage, I used the single-celled eukaryote budding 
yeast RLS, which provides a simplified model of the organismal aging process. 
Given the high similarity of signaling pathways among eukaryotic organisms, the 
knowledge I gained from these analyses may apply to the aging process of 
multicellular eukaryotes as well.  
Here, in the work presented in chapters 3 and 4, I have uncovered a 
global loss of cohesion occurring in replicatively aged cells and this is the likely 
cause of increased rDNA instability and ERC accumulation in old cells, which we 
find, in turn, leads to global genomic instability in replicatively old cells. 
Furthermore, I have discovered a profound defect in DSB repair in replicatively 
old yeast due to limiting levels of key components of the homologous 
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recombination machinery. This DSB repair defect in old cells limits the replicative 
lifespan, because restoration of DSB repair by overexpressing HR proteins 
ameliorates age-associated changes, extending lifespan.  
The vast majority of yeast aging studies to date have focused on 
identifying different mutants or conditions that shorten or lengthen lifespan. This 
was because budding yeast enables the accurate measurement of replicative 
lifespan. Conversely, the experimental difficulty in collecting sufficient numbers of 
old yeast is responsible for the very sparse knowledge of the phenotype, 
physiology and molecular health of replicatively old yeast cells. The 
transformative MEP genetic system has enabled the molecular study of 
replicatively old yeast cells (100) really for the first time. I used the MEP in this 
study to uncover novel events occurring in yeast that are at, or beyond, their 
median replicative lifespan, providing extensive novel insight into genomic 
integrity in these cells and its role in determining lifespan. 
 
Loss of cohesion during replicative aging  
 The likely reason why I observed an increase in rDNA instability during 
aging was the decreased cohesin occupancy at the rDNA locus of aged cells. 
Loss of cohesion may serve as the reason behind unequal recombination in 
between tandem repeats resulting in changes in repeat numbers. In addition to  
the rDNA locus, cohesion defects observed during aging extended also to other 
genomic sites including telomeric and centromeric regions in aged cells. This 
defect is likely caused by the reduced levels of the limiting subunit of cohesin 
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complex, Mcd1, due to reduced protein synthesis of Mcd1 during aging as found 
from the work done in other studies in our lab (unpublished observations). Given 
the reduced levels of cohesin in old cells, it is probable that there is a global loss 
of cohesion in mitotically aged cells beyond the regions that we have examined. 
The potential implications of this loss of cohesion for human disease and lifespan 
are multifold. First, loss of cohesion at centromeres would lead to chromosome 
loss and gain during mitotic aging. Indeed, cohesion loss has previously been 
observed during meiotic aging mostly at centromeres, and to some degree at 
chromosome arms. This loss of cohesion in meiosis has been demonstrated to 
be the leading cause for mis-segregation of chromosomes associated with 
advanced maternal age, giving rise to birth defects and developmental 
abnormalities (157, 158). Loss of cohesion during mitotic aging would also 
contribute towards increased genomic instability given that cohesin is recruited to 
DSBs to promote accurate DSB repair (159, 160). Loss of cohesion would also 
lead to unequal sister chromatid recombination as I observed during aging 
between repeats and ERC accumulation.  
The accumulation of ERCs has long been known to occur during yeast 
aging and has even been proposed to be a causative reason for yeast aging 
(32). However, the molecular reason for ERC accumulation during aging has 
never been known. ERCs accumulate due to unequal sister chromatid 
recombination between the rDNA repeats (107). The loss of cohesion during 
aging that I have uncovered here is undoubtedly the cause for the accumulation 
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of ERCs during aging, as cohesion is essential for equal sister chromatid 
recombination between the rDNA repeats.  
Formation of extrachromosomal circular DNA similar to ERCs has also 
been reported during Drosophila aging (25). Importantly, extrachromosomal 
circular DNAs also appear during both in vitro and in vivo aging of mammalian 
cells (161, 162). It is possible that cohesion is also lost during aging of 
metazoans including mammals, and is responsible for the circular DNA 
accumulation seen in these systems. We know very little about the roles played 
by these circular nucleic acids in complex model organisms during aging. 
Interestingly, rDNA instability has been shown to occur during some adult solid 
tumors as well (143), where cancer is a disease of aging. Given that previous 
studies (149) have correlated the levels of non coding RNA from the rDNA with 
lifespan in budding yeast, it is relevant that I have found that the vast majority of 
the non-coding RNA transcription occurring during aging is coming from the 
ERCs. This places ERCs center stage again for contributing to perturbing cellular 
homeostasis, potentially by sequestering factors that are required for efficient 
DSB repair. This brings us to the causal role that we have observed for rDNA 
instability/ERCs in global chromosomal instability. 
 
Instability of the rDNA and its influence on global chromosomal stability 
during aging 
My findings reveal inability of aging cells to maintain genomic integrity as 
demonstrated by the accumulation of random damage along chromosome arms 
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compromising chromosomal stability. This is most likely due to a declining DNA 
repair efficiency in aging cells. But a potential influence of rDNA instability over 
global genomic integrity cannot be ignored as well. It is probable that an unstable 
rDNA locus and / or accumulated ERCs in the nucleolus that accumulates with 
increased mitotic age, titrates key limiting factors, which would otherwise be 
available to maintain genomic integrity, as suggested previously (29, 32). Future 
studies should aim to determine whether key repair factors translocate to fragile 
sites like rDNA in the genome during age progression. 
Another study using the MEP, albeit analyzing much younger old cells that 
had undergone approximately 9 divisions, compared to our analysis of cells that 
have undergone 25 or more divisions, found reduced pausing of the replication 
machinery at the RFB within the rDNA in older cells (163). The molecular reason 
for this is currently unknown. Regardless, this result is consistent with the fact 
that we find the level of DSBs close to the RFB to be similar in old and young 
cells, while the efficiency of DSB repair is greatly reduced in old cells. As such, it 
is possible that old cells have reduced generation of DSBs near the RFB 
because of reduced replication fork pausing, but in old cells these DSBs are not 
effectively repaired, leading to equivalent steady state levels of DSBs at the RFB 
in young and old cells. This would be in agreement with the fact that the length of 
chromosome XII in old cells adopts two primarily distinct lengths, as opposed to a 
distribution of chromosome XII fragments that would result if there were multiple 
unequal sister chromatid recombination events due to the loss of cohesion in old 
cells. The fact that old cells only show two main lengths of chromosome XII 
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indicates that either somehow all old cells undergo unequal sister chromatid 
cohesion in order to yield similarly reduced and increased numbers of rDNA 
repeats. Alternatively, there may be one event of unequal sister chromatid 
recombination in middle age and subsequent cells maintain these numbers of 
rDNA repeats, perhaps because old cells are unable to efficiently repair the DSB 
at the RFB by recombination.   
 
Reduced homologous recombination in yeast limits the replicative lifespan 
My studies reveal a defect in DSB repair, presumably via homologous 
recombination, in replicatively aged yeast cells that may function to limit 
replicative lifespan. The importance of the role of DSB repair in determining 
lifespan and normal cellular health is consistent with the fact that yeast deleted 
for key HR proteins have a very short lifespan (153). I uncovered the molecular 
reason for the HR repair defect in replicatively old yeast cells as reduced levels 
of key HR proteins in old cells, possibly due to a defect in their protein synthesis 
(Tyler lab, unpublished observation). In agreement with our observations in 
yeast, a decline in HR repair efficiency has been reported during replicative 
senescence of human fibroblast cells in vitro and also during meiotic aging in 
germ cells of old Drosophila using reporter assays (68, 164). It is interesting to 
note that replicative senescence of human fibroblasts was accompanied by 
reduced levels of key HR proteins, including Rad51, Rad52, NBS1 and SIRT6 
(68), demonstrating that reduced levels of key HR proteins is a common feature 
of replicative aging of yeast and humans. In human fibroblasts, however, the HR 
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repair defect during replicative senescence is likely due to reduced protein levels 
of the histone deacetylase SIRT6, as SIRT6 overexpression reestablished DSB 
repair (68).  
 Interestingly, maintaining the optimal levels of the HR protein Rad51 
seems extremely important in maintaining genomic integrity. While deficiency of 
Rad51 renders increased sensitivity for DNA damaging agents in both budding 
and fission yeast (165, 166), targeted Rad51 disruption results into 
accumulations of chromosomal aberrations leading to cell death in vertebrate 
cells and cell lethality in mouse ES cells (167, 168). Rad51-overexpression also 
has certain adverse effects on both yeast influencing DSB-induced HR and 
mammalian cells promoting chromosomal instability (169-171). However, over-
expression of a single copy of Rad51 in yeast seems to be better tolerated and is 
in fact beneficial for longevity, as illustrated by moderate lifespan extension in 
yeast (136). Our analyses further indicate that over-expression of a single copy 
of Rad51 could partially fix the DSB repair defect in aged yeast cells, which may 
serve as a potential reason behind the extension of replicative lifespan observed 
following Rad51 over-expression. Importantly, a single extra copy over-
expression of another protein implicated during DNA repair, Mre11, shows very 
similar effect in aged cells in partially fixing the DSB repair defect. Although very 
limited information is available about the effect of Mre11 over-expression, 
previously deficiency for this protein has been shown to cause increased damage 
sensitivity and a profound deficiency in DSB repair in budding yeast (172). Taken 
together, these results indicate that decline in the level of key proteins during 
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aging results into a compromised genomic integrity and modulating the level of 
repair proteins in a balanced way to compensate the repair defect observed 
during aging may serve as a potential way to extend lifespan.  
 As mentioned earlier, a declining HR response with replicative age seems 
to be a more generalized phenomenon than previously assumed. Aging also 
serves as the greatest carcinogen, and in certain instances aging and cancer 
share common etiologies (76). An impaired HR response has long been 
associated with increased genomic instability to initiate carcinogenesis as well 
(173). While hypoxic microenvironment characteristic to cancer cells seems to 
accelerate genomic instability by reducing Rad51 expression, therefore also 
causing a reduction in HR efficiency (174), wide ranges of tumor tissues also 
show elevated Rad51 levels (171, 175), which seems somewhat counter-
intuitive. In general genomic instability has a negative impact on cell growth. 
Therefore, over-expression of Rad51 may be assumed as a plausible counter-
measure taken by tumor cells with HR defects to selectively overcome that 
defect, in order to re-gain genome stabilization as well as to experience a 
survival advantage as proposed by one earlier model (173). Additionally, Rad51 
over-expression is also associated with a number of consequences including 
increased damage resistance. Over-expression of Rad51 possibly also 
contributes for the resistance to radiation therapy or DNA damage therapeutics 
for these tumors (171). Interestingly, in a similar fashion over-expression of 
Mre11 has also previously been shown to promote radioresistance via an 
enhanced DNA repair mechanism in breast cancer (176). How and where the 
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mechanisms behind these two outcomes, a declining HR response during aging 
and selective pressure of tumor cells to survive by overcoming that response 
diverge remains subject to further investigation, but all these evidence further 
emphasize that tightly controlled and balanced regulation of repair proteins is 
crucial for proper functioning of the cells.  
With mitotic age progression, the available cellular resources become 
limiting, and problems start arising, including defective cohesion, defective DSB 
repair and inaccurate repair of DSB lesions within the rDNA, as we have 
uncovered here (Fig. 26). Eventually the limiting levels of repair factors and 
cohesin in old cells causes the accumulation of genomic damage, chromosomal 
rearrangements and potentially chromosome loss. We propose that eventually a 
threshold of genomic damage is crossed that is sensed by the cell to cause cell 
division to halt marking the end of the replicative lifecycle.  
 
FUTURE DIRECTIONS 
The major limitation in the field of aging research is that most of the time it 
depends on correlational analysis. This is because of the difficulty in performing 
functional analyses at the molecular level, the long length of the aging 
experiments especially when performed in larger eukaryotes and the complexity 
of aging biology with the potential influence of other environmental factors. There 
is still a great deal to learn about this highly complex biological process. 
Development of new vertebrate and invertebrate model systems suitable for 
aging research such as African killifish and naked mole rats, and transformative  
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Figure 26. Working model for rDNA instability and reduced homologous 
recombination (HR) causing global genomic instability to limit lifespan. 
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genetic systems such as the MEP provide invaluable tools in this complex field of 
research. Similarly, development of microfluidic systems also enables 
researchers to perform broad genetic screens in a high throughput manner (98). 
Our current progress in knowledge and extensive utilization of next-generation 
sequencing techniques are further empowering us to analyze age-associated 
changes at ever increasing resolution. These developments, together with 
simultaneous gain-of-function or loss-of-function studies performed in different 
organisms, will enable the field eventually to comprehend the causal effects of 
certain pathways during aging, to move beyond correlation analyses.  
The major body of research illustrated in this thesis work demonstrates 
how genomic stability is perturbed during aging. However, we are only starting to 
learn details about the molecular changes happening during aging, not relying 
solely on the correlative analyses. But there is still a lot to learn about the 
process and there are plenty of unanswered questions. I have observed altered 
levels of key repair proteins in aged yeast cells, but my analyses were restricted 
to only a few proteins. An unbiased approach may have been useful in 
understanding the full detailed picture, such as quantitative mass spectrometry. 
However, it needs to be kept in mind that aging cells undergo profound changes 
in all macromolecular levels. Therefore, use of proper normalization controls and 
cautious interpretation of results are extremely important to derive any logical 
conclusion. It will be also interesting to find out whether there are certain 
changes in cellular localization pattern of these repair proteins and if in aging 
cells whether these proteins are sequestered to regions with high fragility. As 
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mentioned earlier, a possible hypothesis suggests ERCs perturb cellular 
homeostasis during aging, potentially by sequestering factors that are required 
for efficient DSB repair. The use of a microfluidic platform coupled with high-
resolution microscopy will be helpful in addressing this question by tracking large 
number of mother cells and following the events during aging. Specifically, it 
would be of interest to use a marker of induced DNA damage response, to 
visualize whether the DNA damage checkpoint is activated during the final 
replicative cell cycle.  
Since extra-chromosomal circular DNAs similar to ERCs have been found 
in other organisms, and also in aged mammalian cells, another interesting aspect 
of study will be to illustrate the roles of these circular nucleic acids in aging, and 
also in other aspects, as we have very little knowledge about them. It will be also 
of interest to learn if loss of cohesion serves as a causal factor to the generation 
of these circular DNAs. As genomes of larger eukaryotes carry more repeat 
sequences than budding yeast, it is highly likely to happen beyond yeast also. In 
particular, it will be important to investigate the broader impact of loss of 
cohesion during aging and to determine if this can serve as a cue for the cells to 
end replicative lifespan. Analysis of cohesion using the GFP assay that I utilized 
here, coupled with microfluidic analyses of the RLS would enable it to be 
determined whether loss of cohesion was consistently apparent in the final cell 
division. To determine whether the loss of centromeric cohesion leads to 
aneuploidy during aging, chromosome loss assays should be performed during 
the yeast RLS to determine if there is a threshold of maternal age above which 
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chromosome loss and gain (aneuploidy) occurs, much like the threshold of age 
for loss of heterozygosity (LOH) observed by Dan Gottschling’s laboratory 
previously. To further analyze whether loss of cohesion is the cause of aging, 
attempts should be made to overexpress cohesins, to see if they extend lifespan. 
I attempted to do this with Mcd1, but the cells did not tolerate the overexpression 
of Mcd1. Perhaps lower level expression could be attempted, to see if it will 
extend the yeast RLS. I also used a strain where cohesin was artificially driven to 
the rDNA via LacO arrays. Unfortunately, this shortened lifespan, presumably 
due to persistent chromosome cohesion throughout the cell cycle (data not 
shown). To determine the relevance of these studies beyond yeast, it will be of 
interest to determine whether there is a loss of cohesion during mitotic aging in 
other organisms, such as replicative senescence of human fibroblasts in culture, 
or hematopoietic stem cells. 
In addition, as we have observed over-expression of certain DNA repair 
proteins could partially ameliorate certain aging phenotype, another interesting 
area of study will be to address what specific changes are associated with the 
compromised genome in aged cells and how over-expression of particular repair 
proteins helps to overcome those defects to possibly extend lifespan. It will also 
be interesting to know if it is a generalized response or only certain proteins 
involved in the DNA repair pathway may serve as the aging factors. In this 
context, it will be important to remember that many of the DNA repair factors are 
involved in interconnected pathways. Therefore, caution should be taken when 
 119 
interpreting the results, to separate the effects of one pathway from the other and 
in certain contexts it may be very difficult to address.  
As genome instability serves as a general hallmark of aging and there is 
evidence suggesting its conserved nature across different organisms, it will be 
also interesting to test whether the molecular reasons for genome instability 
uncovered in my analyses, such as cohesion loss, rDNA instability, and an 
impaired repair response are responsible for aging pathways in other eukaryotes 
as well. Besides the questions above, from a different approach, it will be 
interesting to find out whether specific lifespan-extending regimens influence this 
particular hallmark of aging to cause an extension of lifespan. For example, does 
calorie restriction or rapamycin treatment promote genomic stability?  Calorie 
restriction is known to reduce ERC accumulation, and therefore it would be of 
interest to look at the integrity of chromosomes during aging upon calorie 
restriction, to provide further support for our hypotheses. However, any lifespan-
extending regimen will likely have an impact on multiple pathways, making it 
difficult again to separate specific effects of individual pathways. 
While some of the molecular changes observed during aging are 
categorized as causal factors of aging, there are other changes that simply 
accompany the aging process. While attempting to characterize the causes or 
consequences of aging, extreme cautions need to be taken, because most of the 
relevant pathways are interconnected with each other. It is thus necessary to 
establish the hierarchical relationship among the relevant pathways to 
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understand the causal network of aging in order to derive effective therapies to 
counteract the aging process and to impede age-induced complications. 
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APPENDIX 1: The commercial antibodies against histone H3 lysine 56 
acetylation (H3K56Ac) are non-specific in vitro and in mammalian cells 
This section is based upon our published work: Pal, S., Graves, H., 
Ohsawa, R., Huang, T.H., Wang, P., Harmacek, L., and Tyler, J. (2016). The 
Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-
Specific in Human and Drosophila Cells. PLoS One 11, e0155409.  
Copyright permission is not required as the copyright policy for PLos One 
journal states “PLOS applies the Creative Commons Attribution (CC BY) 
license to articles and other works we publish. If you submit your paper for 
publication by PLOS, you agree to have the CC BY license applied to your work. 
Under this Open Access license, you as the author agree that anyone can reuse 
your article in whole or part for any purpose, for free, even for commercial 
purposes. Anyone may copy, distribute, or reuse the content as long as the 
author and original source are properly cited. This facilitates freedom in re-use 
and also ensures that PLOS content can be mined without barriers for the needs 
of research.” 
 
INTRODUCTION: 
Chromatin structure is the template for all different nuclear processes in all 
eukaryotes. The basic repeating unit of chromatin is called the nucleosome. It 
consists of approximately 147 base pairs of DNA wrapping two molecules of 
each of the histone proteins, H2A, H2B, H3, and H4 around 1.75 times (177). 
Nucleosomes are responsible for efficient packaging and protecting our entire 
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genome. Earlier studies carried out in budding yeast showed that the histone 
needs to be disassembled from chromatin structure for different processes such 
as transcription, DNA repair, and replication to occur (178, 179). Chromatin 
disassembly allows different other machineries mediating these genomic 
processes to gain proper access to the DNA to perform their function efficiently. 
The process of removal of histones from the DNA during these genomic events 
is, in part, understood from the work done in budding yeast. But this process 
requires the involvement of specific proteins called histone chaperones that bind 
to the histones in a stoichiometric manner to remove them from the DNA (180). 
Histone removal from the DNA is further facilitated by different post-translational 
modifications (PTMs) of histone proteins that potentially weaken histone-DNA 
interactions. One of such PTMs is acetylation of histone H3 lysine 56 (H3 K56Ac) 
(181-183). Although the process of histone removal has been described in 
budding yeast, it is yet to be determined whether similar mechanisms exist during 
these genomic processes in metazoans as well.  
The functional study of histone PTMs is rather simplified in budding yeast, 
as there are only two copies for each histone genes and it is relatively easy to 
study the functional effect of any histone PTM by mutating the histone encoding 
genes. In sharp contrast, in metazoan cells, there are hundreds of genes 
encoding each of the canonical histones (184). Therefore, our current knowledge 
about histone PTMs in metazoan cells is mostly restricted to the correlation 
analysis those examine the genome-wide distribution of histone PTMs (185). 
However, these genome-wide analyses do not provide any functional studies of 
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the histone PTMs, and more importantly, such correlative analyses are largely 
dependent on the specificity of the antibodies used against a particular histone 
PTM.    
Histone H3 K56Ac has been initially identified by mass spectrometry 
analysis in mammalian cells (186, 187). Acetylation at this site of histone H3 is 
catalyzed by the histone acetyl transferases (HATs) CBP and p300 in 
coordination with the histone chaperone Asf1 in humans. Chromatin 
immunoprecipitation (ChIP) analyses demonstrating the localization pattern of H3 
K56Ac in stem cells showed this modification to be associated with the regulatory 
regions of different pluripotency genes (186), indicating a potential role of this 
PTM in transcriptional regulation. Since then, large number of studies implicated 
this PTM in transcriptional regulation in metazoan cells, mostly using commercial 
antibodies against H3 K56Ac, and showing H3 K56Ac to be localized at active 
promoters or enhancers in mammalian cells (186, 188-197). Of note, all newly 
synthesized histone H3 proteins in budding yeast are acetylated on H3 K56 
residue. In contrast, in human cells the abundance of this PTM is exceptionally 
low. Mass spectrometry analysis suggests that only 0.03% of all histones carry 
this particular PTM (198). Because of this difference, it is not possible to directly 
apply the knowledge we gained from studies performed in budding yeast on 
humans, as it may be inaccurate considering the physiological difference. All 
these abovementioned studies imply possible roles H3 K56Ac play in 
transcriptional regulation in metazoan systems mostly based on the of its 
localization and/or distribution patterns. However, it is yet to be tested at the 
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functional level. Earlier, mutational analysis in budding yeast showed that H3 
K56Ac promotes transcriptional activation in budding yeast by promoting 
chromatin disassembly by allowing histone proteins to be dissociated from 
promoter regions more readily (199). Based on all these evidence, we were 
interested to examine whether H3 K56Ac plays a similar role during transcription 
in mammalian cells. As there are certain concerns raised about the specificity of 
commercially available antibodies against H3 K56Ac (198), I rigorously tested the 
specificity of the available commercial antibodies against H3 K56Ac. During our 
analyses, I found that all of the commercially available H3 K56Ac antibodies 
showed non-specificity when tested in vitro, and also in mammalian cells, 
recognizing other acetylated lysine residues than lysine 56 on histone H3. 
Therefore, our study provides the proof that the studies being performed in 
mammalian cells using H3 K56Ac antibodies available commercially should be 
interpreted with caution. 
 
MATERIALS AND METHODS 
 
Dot blot 
Lyophilized peptides were rehydrated in 1X PBS at a 300 µM concentration and 
then diluted 10 fold, prior to spotting 10 µl onto an activated PVDF membrane. 
The membrane was air-dried and then stained with amido black to verify the 
presence of the peptides. The membranes were washed in TBST and then 
blocked in 3% non-fat milk in TBST. The blots were incubated in primary 
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antibodies overnight at 4°C. The blots were washed and probed with specific 
HRP conjugated secondary antibodies at room temperature for 1 hr. 
 
Western blot 
Acid extracted histones were separated by SDS-PAGE, probed with the indicated 
antibodies in each figure. Where necessary, the secondary antibody IR dye 
680RD Goat anti-Rabbit IgG (H + L) multiplexed with the IRDye® 800CW Goat 
anti-Mouse IgG (H + L) was used for the 2-color detection method by the 
Odyssey LI-COR imaging system. The H3 K56Ac antibodies used in this and 
other experiments are: Epitomics monoclonal Ab (2134–1), Epigentek polyclonal 
Ab (A-4026-050), Cell Signaling polyclonal Ab (4243S), Upstate polyclonal Ab 
(07–677), Active Motif polyclonal Ab (39281), Active Motif monoclonal Ab 
(61061). The other antibodies used are: N-terminal histone H3 mAb (Active Motif 
39763), C-terminal histone H3 pAb (Abcam ab1791), IRDye 680 Goat anti-rabbit 
IgG (LICOR 926–32221) and IRDye 800CW Goat anti-mouse IgG (LICOR 926–
32210). 
 
Immunohistochemistry (IHC) 
Slides containing paraffin embedded breast cancer tissue samples fixed in 10% 
neutral buffered formalin were obtained from the MD Anderson Pathology core 
and IHC method was optimized in assistance with the Pathology core. In short, 
the sections of the tissues were deparaffinized with xylene and rehydrated in a 
graded series of ethanol (two 100% ethanol wash, followed by 95% ethanol, 70% 
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ethanol, 50% ethanol, 30% ethanol, followed by water). Antigen retrieval was 
performed using heat-induced method following standard procedure. After 
blocking non-specific binding, the sections were incubated with primary antibody 
at indicated dilution (overnight, 4°C, humidified chamber) followed by incubation 
with HRP-conjugated secondary antibody (1 hr, room temperature). For signal 
detection, DAB substrate kit (Vector Laboratories) was used followed by 
counterstaining with Mayer’s Hematoxylin (Sigma). 
 
RESULTS AND DISCUSSION: 
To ensure the specificity of the H3 K56Ac antibodies commercially 
available, I used multiple approaches and tested the specificity of this PTM 
rigorously both in vitro and in mammalian cells within the context of other cellular 
proteins, which is more similar to physiological setting. I first performed a dot blot 
analysis using purified peptides carrying specifically histone H3 K56Ac 
modification, but I simultaneously also used other purified acetylated peptides on 
other sites of histone H3, to ensure the specific binding of the antibody being 
tested. On the dot blot, several of the commercial antibodies (Epitomics, 
Epigentek, and Upstate) failed to recognize H3 K56Ac specifically and 
recognized one or more other acetylated lysine residues from N-terminus of H3 
in addition to recognizing the peptide carrying H3 K56Ac (Fig. 27). From the dot 
blot analysis, it seemed that the more specific antibodies for H3 K56Ac were the 
antibodies from Cell Signaling and Active Motif (two antibodies form Active Motif, 
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Figure 27. The commercial antibodies against histone H3 lysine 56 
acetylation (H3K56Ac) are non-specific in vitro. Dot blot analysis of the 
indicated commercial H3 K56Ac antibodies, tested against the peptides indicated 
above. 10 µl of each peptide at 300 µM concentration was spotted on the top 
row, followed by 10 fold serial dilutions below. A short and longer exposure are 
shown. 
 
Figure 26 
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one monoclonal, and one polyclonal). Therefore, we continued using these 
antibodies for our next level of specificity test in mammalian cells. 
Next, I analyzed the specificity of the antibodies in more physiologically 
relevant condition that is in a crude protein extract. In a crude protein extract, all 
the acetylated lysine residues would exist in physiologically relevant ratios as 
similar to the level normally found inside the cell. To test the specificity of the H3 
K56Ac antibodies mentioned above, I used mammalian H1299 and 293T cell 
lines carrying stably integrated FLAG tagged H3.1 (200), carrying either a wild 
type lysine (K) or lysine 56 (K56) mutated to arginine (R) to prevent acetylation at 
this specific site. As the FLAG-tagged H3 expression level is only about 5% of 
the level of endogenous histones, for this analysis I used acid extracted histones 
to isolate enough amount of protein and to enrich for histone proteins to achieve 
the level of detection for the FLAG-tagged H3 by western blot. Here in this 
analysis, I included wild type 293T cells not expressing any tagged histones also 
as a control, to ensure that the H3 K56Ac antibody was recognizing the right 
band, and not just a background band. Both the histone H3 antibody and the H3 
K56Ac antibodies being tested could recognize full length FLAG-tagged H3 (Fig. 
28). Interestingly, I observed that all of the commercial H3 K56Ac antibodies 
being tested here (Active Motif polyclonal, Active Motif monoclonal, Cell 
Signaling, and Epitomics) could recognize the mutated residue (H3 K56R-FLAG 
tagged protein) almost to the same efficiency as the wild type H3-FLAG (Fig. 28). 
As K56R mutant is deficient in its ability to be acetylated on this residue, this 
result indicates that all of these H3 K56Ac antibodies could recognize either  
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Figure 28. The commercial antibodies against histone H3 lysine 56 
acetylation (H3K56Ac) are non-specific when tested in mammalian cells. 
Western blot analysis of acid extracted histones from 293 cells that were wild 
type (WT) or stably expressed H3.1c-FLAG or H3.1c K56R-FLAG, or from H1299 
cells that stably expressed H3.1c-FLAG or H3.1c K56R-FLAG. * indicates a 
proteolytic degradation product of H3 generated by cleavage of the N-terminus 
that occurs upon generating the total protein extracts. ** indicates a smaller H3 
degradation product seen in the wild type sample only, due to possible over 
Figure 27 
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handling of the extract. Data is shown for the Active Motif, the Epitomics and the 
Cell signalling H3 K56Ac antibodies. 75 micrograms of total protein extract was 
loaded for each lane, and western blotted with the indicated antibodies, followed 
by detection with infrared antibodies on a Licor Odyssey machine.  
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histone H3 or other acetylated residues on histone H3 in the absence of H3 
K56Ac. In order to eliminate the possibility that this non-specificity shown by 
these antibodies was not due to excess antibody concentration being used, I 
tried different dilutions of these antibodies to find an effective dilution at which 
these antibodies would show specificity for H3 K56Ac residue. But for all the 
dilutions I tested, all of these antibodies recognized both wild type H3-FLAG and 
H3 K56R-FLAG almost to an equal level.  
Because the Active Motif monoclonal antibody was the most recently 
developed commercial antibody and it was supposed to a specific antibody for 
the application of ChIP, for which the success of the application depends on the 
ability of the antibody to recognize the native epitopes, I wanted to test the 
specificity of this antibody for recognizing native epitopes but for the application 
of immunohistochemistry (IHC), which utilizes a similar mode of recognition 
following similar fixation approach (Fig. 29A, B). Interestingly, I found this 
antibody to recognize significant amounts of cytoplasmic proteins, even at high 
dilutions (Fig. 29B), further confirming its non-specificity as occurrence of H3 
K56Ac is presumably mostly restricted to the nucleus given that this event is 
mediated by p300 and CBP (187). We also further confirmed the non-specific 
nature of these antibodies in an in vivo model using flies (201).  
Taken together, all these data indicate that at least in my analyses, I could 
not achieve enough specificity for any of the commercially available H3 K56Ac 
antibodies, via dot blot, western analyses, or in certain instances IHC application. 
The non-specificity conferred by these available H3 K56Ac antibodies would  
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Figure 29. A commercial antibody against histone H3 lysine 56 acetylation 
(H3K56Ac) showing specificity in vitro is non-specific when tested in breast 
cancer tissue. (A) Immunohistochemintry (IHC) analysis of the Active Motif 
monoclonal antibody, on breast cancer tissue samples shows non-specific 
cytoplasmic staining instead of distinct nuclear staining. Green arrows point to 
cytoplasm and black arrows point to nuclei. Both slides are also stained with 
haematoxylin and eosin (H&E) stain, which stains nuclei blue and eosinophilic 
structures pink. (B) IHC analysis of breast cancer tissue as (A), using either no 
primary antibody or other indicated dilutions of the antibody being tested here. 
 
 
 
 
Figure 28 
A 
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possibly explain the reason for the confusion for identifying the responsible 
histone deacetylase (HDAC) in mammalian cells, because SIRT1, SIRT2, SIRT6, 
HDAC1, and HDAC2 each have been reported as the potential H3 K56Ac HDAC 
(187, 202-210). Furthermore, the non-specificity of these antibodies could also 
explain the contradictory findings of the occurrence of H3 K56Ac during different 
cellular events such as during the cell cycle and DNA repair (187, 200, 202, 211-
218). Therefore, data obtained with commercially available H3 K56Ac antibodies 
in metazoan cells, is likely due to its ability to recognize additional acetylated 
lysine residues on histone H3, and should be interpreted with utmost caution. 
 
 
 
 
 
 
 
 
 
 
 
 
 	  
 134 
Bibliography 
 
1. Moskalev, A. A., A. M. Aliper, Z. Smit-McBride, A. Buzdin, and A. 
Zhavoronkov. 2014. Genetics and epigenetics of aging and longevity. Cell 
Cycle 13: 1063-1077. 
2. Brunet, A., and S. L. Berger. 2014. Epigenetics of aging and aging-related 
disease. The journals of gerontology. Series A, Biological sciences and 
medical sciences 69 Suppl 1: S17-20. 
3. Kennedy, B. K., S. L. Berger, A. Brunet, J. Campisi, A. M. Cuervo, E. S. 
Epel, C. Franceschi, G. J. Lithgow, R. I. Morimoto, J. E. Pessin, T. A. 
Rando, A. Richardson, E. E. Schadt, T. Wyss-Coray, and F. Sierra. 2014. 
Geroscience: linking aging to chronic disease. Cell 159: 709-713. 
4. Feser, J., and J. Tyler. 2011. Chromatin structure as a mediator of aging. 
FEBS Lett 585: 2041-2048. 
5. Sen, P., P. P. Shah, R. Nativio, and S. L. Berger. 2016. Epigenetic 
Mechanisms of Longevity and Aging. Cell 166: 822-839. 
6. Pal, S., and J. K. Tyler. 2016. Epigenetics and aging. Science advances 2: 
e1600584. 
7. Booth, L. N., and A. Brunet. 2016. The Aging Epigenome. Mol Cell 62: 
728-744. 
8. Guarente, L., and C. Kenyon. 2000. Genetic pathways that regulate 
ageing in model organisms. Nature 408: 255-262. 
 135 
9. Lopez-Otin, C., M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer. 
2013. The hallmarks of aging. Cell 153: 1194-1217. 
10. Goldberg, A. D., C. D. Allis, and E. Bernstein. 2007. Epigenetics: a 
landscape takes shape. Cell 128: 635-638. 
11. Munoz-Najar, U., and J. M. Sedivy. 2011. Epigenetic control of aging. 
Antioxidants & redox signaling 14: 241-259. 
12. O'Sullivan, R. J., and J. Karlseder. 2012. The great unravelling: chromatin 
as a modulator of the aging process. Trends Biochem Sci 37: 466-476. 
13. Zane, L., V. Sharma, and T. Misteli. 2014. Common features of chromatin 
in aging and cancer: cause or coincidence? Trends in cell biology 24: 686-
694. 
14. Fraga, M. F., E. Ballestar, M. F. Paz, S. Ropero, F. Setien, M. L. Ballestar, 
D. Heine-Suner, J. C. Cigudosa, M. Urioste, J. Benitez, M. Boix-Chornet, 
A. Sanchez-Aguilera, C. Ling, E. Carlsson, P. Poulsen, A. Vaag, Z. 
Stephan, T. D. Spector, Y. Z. Wu, C. Plass, and M. Esteller. 2005. 
Epigenetic differences arise during the lifetime of monozygotic twins. Proc 
Natl Acad Sci U S A 102: 10604-10609. 
15. Sargent, M. 2010. Why twins age differently. 
16. Poulsen, P., M. Esteller, A. Vaag, and M. F. Fraga. 2007. The epigenetic 
basis of twin discordance in age-related diseases. Pediatric research 61: 
38R-42R. 
17. Herskind, A. M., M. McGue, N. V. Holm, T. I. Sorensen, B. Harvald, and J. 
W. Vaupel. 1996. The heritability of human longevity: a population-based 
 136 
study of 2872 Danish twin pairs born 1870-1900. Human genetics 97: 319-
323. 
18. Kucharski, R., J. Maleszka, S. Foret, and R. Maleszka. 2008. Nutritional 
control of reproductive status in honeybees via DNA methylation. Science 
319: 1827-1830. 
19. Luger, K., A. W. Mader, R. K. Richmond, D. F. Sargent, and T. J. 
Richmond. 1997. Crystal structure of the nucleosome core particle at 2.8 
A resolution. Nature 389: 251-260. 
20. Kornberg, R. D. 1974. Chromatin structure: a repeating unit of histones 
and DNA. Science 184: 868-871. 
21. Maison, C., and G. Almouzni. 2004. HP1 and the dynamics of 
heterochromatin maintenance. Nat Rev Mol Cell Biol 5: 296-304. 
22. Villeponteau, B. 1997. The heterochromatin loss model of aging. Exp 
Gerontol 32: 383-394. 
23. Tsurumi, A., and W. X. Li. 2012. Global heterochromatin loss: a unifying 
theory of aging? Epigenetics 7: 680-688. 
24. Smeal, T., J. Claus, B. Kennedy, F. Cole, and L. Guarente. 1996. Loss of 
transcriptional silencing causes sterility in old mother cells of S. cerevisiae. 
Cell 84: 633-642. 
25. Larson, K., S. J. Yan, A. Tsurumi, J. Liu, J. Zhou, K. Gaur, D. Guo, T. H. 
Eickbush, and W. X. Li. 2012. Heterochromatin formation promotes 
longevity and represses ribosomal RNA synthesis. PLoS Genet 8: 
e1002473. 
 137 
26. Haithcock, E., Y. Dayani, E. Neufeld, A. J. Zahand, N. Feinstein, A. 
Mattout, Y. Gruenbaum, and J. Liu. 2005. Age-related changes of nuclear 
architecture in Caenorhabditis elegans. Proc Natl Acad Sci U S A 102: 
16690-16695. 
27. Haigis, M. C., and D. A. Sinclair. 2010. Mammalian sirtuins: biological 
insights and disease relevance. Annual review of pathology 5: 253-295. 
28. Guarente, L. 2011. Franklin H. Epstein Lecture: Sirtuins, aging, and 
medicine. The New England journal of medicine 364: 2235-2244. 
29. Oberdoerffer, P., S. Michan, M. McVay, R. Mostoslavsky, J. Vann, S. K. 
Park, A. Hartlerode, J. Stegmuller, A. Hafner, P. Loerch, S. M. Wright, K. 
D. Mills, A. Bonni, B. A. Yankner, R. Scully, T. A. Prolla, F. W. Alt, and D. 
A. Sinclair. 2008. SIRT1 redistribution on chromatin promotes genomic 
stability but alters gene expression during aging. Cell 135: 907-918. 
30. Kennedy, B. K., M. Gotta, D. A. Sinclair, K. Mills, D. S. McNabb, M. 
Murthy, S. M. Pak, T. Laroche, S. M. Gasser, and L. Guarente. 1997. 
Redistribution of silencing proteins from telomeres to the nucleolus is 
associated with extension of life span in S. cerevisiae. Cell 89: 381-391. 
31. Oberdoerffer, P., and D. A. Sinclair. 2007. The role of nuclear architecture 
in genomic instability and ageing. Nat Rev Mol Cell Biol 8: 692-702. 
32. Sinclair, D. A., and L. Guarente. 1997. Extrachromosomal rDNA circles--a 
cause of aging in yeast. Cell 91: 1033-1042. 
 138 
33. Kobayashi, T. 2011. Regulation of ribosomal RNA gene copy number and 
its role in modulating genome integrity and evolutionary adaptability in 
yeast. Cell Mol Life Sci 68: 1395-1403. 
34. Shumaker, D. K., T. Dechat, A. Kohlmaier, S. A. Adam, M. R. Bozovsky, 
M. R. Erdos, M. Eriksson, A. E. Goldman, S. Khuon, F. S. Collins, T. 
Jenuwein, and R. D. Goldman. 2006. Mutant nuclear lamin A leads to 
progressive alterations of epigenetic control in premature aging. Proc Natl 
Acad Sci U S A 103: 8703-8708. 
35. Scaffidi, P., and T. Misteli. 2006. Lamin A-dependent nuclear defects in 
human aging. Science 312: 1059-1063. 
36. Goldman, R. D., D. K. Shumaker, M. R. Erdos, M. Eriksson, A. E. 
Goldman, L. B. Gordon, Y. Gruenbaum, S. Khuon, M. Mendez, R. Varga, 
and F. S. Collins. 2004. Accumulation of mutant lamin A causes 
progressive changes in nuclear architecture in Hutchinson-Gilford progeria 
syndrome. Proc Natl Acad Sci U S A 101: 8963-8968. 
37. Zhang, W., J. Li, K. Suzuki, J. Qu, P. Wang, J. Zhou, X. Liu, R. Ren, X. 
Xu, A. Ocampo, T. Yuan, J. Yang, Y. Li, L. Shi, D. Guan, H. Pan, S. Duan, 
Z. Ding, M. Li, F. Yi, R. Bai, Y. Wang, C. Chen, F. Yang, X. Li, Z. Wang, E. 
Aizawa, A. Goebl, R. D. Soligalla, P. Reddy, C. R. Esteban, F. Tang, G. H. 
Liu, and J. C. Belmonte. 2015. Aging stem cells. A Werner syndrome stem 
cell model unveils heterochromatin alterations as a driver of human aging. 
Science 348: 1160-1163. 
 139 
38. Feser, J., D. Truong, C. Das, J. J. Carson, J. Kieft, T. Harkness, and J. K. 
Tyler. 2010. Elevated histone expression promotes life span extension. 
Mol Cell 39: 724-735. 
39. Dang, W., K. K. Steffen, R. Perry, J. A. Dorsey, F. B. Johnson, A. 
Shilatifard, M. Kaeberlein, B. K. Kennedy, and S. L. Berger. 2009. Histone 
H4 lysine 16 acetylation regulates cellular lifespan. Nature 459: 802-807. 
40. Hu, Z., K. Chen, Z. Xia, M. Chavez, S. Pal, J. H. Seol, C. C. Chen, W. Li, 
and J. K. Tyler. 2014. Nucleosome loss leads to global transcriptional up-
regulation and genomic instability during yeast aging. Genes Dev 28: 396-
408. 
41. Chen, K., Z. Hu, Z. Xia, D. Zhao, W. Li, and J. K. Tyler. 2015. The 
Overlooked Fact: Fundamental Need for Spike-In Control for Virtually All 
Genome-Wide Analyses. Mol Cell Biol 36: 662-667. 
42. Lesur, I., and J. L. Campbell. 2004. The transcriptome of prematurely 
aging yeast cells is similar to that of telomerase-deficient cells. Mol Biol 
Cell 15: 1297-1312. 
43. Liu, L., T. H. Cheung, G. W. Charville, B. M. Hurgo, T. Leavitt, J. Shih, A. 
Brunet, and T. A. Rando. 2013. Chromatin modifications as determinants 
of muscle stem cell quiescence and chronological aging. Cell reports 4: 
189-204. 
44. McCormick, M. A., J. R. Delaney, M. Tsuchiya, S. Tsuchiyama, A. 
Shemorry, S. Sim, A. C. Chou, U. Ahmed, D. Carr, C. J. Murakami, J. 
Schleit, G. L. Sutphin, B. M. Wasko, C. F. Bennett, A. M. Wang, B. Olsen, 
 140 
R. P. Beyer, T. K. Bammler, D. Prunkard, S. C. Johnson, J. K. 
Pennypacker, E. An, A. Anies, A. S. Castanza, E. Choi, N. Dang, S. 
Enerio, M. Fletcher, L. Fox, S. Goswami, S. A. Higgins, M. A. Holmberg, 
D. Hu, J. Hui, M. Jelic, K. S. Jeong, E. Johnston, E. O. Kerr, J. Kim, D. 
Kim, K. Kirkland, S. Klum, S. Kotireddy, E. Liao, M. Lim, M. S. Lin, W. C. 
Lo, D. Lockshon, H. A. Miller, R. M. Moller, B. Muller, J. Oakes, D. N. Pak, 
Z. J. Peng, K. M. Pham, T. G. Pollard, P. Pradeep, D. Pruett, D. Rai, B. 
Robison, A. A. Rodriguez, B. Ros, M. Sage, M. K. Singh, E. D. Smith, K. 
Snead, A. Solanky, B. L. Spector, K. K. Steffen, B. N. Tchao, M. K. Ting, 
H. Vander Wende, D. Wang, K. L. Welton, E. A. Westman, R. B. Brem, X. 
G. Liu, Y. Suh, Z. Zhou, M. Kaeberlein, and B. K. Kennedy. 2015. A 
Comprehensive Analysis of Replicative Lifespan in 4,698 Single-Gene 
Deletion Strains Uncovers Conserved Mechanisms of Aging. Cell 
metabolism 22: 895-906. 
45. Lee, C., and V. Longo. 2016. Dietary restriction with and without caloric 
restriction for healthy aging. F1000Research 5. 
46. McColl, G., D. W. Killilea, A. E. Hubbard, M. C. Vantipalli, S. Melov, and 
G. J. Lithgow. 2008. Pharmacogenetic analysis of lithium-induced delayed 
aging in Caenorhabditis elegans. J Biol Chem 283: 350-357. 
47. Ni, Z., A. Ebata, E. Alipanahiramandi, and S. S. Lee. 2012. Two SET 
domain containing genes link epigenetic changes and aging in 
Caenorhabditis elegans. Aging Cell 11: 315-325. 
 141 
48. O'Sullivan, R. J., S. Kubicek, S. L. Schreiber, and J. Karlseder. 2010. 
Reduced histone biosynthesis and chromatin changes arising from a 
damage signal at telomeres. Nat Struct Mol Biol 17: 1218-1225. 
49. Ivanov, A., J. Pawlikowski, I. Manoharan, J. van Tuyn, D. M. Nelson, T. S. 
Rai, P. P. Shah, G. Hewitt, V. I. Korolchuk, J. F. Passos, H. Wu, S. L. 
Berger, and P. D. Adams. 2013. Lysosome-mediated processing of 
chromatin in senescence. J Cell Biol 202: 129-143. 
50. Vijg, J., and Y. Suh. 2013. Genome instability and aging. Annual review of 
physiology 75: 645-668. 
51. Maslov, A. Y., and J. Vijg. 2009. Genome instability, cancer and aging. 
Biochim Biophys Acta 1790: 963-969. 
52. Sedelnikova, O. A., I. Horikawa, D. B. Zimonjic, N. C. Popescu, W. M. 
Bonner, and J. C. Barrett. 2004. Senescing human cells and ageing mice 
accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell 
Biol 6: 168-170. 
53. Sedelnikova, O. A., I. Horikawa, C. Redon, A. Nakamura, D. B. Zimonjic, 
N. C. Popescu, and W. M. Bonner. 2008. Delayed kinetics of DNA double-
strand break processing in normal and pathological aging. Aging Cell 7: 
89-100. 
54. Mah, L. J., A. El-Osta, and T. C. Karagiannis. 2010. gammaH2AX: a 
sensitive molecular marker of DNA damage and repair. Leukemia 24: 679-
686. 
 142 
55. Liu, B., R. Yip, and Z. Zhou. 2012. Chromatin remodeling, DNA damage 
repair and aging. Current genomics 13: 533-547. 
56. Forsberg, L. A., C. Rasi, H. R. Razzaghian, G. Pakalapati, L. Waite, K. S. 
Thilbeault, A. Ronowicz, N. E. Wineinger, H. K. Tiwari, D. Boomsma, M. P. 
Westerman, J. R. Harris, R. Lyle, M. Essand, F. Eriksson, T. L. Assimes, 
C. Iribarren, E. Strachan, T. P. O'Hanlon, L. G. Rider, F. W. Miller, V. 
Giedraitis, L. Lannfelt, M. Ingelsson, A. Piotrowski, N. L. Pedersen, D. 
Absher, and J. P. Dumanski. 2012. Age-related somatic structural 
changes in the nuclear genome of human blood cells. American journal of 
human genetics 90: 217-228. 
57. Faggioli, F., T. Wang, J. Vijg, and C. Montagna. 2012. Chromosome-
specific accumulation of aneuploidy in the aging mouse brain. Hum Mol 
Genet 21: 5246-5253. 
58. Wang, J., G. J. Geesman, S. L. Hostikka, M. Atallah, B. Blackwell, E. Lee, 
P. J. Cook, B. Pasaniuc, G. Shariat, E. Halperin, M. Dobke, M. G. 
Rosenfeld, I. K. Jordan, and V. V. Lunyak. 2011. Inhibition of activated 
pericentromeric SINE/Alu repeat transcription in senescent human adult 
stem cells reinstates self-renewal. Cell Cycle 10: 3016-3030. 
59. Li, W., L. Prazak, N. Chatterjee, S. Gruninger, L. Krug, D. Theodorou, and 
J. Dubnau. 2013. Activation of transposable elements during aging and 
neuronal decline in Drosophila. Nature neuroscience 16: 529-531. 
60. Dennis, S., U. Sheth, J. L. Feldman, K. A. English, and J. R. Priess. 2012. 
C. elegans germ cells show temperature and age-dependent expression 
 143 
of Cer1, a Gypsy/Ty3-related retrotransposon. PLoS pathogens 8: 
e1002591. 
61. Maxwell, P. H., W. C. Burhans, and M. J. Curcio. 2011. Retrotransposition 
is associated with genome instability during chronological aging. Proc Natl 
Acad Sci U S A 108: 20376-20381. 
62. De Cecco, M., S. W. Criscione, E. J. Peckham, S. Hillenmeyer, E. A. 
Hamm, J. Manivannan, A. L. Peterson, J. A. Kreiling, N. Neretti, and J. M. 
Sedivy. 2013. Genomes of replicatively senescent cells undergo global 
epigenetic changes leading to gene silencing and activation of 
transposable elements. Aging Cell 12: 247-256. 
63. De Cecco, M., S. W. Criscione, A. L. Peterson, N. Neretti, J. M. Sedivy, 
and J. A. Kreiling. 2013. Transposable elements become active and 
mobile in the genomes of aging mammalian somatic tissues. Aging 
(Albany NY) 5: 867-883. 
64. Wood, J. G., and S. L. Helfand. 2013. Chromatin structure and 
transposable elements in organismal aging. Frontiers in genetics 4: 274. 
65. Kanfi, Y., S. Naiman, G. Amir, V. Peshti, G. Zinman, L. Nahum, Z. Bar-
Joseph, and H. Y. Cohen. 2012. The sirtuin SIRT6 regulates lifespan in 
male mice. Nature 483: 218-221. 
66. Mostoslavsky, R., K. F. Chua, D. B. Lombard, W. W. Pang, M. R. Fischer, 
L. Gellon, P. Liu, G. Mostoslavsky, S. Franco, M. M. Murphy, K. D. Mills, 
P. Patel, J. T. Hsu, A. L. Hong, E. Ford, H. L. Cheng, C. Kennedy, N. 
Nunez, R. Bronson, D. Frendewey, W. Auerbach, D. Valenzuela, M. 
 144 
Karow, M. O. Hottiger, S. Hursting, J. C. Barrett, L. Guarente, R. Mulligan, 
B. Demple, G. D. Yancopoulos, and F. W. Alt. 2006. Genomic instability 
and aging-like phenotype in the absence of mammalian SIRT6. Cell 124: 
315-329. 
67. Van Meter, M., M. Kashyap, S. Rezazadeh, A. J. Geneva, T. D. Morello, 
A. Seluanov, and V. Gorbunova. 2014. SIRT6 represses LINE1 
retrotransposons by ribosylating KAP1 but this repression fails with stress 
and age. Nature communications 5: 5011. 
68. Mao, Z., X. Tian, M. Van Meter, Z. Ke, V. Gorbunova, and A. Seluanov. 
2012. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination 
repair during replicative senescence. Proc Natl Acad Sci U S A 109: 
11800-11805. 
69. Vijg, J., and M. E. Dolle. 2002. Large genome rearrangements as a 
primary cause of aging. Mech Ageing Dev 123: 907-915. 
70. Garcia, A. M., R. B. Calder, M. E. Dolle, M. Lundell, P. Kapahi, and J. Vijg. 
2010. Age- and temperature-dependent somatic mutation accumulation in 
Drosophila melanogaster. PLoS Genet 6: e1000950. 
71. Kaya, A., A. V. Lobanov, and V. N. Gladyshev. 2015. Evidence that 
mutation accumulation does not cause aging in Saccharomyces 
cerevisiae. Aging Cell 14: 366-371. 
72. Lombard, D. B., K. F. Chua, R. Mostoslavsky, S. Franco, M. Gostissa, and 
F. W. Alt. 2005. DNA repair, genome stability, and aging. Cell 120: 497-
512. 
 145 
73. MacRae, S. L., M. M. Croken, R. B. Calder, A. Aliper, B. Milholland, R. R. 
White, A. Zhavoronkov, V. N. Gladyshev, A. Seluanov, V. Gorbunova, Z. 
D. Zhang, and J. Vijg. 2015. DNA repair in species with extreme lifespan 
differences. Aging (Albany NY) 7: 1171-1184. 
74. Campisi, J., J. K. Andersen, P. Kapahi, and S. Melov. 2011. Cellular 
senescence: a link between cancer and age-related degenerative 
disease? Seminars in cancer biology 21: 354-359. 
75. Campisi, J. 2013. Aging, cellular senescence, and cancer. Annual review 
of physiology 75: 685-705. 
76. Finkel, T., M. Serrano, and M. A. Blasco. 2007. The common biology of 
cancer and ageing. Nature 448: 767-774. 
77. Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: the next 
generation. Cell 144: 646-674. 
78. Wolters, S., and B. Schumacher. 2013. Genome maintenance and 
transcription integrity in aging and disease. Frontiers in genetics 4: 19. 
79. Hasty, P., J. Campisi, J. Hoeijmakers, H. van Steeg, and J. Vijg. 2003. 
Aging and genome maintenance: lessons from the mouse? Science 299: 
1355-1359. 
80. Burtner, C. R., and B. K. Kennedy. 2010. Progeria syndromes and ageing: 
what is the connection? Nat Rev Mol Cell Biol 11: 567-578. 
81. Arancio, W., G. Pizzolanti, S. I. Genovese, M. Pitrone, and C. Giordano. 
2014. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a 
mini-review. Gerontology 60: 197-203. 
 146 
82. Misteli, T., and P. Scaffidi. 2005. Genome instability in progeria: when 
repair gets old. Nature medicine 11: 718-719. 
83. Tissenbaum, H. A., and L. Guarente. 2002. Model organisms as a guide to 
mammalian aging. Developmental cell 2: 9-19. 
84. Harel, I., B. A. Benayoun, B. Machado, P. P. Singh, C. K. Hu, M. F. Pech, 
D. R. Valenzano, E. Zhang, S. C. Sharp, S. E. Artandi, and A. Brunet. 
2015. A platform for rapid exploration of aging and diseases in a naturally 
short-lived vertebrate. Cell 160: 1013-1026. 
85. Bitterman, K. J., O. Medvedik, and D. A. Sinclair. 2003. Longevity 
regulation in Saccharomyces cerevisiae: linking metabolism, genome 
stability, and heterochromatin. Microbiol Mol Biol Rev 67: 376-399, table of 
contents. 
86. Steinkraus, K. A., M. Kaeberlein, and B. K. Kennedy. 2008. Replicative 
aging in yeast: the means to the end. Annu Rev Cell Dev Biol 24: 29-54. 
87. Longo, V. D., G. S. Shadel, M. Kaeberlein, and B. Kennedy. 2012. 
Replicative and chronological aging in Saccharomyces cerevisiae. Cell 
metabolism 16: 18-31. 
88. Fabrizio, P., and V. D. Longo. 2007. The chronological life span of 
Saccharomyces cerevisiae. Methods Mol Biol 371: 89-95. 
89. Mortimer, R. K., and J. R. Johnston. 1959. Life span of individual yeast 
cells. Nature 183: 1751-1752. 
90. Steffen, K. K., B. K. Kennedy, and M. Kaeberlein. 2009. Measuring 
replicative life span in the budding yeast. J Vis Exp. 
 147 
91. Sutphin, G. L., J. R. Delaney, and M. Kaeberlein. 2014. Replicative life 
span analysis in budding yeast. Methods Mol Biol 1205: 341-357. 
92. Lee, S. S., I. Avalos Vizcarra, D. H. Huberts, L. P. Lee, and M. 
Heinemann. 2012. Whole lifespan microscopic observation of budding 
yeast aging through a microfluidic dissection platform. Proc Natl Acad Sci 
U S A 109: 4916-4920. 
93. Egilmez, N. K., J. B. Chen, and S. M. Jazwinski. 1990. Preparation and 
partial characterization of old yeast cells. Journal of gerontology 45: B9-
17. 
94. Kennedy, B. K., N. R. Austriaco, Jr., and L. Guarente. 1994. Daughter 
cells of Saccharomyces cerevisiae from old mothers display a reduced life 
span. J Cell Biol 127: 1985-1993. 
95. Muller, I. 1971. Experiments on ageing in single cells of Saccharomyces 
cerevisiae. Archiv fur Mikrobiologie 77: 20-25. 
96. Pichova, A., D. Vondrakova, and M. Breitenbach. 1997. Mutants in the 
Saccharomyces cerevisiae RAS2 gene influence life span, cytoskeleton, 
and regulation of mitosis. Canadian journal of microbiology 43: 774-781. 
97. Bacon, J. S., E. D. Davidson, D. Jones, and I. F. Taylor. 1966. The 
location of chitin in the yeast cell wall. The Biochemical journal 101: 36C-
38C. 
98. Jo, M. C., W. Liu, L. Gu, W. Dang, and L. Qin. 2015. High-throughput 
analysis of yeast replicative aging using a microfluidic system. Proc Natl 
Acad Sci U S A 112: 9364-9369. 
 148 
99. Lin, S. S., J. K. Manchester, and J. I. Gordon. 2001. Enhanced 
gluconeogenesis and increased energy storage as hallmarks of aging in 
Saccharomyces cerevisiae. J Biol Chem 276: 36000-36007. 
100. Lindstrom, D. L., and D. E. Gottschling. 2009. The mother 
enrichment program: a genetic system for facile replicative life span 
analysis in Saccharomyces cerevisiae. Genetics 183: 413-422, 411SI-
413SI. 
101. Kobayashi, T. 2006. Strategies to maintain the stability of the 
ribosomal RNA gene repeats--collaboration of recombination, cohesion, 
and condensation. Genes Genet Syst 81: 155-161. 
102. Kobayashi, T. 2011. How does genome instability affect lifespan?: 
roles of rDNA and telomeres. Genes Cells 16: 617-624. 
103. Kobayashi, T. 2008. A new role of the rDNA and nucleolus in the 
nucleus--rDNA instability maintains genome integrity. Bioessays 30: 267-
272. 
104. Ganley, A. R., S. Ide, K. Saka, and T. Kobayashi. 2009. The effect 
of replication initiation on gene amplification in the rDNA and its 
relationship to aging. Mol Cell 35: 683-693. 
105. Unal, E., B. Kinde, and A. Amon. 2011. Gametogenesis eliminates 
age-induced cellular damage and resets life span in yeast. Science 332: 
1554-1557. 
 149 
106. Sinclair, D. A., K. Mills, and L. Guarente. 1997. Accelerated aging 
and nucleolar fragmentation in yeast sgs1 mutants. Science 277: 1313-
1316. 
107. Sinclair, D. A., K. Mills, and L. Guarente. 1998. Molecular 
mechanisms of yeast aging. Trends Biochem Sci 23: 131-134. 
108. Kaeberlein, M., K. T. Kirkland, S. Fields, and B. K. Kennedy. 2005. 
Genes determining yeast replicative life span in a long-lived genetic 
background. Mech Ageing Dev 126: 491-504. 
109. Kaeberlein, M., M. McVey, and L. Guarente. 1999. The SIR2/3/4 
complex and SIR2 alone promote longevity in Saccharomyces cerevisiae 
by two different mechanisms. Genes Dev 13: 2570-2580. 
110. Defossez, P. A., R. Prusty, M. Kaeberlein, S. J. Lin, P. Ferrigno, P. 
A. Silver, R. L. Keil, and L. Guarente. 1999. Elimination of replication block 
protein Fob1 extends the life span of yeast mother cells. Mol Cell 3: 447-
455. 
111. Kaeberlein, M. 2010. Lessons on longevity from budding yeast. 
Nature 464: 513-519. 
112. Ganley, A. R., and T. Kobayashi. 2014. Ribosomal DNA and 
cellular senescence: new evidence supporting the connection between 
rDNA and aging. FEMS yeast research 14: 49-59. 
113. Kobayashi, T., and A. R. Ganley. 2005. Recombination regulation 
by transcription-induced cohesin dissociation in rDNA repeats. Science 
309: 1581-1584. 
 150 
114. Mehta, A., and J. E. Haber. 2014. Sources of DNA double-strand 
breaks and models of recombinational DNA repair. Cold Spring Harbor 
perspectives in biology 6: a016428. 
115. Ciccia, A., and S. J. Elledge. 2010. The DNA damage response: 
making it safe to play with knives. Mol Cell 40: 179-204. 
116. Polo, S. E., and S. P. Jackson. 2011. Dynamics of DNA damage 
response proteins at DNA breaks: a focus on protein modifications. Genes 
Dev 25: 409-433. 
117. Li, X., and W. D. Heyer. 2008. Homologous recombination in DNA 
repair and DNA damage tolerance. Cell research 18: 99-113. 
118. Paques, F., and J. E. Haber. 1999. Multiple pathways of 
recombination induced by double-strand breaks in Saccharomyces 
cerevisiae. Microbiol Mol Biol Rev 63: 349-404. 
119. Jasin, M., and R. Rothstein. 2013. Repair of strand breaks by 
homologous recombination. Cold Spring Harbor perspectives in biology 5: 
a012740. 
120. Sung, P., and H. Klein. 2006. Mechanism of homologous 
recombination: mediators and helicases take on regulatory functions. Nat 
Rev Mol Cell Biol 7: 739-750. 
121. Burgess, R. C., T. Misteli, and P. Oberdoerffer. 2012. DNA 
damage, chromatin, and transcription: the trinity of aging. Curr Opin Cell 
Biol. 
 151 
122. Chen, J. H., C. N. Hales, and S. E. Ozanne. 2007. DNA damage, 
cellular senescence and organismal ageing: causal or correlative? Nucleic 
Acids Res 35: 7417-7428. 
123. Gorbunova, V., and A. Seluanov. 2016. DNA double strand break 
repair, aging and the chromatin connection. Mutat Res 788: 2-6. 
124. White, R. R., and J. Vijg. 2016. Do DNA Double-Strand Breaks 
Drive Aging? Mol Cell 63: 729-738. 
125. Meyer, J. N., W. A. Boyd, G. A. Azzam, A. C. Haugen, J. H. 
Freedman, and B. Van Houten. 2007. Decline of nucleotide excision repair 
capacity in aging Caenorhabditis elegans. Genome biology 8: R70. 
126. Rao, K. S. 2007. DNA repair in aging rat neurons. Neuroscience 
145: 1330-1340. 
127. Goukassian, D., F. Gad, M. Yaar, M. S. Eller, U. S. Nehal, and B. 
A. Gilchrest. 2000. Mechanisms and implications of the age-associated 
decrease in DNA repair capacity. Faseb J 14: 1325-1334. 
128. Chen, J. H., C. N. Hales, and S. E. Ozanne. 2007. DNA damage, 
cellular senescence and organismal ageing: causal or correlative? Nucleic 
Acids Res 35: 7417-7428. 
129. Singh, N. P., D. B. Danner, R. R. Tice, L. Brant, and E. L. 
Schneider. 1990. DNA damage and repair with age in individual human 
lymphocytes. Mutat Res 237: 123-130. 
 152 
130. Mayer, P. J., C. S. Lange, M. O. Bradley, and W. W. Nichols. 1989. 
Age-dependent decline in rejoining of X-ray-induced DNA double-strand 
breaks in normal human lymphocytes. Mutat Res 219: 95-100. 
131. Garm, C., M. Moreno-Villanueva, A. Burkle, I. Petersen, V. A. Bohr, 
K. Christensen, and T. Stevnsner. 2013. Age and gender effects on DNA 
strand break repair in peripheral blood mononuclear cells. Aging Cell 12: 
58-66. 
132. Longtine, M. S., A. McKenzie, 3rd, D. J. Demarini, N. G. Shah, A. 
Wach, A. Brachat, P. Philippsen, and J. R. Pringle. 1998. Additional 
modules for versatile and economical PCR-based gene deletion and 
modification in Saccharomyces cerevisiae. Yeast 14: 953-961. 
133. Ide, S., T. Miyazaki, H. Maki, and T. Kobayashi. 2010. Abundance 
of ribosomal RNA gene copies maintains genome integrity. Science 327: 
693-696. 
134. Hoffman, C. S., and F. Winston. 1987. A ten-minute DNA 
preparation from yeast efficiently releases autonomous plasmids for 
transformation of Escherichia coli. Gene 57: 267-272. 
135. Gietz, D., A. St Jean, R. A. Woods, and R. H. Schiestl. 1992. 
Improved method for high efficiency transformation of intact yeast cells. 
Nucleic Acids Res 20: 1425. 
136. Dang, W., G. L. Sutphin, J. A. Dorsey, G. L. Otte, K. Cao, R. M. 
Perry, J. J. Wanat, D. Saviolaki, C. J. Murakami, S. Tsuchiyama, B. 
Robison, B. D. Gregory, M. Vermeulen, R. Shiekhattar, F. B. Johnson, B. 
 153 
K. Kennedy, M. Kaeberlein, and S. L. Berger. 2014. Inactivation of Yeast 
Isw2 Chromatin Remodeling Enzyme Mimics Longevity Effect of Calorie 
Restriction via Induction of Genotoxic Stress Response. Cell metabolism. 
137. Weitao, T., M. Budd, L. L. Hoopes, and J. L. Campbell. 2003. Dna2 
helicase/nuclease causes replicative fork stalling and double-strand 
breaks in the ribosomal DNA of Saccharomyces cerevisiae. J Biol Chem 
278: 22513-22522. 
138. Park, P. U., M. McVey, and L. Guarente. 2002. Separation of 
mother and daughter cells. Methods in enzymology 351: 468-477. 
139. Tamburini, B. A., and J. K. Tyler. 2005. Localized histone 
acetylation and deacetylation triggered by the homologous recombination 
pathway of double-strand DNA repair. Mol Cell Biol 25: 4903-4913. 
140. Chen, C. C., J. J. Carson, J. Feser, B. Tamburini, S. Zabaronick, J. 
Linger, and J. K. Tyler. 2008. Acetylated lysine 56 on histone H3 drives 
chromatin assembly after repair and signals for the completion of repair. 
Cell 134: 231-243. 
141. Szilard, R. K., P. E. Jacques, L. Laramee, B. Cheng, S. Galicia, A. 
R. Bataille, M. Yeung, M. Mendez, M. Bergeron, F. Robert, and D. 
Durocher. 2010. Systematic identification of fragile sites via genome-wide 
location analysis of gamma-H2AX. Nat Struct Mol Biol 17: 299-305. 
142. Lindstrom, D. L., C. K. Leverich, K. A. Henderson, and D. E. 
Gottschling. 2011. Replicative age induces mitotic recombination in the 
 154 
ribosomal RNA gene cluster of Saccharomyces cerevisiae. PLoS Genet 7: 
e1002015. 
143. Stults, D. M., M. W. Killen, E. P. Williamson, J. S. Hourigan, H. D. 
Vargas, S. M. Arnold, J. A. Moscow, and A. J. Pierce. 2009. Human rRNA 
gene clusters are recombinational hotspots in cancer. Cancer Res 69: 
9096-9104. 
144. Huang, J., and D. Moazed. 2003. Association of the RENT complex 
with nontranscribed and coding regions of rDNA and a regional 
requirement for the replication fork block protein Fob1 in rDNA silencing. 
Genes Dev 17: 2162-2176. 
145. Ganley, A. R., K. Hayashi, T. Horiuchi, and T. Kobayashi. 2005. 
Identifying gene-independent noncoding functional elements in the yeast 
ribosomal DNA by phylogenetic footprinting. Proc Natl Acad Sci U S A 
102: 11787-11792. 
146. Cesarini, E., F. R. Mariotti, F. Cioci, and G. Camilloni. 2010. RNA 
polymerase I transcription silences noncoding RNAs at the ribosomal DNA 
locus in Saccharomyces cerevisiae. Eukaryot Cell 9: 325-335. 
147. Heidinger-Pauli, J. M., O. Mert, C. Davenport, V. Guacci, and D. 
Koshland. 2010. Systematic reduction of cohesin differentially affects 
chromosome segregation, condensation, and DNA repair. Curr Biol 20: 
957-963. 
148. Laloraya, S., V. Guacci, and D. Koshland. 2000. Chromosomal 
addresses of the cohesin component Mcd1p. J Cell Biol 151: 1047-1056. 
 155 
149. Saka, K., S. Ide, A. R. Ganley, and T. Kobayashi. 2013. Cellular 
senescence in yeast is regulated by rDNA noncoding transcription. Curr 
Biol 23: 1794-1798. 
150. Freitas, A. A., and J. P. de Magalhaes. 2011. A review and 
appraisal of the DNA damage theory of ageing. Mutat Res 728: 12-22. 
151. Burhans, W. C., and M. Weinberger. 2012. DNA damage and DNA 
replication stress in yeast models of aging. Sub-cellular biochemistry 57: 
187-206. 
152. Kyng, K. J., A. May, T. Stevnsner, K. G. Becker, S. Kolvra, and V. 
A. Bohr. 2005. Gene expression responses to DNA damage are altered in 
human aging and in Werner Syndrome. Oncogene 24: 5026-5042. 
153. Park, P. U., P. A. Defossez, and L. Guarente. 1999. Effects of 
mutations in DNA repair genes on formation of ribosomal DNA circles and 
life span in Saccharomyces cerevisiae. Mol Cell Biol 19: 3848-3856. 
154. Weinert, T. A., and L. H. Hartwell. 1988. The RAD9 gene controls 
the cell cycle response to DNA damage in Saccharomyces cerevisiae. 
Science 241: 317-322. 
155. Stark, G. R., and W. R. Taylor. 2004. Analyzing the G2/M 
checkpoint. Methods Mol Biol 280: 51-82. 
156. Renkawitz, J., C. A. Lademann, and S. Jentsch. 2014. Mechanisms 
and principles of homology search during recombination. Nat Rev Mol Cell 
Biol 15: 369-383. 
 156 
157. Lister, L. M., A. Kouznetsova, L. A. Hyslop, D. Kalleas, S. L. Pace, 
J. C. Barel, A. Nathan, V. Floros, C. Adelfalk, Y. Watanabe, R. 
Jessberger, T. B. Kirkwood, C. Hoog, and M. Herbert. 2010. Age-related 
meiotic segregation errors in mammalian oocytes are preceded by 
depletion of cohesin and Sgo2. Curr Biol 20: 1511-1521. 
158. Chiang, T., F. E. Duncan, K. Schindler, R. M. Schultz, and M. A. 
Lampson. 2010. Evidence that weakened centromere cohesion is a 
leading cause of age-related aneuploidy in oocytes. Curr Biol 20: 1522-
1528. 
159. Brooker, A. S., and K. M. Berkowitz. 2014. The roles of cohesins in 
mitosis, meiosis, and human health and disease. Methods Mol Biol 1170: 
229-266. 
160. Peters, J. M., A. Tedeschi, and J. Schmitz. 2008. The cohesin 
complex and its roles in chromosome biology. Genes Dev 22: 3089-3114. 
161. Kunisada, T., H. Yamagishi, Z. Ogita, T. Kirakawa, and Y. Mitsui. 
1985. Appearance of extrachromosomal circular DNAs during in vivo and 
in vitro ageing of mammalian cells. Mech Ageing Dev 29: 89-99. 
162. Cohen, Z., and S. Lavi. 2009. Replication independent formation of 
extrachromosomal circular DNA in mammalian cell-free system. PLoS 
One 4: e6126. 
163. Cabral, M., X. Cheng, S. Singh, and A. S. Ivessa. 2016. Absence of 
Non-histone Protein Complexes at Natural Chromosomal Pause Sites 
 157 
Results in Reduced Replication Pausing in Aging Yeast Cells. Cell reports 
17: 1747-1754. 
164. Delabaere, L., H. A. Ertl, D. J. Massey, C. M. Hofley, F. Sohail, E. 
J. Bienenstock, H. Sebastian, I. Chiolo, and J. R. LaRocque. 2016. Aging 
impairs double-strand break repair by homologous recombination in 
Drosophila germ cells. Aging Cell. 
165. Saeki, T., I. Machida, and S. Nakai. 1980. Genetic control of diploid 
recovery after gamma-irradiation in the yeast Saccharomyces cerevisiae. 
Mutat Res 73: 251-265. 
166. Muris, D. F., K. Vreeken, A. M. Carr, B. C. Broughton, A. R. 
Lehmann, P. H. Lohman, and A. Pastink. 1993. Cloning the RAD51 
homologue of Schizosaccharomyces pombe. Nucleic Acids Res 21: 4586-
4591. 
167. Sonoda, E., M. S. Sasaki, J. M. Buerstedde, O. Bezzubova, A. 
Shinohara, H. Ogawa, M. Takata, Y. Yamaguchi-Iwai, and S. Takeda. 
1998. Rad51-deficient vertebrate cells accumulate chromosomal breaks 
prior to cell death. Embo J 17: 598-608. 
168. Tsuzuki, T., Y. Fujii, K. Sakumi, Y. Tominaga, K. Nakao, M. 
Sekiguchi, A. Matsushiro, Y. Yoshimura, and MoritaT. 1996. Targeted 
disruption of the Rad51 gene leads to lethality in embryonic mice. Proc 
Natl Acad Sci U S A 93: 6236-6240. 
 158 
169. Richardson, C., J. M. Stark, M. Ommundsen, and M. Jasin. 2004. 
Rad51 overexpression promotes alternative double-strand break repair 
pathways and genome instability. Oncogene 23: 546-553. 
170. Paffett, K. S., J. A. Clikeman, S. Palmer, and J. A. Nickoloff. 2005. 
Overexpression of Rad51 inhibits double-strand break-induced 
homologous recombination but does not affect gene conversion tract 
lengths. DNA Repair (Amst) 4: 687-698. 
171. Klein, H. L. 2008. The consequences of Rad51 overexpression for 
normal and tumor cells. DNA Repair (Amst) 7: 686-693. 
172. Bressan, D. A., B. K. Baxter, and J. H. Petrini. 1999. The Mre11-
Rad50-Xrs2 protein complex facilitates homologous recombination-based 
double-strand break repair in Saccharomyces cerevisiae. Mol Cell Biol 19: 
7681-7687. 
173. Schild, D., and C. Wiese. 2010. Overexpression of RAD51 
suppresses recombination defects: a possible mechanism to reverse 
genomic instability. Nucleic Acids Res 38: 1061-1070. 
174. Bindra, R. S., P. J. Schaffer, A. Meng, J. Woo, K. Maseide, M. E. 
Roth, P. Lizardi, D. W. Hedley, R. G. Bristow, and P. M. Glazer. 2004. 
Down-regulation of Rad51 and decreased homologous recombination in 
hypoxic cancer cells. Mol Cell Biol 24: 8504-8518. 
175. Raderschall, E., K. Stout, S. Freier, V. Suckow, S. Schweiger, and 
T. Haaf. 2002. Elevated levels of Rad51 recombination protein in tumor 
cells. Cancer Res 62: 219-225. 
 159 
176. Yuan, S. S., M. F. Hou, Y. C. Hsieh, C. Y. Huang, Y. C. Lee, Y. J. 
Chen, and S. Lo. 2012. Role of MRE11 in cell proliferation, tumor 
invasion, and DNA repair in breast cancer. Journal of the National Cancer 
Institute 104: 1485-1502. 
177. Van Holde, K. E. 1989. Chromatin. Springer-Verlag, New York. 
178. Ransom, M., B. K. Dennehey, and J. K. Tyler. 2010. Chaperoning 
histones during DNA replication and repair. Cell 140: 183-195. 
179. Venkatesh, S., and J. L. Workman. 2015. Histone exchange, 
chromatin structure and the regulation of transcription. Nat Rev Mol Cell 
Biol 16: 178-189. 
180. Filipescu, D., S. Muller, and G. Almouzni. 2014. Histone H3 
variants and their chaperones during development and disease: 
contributing to epigenetic control. Annu Rev Cell Dev Biol 30: 615-646. 
181. Neumann, H., S. M. Hancock, R. Buning, A. Routh, L. Chapman, J. 
Somers, T. Owen-Hughes, J. van Noort, D. Rhodes, and J. W. Chin. 2009. 
A method for genetically installing site-specific acetylation in recombinant 
histones defines the effects of H3 K56 acetylation. Molecular cell 36: 153-
163. 
182. North, J. A., J. C. Shimko, S. Javaid, A. M. Mooney, M. A. Shoffner, 
S. D. Rose, R. Bundschuh, R. Fishel, J. J. Ottesen, and M. G. Poirier. 
2012. Regulation of the nucleosome unwrapping rate controls DNA 
accessibility. Nucleic acids research 40: 10215-10227. 
 160 
183. Williams, S. K., D. Truong, and J. K. Tyler. 2008. Acetylation in the 
globular core of histone H3 on lysine-56 promotes chromatin disassembly 
during transcriptional activation. Proc Natl Acad Sci U S A 105: 9000-
9005. 
184. Marzluff, W. F., E. J. Wagner, and R. J. Duronio. 2008. Metabolism 
and regulation of canonical histone mRNAs: life without a poly(A) tail. 
Nature reviews. Genetics 9: 843-854. 
185. Kouzarides, T. 2007. Chromatin modifications and their function. 
Cell 128: 693-705. 
186. Xie, W., C. Song, N. L. Young, A. S. Sperling, F. Xu, R. Sridharan, 
A. E. Conway, B. A. Garcia, K. Plath, A. T. Clark, and M. Grunstein. 2009. 
Histone h3 lysine 56 acetylation is linked to the core transcriptional 
network in human embryonic stem cells. Mol Cell 33: 417-427. 
187. Das, C., M. S. Lucia, K. C. Hansen, and J. K. Tyler. 2009. 
CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459: 
113-117. 
188. Tan, Y., Y. Xue, C. Song, and M. Grunstein. 2013. Acetylated 
histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell 
pluripotency. Proceedings of the National Academy of Sciences of the 
United States of America 110: 11493-11498. 
189. Skalska, L., R. Stojnic, J. Li, B. Fischer, G. Cerda-Moya, H. Sakai, 
S. Tajbakhsh, S. Russell, B. Adryan, and S. J. Bray. 2015. Chromatin 
 161 
signatures at Notch-regulated enhancers reveal large-scale changes in 
H3K56ac upon activation. The EMBO journal 34: 1889-1904. 
190. Jack, A. P., S. Bussemer, M. Hahn, S. Punzeler, M. Snyder, M. 
Wells, G. Csankovszki, I. Solovei, G. Schotta, and S. B. Hake. 2013. 
H3K56me3 is a novel, conserved heterochromatic mark that largely but 
not completely overlaps with H3K9me3 in both regulation and localization. 
PloS one 8: e51765. 
191. Liu, Y., D. L. Wang, S. Chen, L. Zhao, and F. L. Sun. 2012. 
Oncogene Ras/phosphatidylinositol 3-kinase signaling targets histone H3 
acetylation at lysine 56. The Journal of biological chemistry 287: 41469-
41480. 
192. Yu, Y., C. Song, Q. Zhang, P. A. DiMaggio, B. A. Garcia, A. York, 
M. F. Carey, and M. Grunstein. 2012. Histone H3 lysine 56 methylation 
regulates DNA replication through its interaction with PCNA. Mol Cell 46: 
7-17. 
193. Gu, B., K. Watanabe, and X. Dai. 2012. Pygo2 regulates histone 
gene expression and H3 K56 acetylation in human mammary epithelial 
cells. Cell cycle 11: 79-87. 
194. Lo, K. A., M. K. Bauchmann, A. P. Baumann, C. J. Donahue, M. A. 
Thiede, L. S. Hayes, S. A. des Etages, and E. Fraenkel. 2011. Genome-
wide profiling of H3K56 acetylation and transcription factor binding sites in 
human adipocytes. PloS one 6: e19778. 
 162 
195. Saenz Robles, M. T., C. Shivalila, J. Wano, S. Sorrells, A. Roos, 
and J. M. Pipas. 2013. Two independent regions of simian virus 40 T 
antigen increase CBP/p300 levels, alter patterns of cellular histone 
acetylation, and immortalize primary cells. J Virol 87: 13499-13509. 
196. Ura, H., K. Murakami, T. Akagi, K. Kinoshita, S. Yamaguchi, S. 
Masui, H. Niwa, H. Koide, and T. Yokota. 2011. Eed/Sox2 regulatory loop 
controls ES cell self-renewal through histone methylation and acetylation. 
EMBO J 30: 2190-2204. 
197. Dutta, D., S. Ray, P. Home, B. Saha, S. Wang, N. Sheibani, O. 
Tawfik, N. Cheng, and S. Paul. 2010. Regulation of angiogenesis by 
histone chaperone HIRA-mediated incorporation of lysine 56-acetylated 
histone H3.3 at chromatin domains of endothelial genes. J Biol Chem 285: 
41567-41577. 
198. Drogaris, P., V. Villeneuve, C. Pomies, E. H. Lee, V. Bourdeau, E. 
Bonneil, G. Ferbeyre, A. Verreault, and P. Thibault. 2012. Histone 
deacetylase inhibitors globally enhance h3/h4 tail acetylation without 
affecting h3 lysine 56 acetylation. Scientific reports 2: 220. 
199. Williams, S. K., D. Truong, and J. K. Tyler. 2008. Acetylation in the 
globular core of histone H3 on lysine-56 promotes chromatin disassembly 
during transcriptional activation. Proceedings of the National Academy of 
Sciences of the United States of America 105: 9000-9005. 
 163 
200. Yuan, J., M. Pu, Z. Zhang, and Z. Lou. 2009. Histone H3-K56 
acetylation is important for genomic stability in mammals. Cell Cycle 8: 
1747-1753. 
201. Pal, S., H. Graves, R. Ohsawa, T. H. Huang, P. Wang, L. 
Harmacek, and J. Tyler. 2016. The Commercial Antibodies Widely Used to 
Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila 
Cells. PLoS One 11: e0155409. 
202. Zhu, Q., A. Battu, A. Ray, G. Wani, J. Qian, J. He, Q. E. Wang, and 
A. A. Wani. 2015. Damaged DNA-binding protein down-regulates 
epigenetic mark H3K56Ac through histone deacetylase 1 and 2. Mutat 
Res 776: 16-23. 
203. Etchegaray, J. P., L. Chavez, Y. Huang, K. N. Ross, J. Choi, B. 
Martinez-Pastor, R. M. Walsh, C. A. Sommer, M. Lienhard, A. Gladden, S. 
Kugel, D. M. Silberman, S. Ramaswamy, G. Mostoslavsky, K. 
Hochedlinger, A. Goren, A. Rao, and R. Mostoslavsky. 2015. The histone 
deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated 
production of 5-hydroxymethylcytosine. Nat Cell Biol 17: 545-557. 
204. Toiber, D., F. Erdel, K. Bouazoune, D. M. Silberman, L. Zhong, P. 
Mulligan, C. Sebastian, C. Cosentino, B. Martinez-Pastor, S. Giacosa, A. 
D'Urso, A. M. Naar, R. Kingston, K. Rippe, and R. Mostoslavsky. 2013. 
SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability 
through chromatin remodeling. Mol Cell 51: 454-468. 
 164 
205. Liu, J., K. McConnell, M. Dixon, and B. R. Calvi. 2012. Analysis of 
model replication origins in Drosophila reveals new aspects of the 
chromatin landscape and its relationship to origin activity and the 
prereplicative complex. Molecular biology of the cell 23: 200-212. 
206. Kawakami, K., A. Nakamura, and S. Goto. 2012. Dietary restriction 
increases site-specific histone H3 acetylation in rat liver: possible 
modulation by sirtuins. Biochem Biophys Res Commun 418: 836-840. 
207. Kong, S., S. J. Kim, B. Sandal, S. M. Lee, B. Gao, D. D. Zhang, and 
D. Fang. 2011. The type III histone deacetylase Sirt1 protein suppresses 
p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to 
inhibit T cell activation. J Biol Chem 286: 16967-16975. 
208. Miller, K. M., J. V. Tjeertes, J. Coates, G. Legube, S. E. Polo, S. 
Britton, and S. P. Jackson. 2010. Human HDAC1 and HDAC2 function in 
the DNA-damage response to promote DNA nonhomologous end-joining. 
Nat Struct Mol Biol 17: 1144-1151. 
209. Dovey, O. M., C. T. Foster, and S. M. Cowley. 2010. Histone 
deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell 
differentiation. Proc Natl Acad Sci U S A 107: 8242-8247. 
210. Michishita, E., R. A. McCord, L. D. Boxer, M. F. Barber, T. Hong, O. 
Gozani, and K. F. Chua. 2009. Cell cycle-dependent deacetylation of 
telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8: 2664-
2666. 
 165 
211. Stejskal, S., K. Stepka, L. Tesarova, K. Stejskal, M. Matejkova, P. 
Simara, Z. Zdrahal, and I. Koutna. 2015. Cell cycle-dependent changes in 
H3K56ac in human cells. Cell Cycle 14: 3851-3863. 
212. Maroschik, B., A. Gurtler, A. Kramer, U. Rossler, M. Gomolka, S. 
Hornhardt, S. Mortl, and A. A. Friedl. 2014. Radiation-induced alterations 
of histone post-translational modification levels in lymphoblastoid cell 
lines. Radiat Oncol 9: 15. 
213. Li, B., T. Su, R. Ferrari, J. Y. Li, and S. K. Kurdistani. 2014. A 
unique epigenetic signature is associated with active DNA replication loci 
in human embryonic stem cells. Epigenetics : official journal of the DNA 
Methylation Society 9: 257-267. 
214. Chen, H., M. Fan, L. M. Pfeffer, and R. N. Laribee. 2012. The 
histone H3 lysine 56 acetylation pathway is regulated by target of 
rapamycin (TOR) signaling and functions directly in ribosomal RNA 
biogenesis. Nucleic Acids Res 40: 6534-6546. 
215. Vempati, R. K., and D. Haldar. 2012. DNA damage in the presence 
of chemical genotoxic agents induce acetylation of H3K56 and H4K16 but 
not H3K9 in mammalian cells. Mol Biol Rep 39: 303-308. 
216. Battu, A., A. Ray, and A. A. Wani. 2011. ASF1A and ATM regulate 
H3K56-mediated cell-cycle checkpoint recovery in response to UV 
irradiation. Nucleic Acids Res 39: 7931-7945. 
217. Vempati, R. K., R. S. Jayani, D. Notani, A. Sengupta, S. Galande, 
and D. Haldar. 2010. p300-mediated acetylation of histone H3 lysine 56 
 166 
functions in DNA damage response in mammals. J Biol Chem 285: 28553-
28564. 
218. Tjeertes, J. V., K. M. Miller, and S. P. Jackson. 2009. Screen for 
DNA-damage-responsive histone modifications identifies H3K9Ac and 
H3K56Ac in human cells. EMBO J 28: 1878-1889. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 167 
Vita 
 
Sangita Pal was born in Berhampore, West Bengal, India on September 
27th, 1983, the younger daughter of Dr. Ranjan Kumar Pal and Mrs. Puspa Pal. 
After graduating from Barasat Girls’ High School in Barasat, West Bengal in 
2002, she attended West Bengal University of Animal and Fishery Sciences in 
Kolkata, India and received her Bachelor’s degree in Veterinary Medicine in 
2007. In January of 2008, she started to pursue her Master’s degree with a major 
in Biological Sciences at The University of Texas at El Paso, El Paso, Texas and 
earned her Master’s degree in 2010. In 2010 fall, she entered The University of 
Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical 
Sciences to pursue her doctoral studies majoring in Biomedical Sciences. A year 
later in 2011, she joined the Genes and Development graduate program and 
performed her dissertation research under the guidance of Dr. Jessica Tyler. 
 
Permanent address: 
57/16, Sitalatala Road,  
Barasat, West Bengal, India, 700124. 
 
 
